{"title": "PDF", "author": "PDF", "url": "https://www.tdx.cat/bitstream/10803/457744/1/jgcp1de1.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "ADVERTIMENT. T\u02bcacc\u00e9s als continguts d\u02bcaquesta tesi queda condicionat a l\u02bcacceptaci\u00f3 de les condicions d\u02bc\u00fas\nestablertes per la seg\u00fcent llic\u00e8ncia Creative Commons: http://cat.creativecommons.org/?page_id=184\nADVERTENCIA. El acceso a los contenidos de esta tesis queda condicionado a la aceptaci\u00f3n de las condiciones de uso\nestablecidas por la siguiente licencia Creative Commons: http://es.creativecommons.org/blog/licencias/\nWARNING. _he access to the contents of this doctoral thesis it is limited to the acceptance of the use conditions set\nby the following Creative Commons license: https://creativecommons.org/licenses/?lang=en\n \n  \n \nCampylobacter spp. en granjas de pollos de \nengorde: diversidad gen\u00e9tica, resistencia \nantimicr obiana y factores de virulencia  \n \n \n  \n \n \n \n \nJuan Guillermo Cantero Portillo  \nTesis Doctoral  \nBellaterra, 2017  \n   \n  \n \n \n \n   \n  \n \nCampylobacter spp. in broiler farms: genetic \ndiversity, antimicrobial resistance and \nvirulence factors  \n \n \n \n \n \n \n \n \nJuan Guillermo Cantero Portillo  \nPhD Thesis  \nBellaterra, 2017   \n    \n \n \n \n \n \nCampylobacter spp. en granjas de pollos de engorde: \ndiversidad gen\u00e9tica, resistencia antimicrobiana y factores \nde virulencia  \n \n \nTesis doctoral presentada por Juan Guillermo Cantero Portillo para optar al \ngrado de Doctor dentro del programa de Doctorado en Medicina y Sanidad \nAnimales del Departamento de Sanidad y Anatom\u00eda Animales de la Facultad de \nVeterinaria de la Universitat Aut\u00f2 noma  de Barcelona , bajo la direcci\u00f3n de la Dra. \nMarta Cerd\u00e0 Cu \u00e9llar  y la tutor\u00eda de l Dr. Antonio Ramis Salv\u00e1.  \n \nBellaterra,  2017 \n \n \n \n    \n La Dra. Marta Cerd\u00e0 Cu\u00e9llar, investigadora del  Centro de investigaci\u00f3n de \nSanidad Animal del Instituto de Investigaci\u00f3n  y Tecnolog\u00eda Agroalimentaria s \n(CReSA -IRTA) como directora de esta tesis y el Dr. Antonio Ramis Salv\u00e1 , profesor \ntitular del Departament o de Sanidad y  Anatom\u00eda  Animal es de la Facultad de \nVeterinaria de la Universidad  Aut\u00f3noma de Barcelona (UAB) y  tutor de esta tesis . \n \nCertifican : \nQue la  memoria titulada \u00ab Campylobacter spp. en granjas de pollos de engorde: \ndiversidad gen\u00e9tica, resistencia antimicrobiana y factores de virulencia \u00bb \npresentada po r Juan Guillermo Cantero Portillo  para la obtenci\u00f3n del grado \nDoctor en Medicina y Sani dad Animal,  se ha realizado bajo su direcci\u00f3n y \nsupervisi\u00f3n.  \n \nY para que as\u00ed conste a los efectos oportunos, firman el presente certificado en \nBellaterra (Barcelona), el 08 de junio del 2017.  \n \n \nDra. Marta Cerd\u00e0 -Cu\u00e9llar    Dr. Antonio Ramis Salv\u00e1  \nDirectora       Tutor  \n \nJuan Guillermo Cantero Portillo  \nDoctorando   \n Los estudios de doctorado presentado s por Juan Guillermo Cantero Portillo fueron \napoyados financieramente por el PROGRAMA DE BECAS DE POSTGRADO DE \nITAIPU \u2013 Paraguay.  \n   \n Dedicatoria  \n   \n  \n   \n Agradecimiento  \n   \n  \n   \n  \n   \n  \n   \nI \n TABLA DE CONTENIDO \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026... \u2026 I \nLISTA DE ABR EVIACIONES\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026... \u2026\u2026\u2026\u2026  V \nSUMMARY \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026... \u2026\u2026\u2026\u2026.  VII \nRESUMEN \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026... \u2026\u2026\u2026\u2026\u2026.. X \nRESUM \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026  XIII \nPUBLICACION ES\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026\u2026\u2026.  XVII  \n \nPARTE I: INTRODUCCION GENERAL Y OBJETIVOS  \n1. Introducci\u00f3n General \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. \u2026\u2026..5 \n2. Taxonom\u00eda de  Campylobacter \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026... ..7 \n2.1 El g\u00e9nero de Campylobacter \u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. \u2026\u2026\u2026\u20268 \n2.1.1 Caracter\u00edsticas microbiol\u00f3gicas y de cultivo \u2026\u2026\u2026\u2026... \u2026 10 \n2.1.2 Aislamiento e  identificaci\u00f3n\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026 \u2026.. 11 \n3. Signos cl\u00ednicos de la campilobacteriosis \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026 \u2026\u2026.  13 \n4. Aspectos Epidemiol\u00f3gicos del Campylobacter \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026.. \u2026.. 14 \n4.1 Transmisi\u00f3n de Campylobacter \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026..  15 \n4.1.1Fuentes y transmisi\u00f3n en humanos\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026.. 15 \n4.1.2  Transmisi\u00f3n horizontal en aves\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026 17 \n4.1.3 Transmisi \u00f3n vertical en aves\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026  19 \n4.2 Estacionalidad de la campilobacteriosis \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026  20 \n4.3 Campilobacteriosis: el papel de la carne de  aves de corral.. ..... 21 \n5. Patog\u00e9nesis de la campylobacteriosis \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026..  22 \n5.1 Motilidad\u2026\u2026\u2026\u2026\u2026.. \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026...  23 \n5.2 Quimiotaxis\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026\u2026  25 \n5.3 Adhesi\u00f3n\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026.  26 \n5.4 Invasi\u00f3n\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026\u2026\u2026  27 \n5.5 Producci\u00f3n de toxinas\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026.. \u2026\u2026\u2026.  28  \nII \n 5.6 Resistencia a las sales biliares y a antimicrobianos\u2026\u2026 \u2026\u2026\u2026 \u2026 29 \n5.7 Respuesta al estr\u00e9s y supervivencia\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026\u2026\u2026  30 \n6. Tratamiento \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026  30 \n7. Tipificaci\u00f3n de Campylobacte r\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026\u2026\u2026 . 31 \n7.1 M\u00e9todos fenot\u00edpicos \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026.. \u2026\u2026\u2026\u2026\u2026.  31 \n7.2 M\u00e9todos genot\u00edpicos \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026.  32 \n7.2.1 Pulsed -field gel electropho resis ( PFGE) \u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026..  33 \n7.2.2 Multilocus Sequence  Typing  (MLST )\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026..  36 \n7.2.3 Whole genome Sequencing  (WGS )\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026.  37 \n8. Antimicrobianos \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026  38 \n8.1 Resistencia antimicrobiana \u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026..\u2026\u2026\u2026.  39 \n8.2 Tipo  de resistencia antimicrobiana \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026. . 41 \n8.2.1 Natural o intr\u00ednseca\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. \u2026\u2026\u2026\u2026 \u2026\u2026\u2026 \u2026\u2026\u2026\u2026..  41 \n8.2.2 Adquirida\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026 \u2026\u2026\u2026..  41 \n8.3 Genes de resistencia\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026 \u2026\u2026.. 41 \n8.4 Principales mecanismos de resistencia antimicrobiana \u2026\u2026\u2026.. 42 \n8.4.1 Modificaci\u00f3n enzim\u00e1tica del antibi\u00f3tico \u2026\u2026\u2026 \u2026\u2026\u2026 \u2026\u2026 42 \n8.4.2 Bombas de eflujo \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026\u2026\u2026  42 \n8.4.3 Cambios en la permeabilidad de la membrana externa \nde la bacteria \u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.......................... ...\u202642 \n8.4.4 Alteraciones de las dianas del antibi\u00f3tico \u2026\u2026\u2026. \u2026\u2026\u2026\u2026  43 \n8.5 Mecanismo de Resistencia en Campylobacter \u2026\u2026\u2026\u2026\u2026 \u2026...\u2026\u2026.  43 \n8.5.1 Resistencia a fluoroquinolonas\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026 \u2026\u2026 43 \n8.5.2 Resistencia a macr\u00f3lidos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026 44 \n8.5.2.1  Resistencia a \u03b2 -lact\u00e1micos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026..  45 \n8.5.3 Resistencia a tetraciclinas\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026. 45 \n8.5.4 Resistencia a aminogluc\u00f3sidos\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026  46 \n8.5.5 Resistencia a cloranfenicol\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026. \u2026\u2026\u2026  46   \nIII \n 9. Utilizaci\u00f3n de  antimicrobianos en la industria av\u00edcola \u2026\u2026\u2026\u2026\u2026\u2026.  47 \nObjetivos \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026...\u2026\u2026..  51 \n \nPART II: STUDIES  \nStudy I\u2026\u2026\u2026\u2026\u2026. \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026..\u2026\u2026 55 \nAbstract \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 .\u2026\u2026. \u2026. 57 \nIntroduction \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026.  58 \nMaterials and methods \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026..  60 \nResults \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026.. \u2026\u2026\u2026\u2026  63 \nDiscussion \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026.. \u2026\u2026\u2026.  77 \nStudy  II\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026.\u2026. 83 \nAbstract \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026.  85 \nIntroduction \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026\u2026.  86 \nMaterials and methods \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026\u2026..  88 \nResults\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026  90 \nDiscussion\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026.  98 \nStudy  III\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026  103  \nAbstract\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026.. \u2026\u2026\u2026\u2026.  105  \nIntroduction\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.  106  \nMaterials and methods \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..  107  \nResults \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026.. \u2026\u2026\u2026\u2026\u2026\u2026\u2026  111  \nDiscussion\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026.. \u2026\u2026\u2026\u2026\u2026\u2026.  119  \n \nPARTE III: CONCLUSIONES  GENERALES  \nConclusiones\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026.  125  \nReferencias \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026. \u2026\u2026\u2026.  129  \n \n    \nV \n LISTA DE ABREVIACIONES  \nCCDA  Charcoal cefoperazone deoxycholate agar  \nCDT  Cytolethal distending t oxin  \nCFU  Colony form units  \nDNA  Deoxyribonucleic  acid  \nECDC  European Centre for Disease Prevention and Control  \nEFSA  European Food Safety Authority  \nEM*  Estados Miembros*  \nEU European Union  \nISO International Organization for S tandardization  \nKb Kilo base  \nPb Pares de bases  \nLPS o LOS Lipopolisacharide o lipopolis\u00e1carido  \nMLST  Multilocus sequence t yping  \nSTs Sequence type o secuencia tipo  \nCC Clonal Complex  o complejo clonal  \nPFGE   Pulsed Field Gel Electrophoresis  \nWGS   Whole Genomic Sequence  \nPBS  Phosphate buffer solution  \nPCR  Polymerase Chain Reaction  \nSGB*   S\u00edndrome de G uillain -Barr\u00e9*  \nUFC*  Unidad Formadora de Colonias*  \nUE*  Uni\u00f3n Europea*  \nUV*  Ultravioleta*  \nWHO  World Health  Organization  \nCGE   Center for Genomic Epidemiologic  \nNCBI  National  Center for Biotechnology Information   \nVI \n SNPs  Polimorfismo de nucle\u00f3tido  \u00fanico*  \n*Del castellano  \n \n    \nVII \n SUMMARY  \nCamp ylobacteriosis is the most commonly reported food -borne zoonosis in the \nEuropean Union (EU) since 2005. The main source of infection is the consumption \nof chicken meat contaminated with Campylobacter  (mainly  C. jejuni  and C. coli ). \nThe high prevalence of Campylobacter  in broiler s on  farm represents a high risk of \ncontamination of the final product and thereby the risk  of infection for the \nconsumer. Therefore,  it is a priority for the EU to prevent and reduce the number \nof Campylobacter  positive batches at slaughter age . For this , it is necessary  to gain \ninsight into  the behaviour and epidemiology of this pathogen. Thus , within the \nframework of this PhD thesis  we performed a number of studies:  (i) we studied \nthe diversity and dynamics of Campylobacter  strains from  broiler s on  farm; (ii) we \ncharacterized the isolates in terms  of resistance against a panel of antimicrobials \nand the presence of  virulence -associated  genes; (iii) we characterized in depth a \nselection of isolates by whole genome sequencing , anal ysing the mechanisms for \nresistance, the distribution of virulence -associated  gene s, the genotypes and their \nphylogenetic relations hip. The isolates of these stud ies came from a two-year \nlongitudinal study, performed in five different farms from Catalonia. From the \nCampylobacter -positive crops , randomly selected isolates from different birds \nalong the rearing cycles  were pres erved.  \nIn order to study in depth the diversity, seasonality and dynamics of \nCampylobacter  strains circulating in farms, molecular typi ng of the isolates was \nperformed using Pulsed Field Gel Electrophoresis  (PFGE) and Multilocus Sequence \nTyping (MLST). By PFGE and using two restriction enzymes, a total of 343 isolates \nwere analysed ( C. jejuni  n = 254  and C. coli  n = 89) and overall 92 macrorestriction \nprofiles (between 12 and 24 profiles per farm) were identified.  Overall, a  large  \ngenotypic diversity was detected, identifying mostly between 1 and 2 different \ngenotypes pe r crop , although not isolated from successive crop s. On the other \nhand, it was observed persisten t genotypes within the same crop  along  the rearing \ncycle . When c omparing the isolates from different farms, common C. jejuni   \nVIII \n genotypes among  different farms were found. A total of 127 isolates were selected \n(93 C. jejuni  and 34 C. coli ) from the different PFGE genotypes, which were \nanalysed by MLST,  and high genetic diversity was observed as well . The C. jejuni  \nisolates were grouped in 15 diff erent clonal complexes (CC) distributed in 34 \nsequence types (ST), whereas the C. coli  isolates were all grouped within the \nCC828, distributed in 12 STs. In addition, we identified five novel STs of C. jejuni  \nand two of C. coli . Certain s easonality was obs erved for some  CC. The CC21 and \nCC206 were found along the year, except during the coldest trimester, being more \ncommonly found during the warmer months.  \nIn the second study, we evaluated the susceptibility of the 344 isolates against a \npanel of 12 antimic robials of different  families using the disc diffusion method. \nResistance to quinolones (nalidixic acid and ciprofloxacin) was the most frequen t, \nfollowed by tetracyclines. This represents a major public health problem, given \nthat these are the drugs of ch oice  for treating human enteric infections. In \ncontrast, resistance against erythromycin and gentamycin were the less prevalent. \nAll the analysed isolates were sensitive to chloramphenicol, amoxicillin + \nclav ulanate, imipenem and meropenem.  A 62,2 % of all the isolates were multi drug \nresistant, being nalidixic acid, ciprofloxacin, enrofloxacin, tetracycline, doxicycline  \nand ampicillin, the most frequent profile. On the other hand, 14 virulence genes \ninvolved in colonization and infection were analysed, and a heterogeneous \ndistribution in the analysed isolates was observed. It is worth noting the detection \nof the wlaN gene in 19% of the isolates; this gene is involved in  the Guillain -Barr\u00e9 \nsyndrome, a serious neurological syndrome that may develop after Campy lobacter  \ninfection.  \nIn the last study, whole genome sequencing using the Illumina platform  was \nperformed in 16 C. jejuni  and C. coli  isolates for their in -depth characterization. \nHigh throughput sequencing ha s become a po werful , fast and accessible tool f or \ncharacterizing pathogens such as Campylobacter  in epidemiological studies.    \nIX \n Data obtained in this PhD  thesis confirms the genetic diversity of Campylobacter  in \nbroilers and the great complexity of strain dynamics on farm. This may be the \nmain factor that  hampers  effective control strategies of this bacteri um on farm. \nLikewise, the high frequency  of resistan t and multiresista nt strains isolated from \nbroilers highlight  the importance of making the producers an  d/or managers of \nintensive poultry production aware about the prudent  use of antimicrobials. \nEffective bios ecurity  measures to control Campylobacter  in the farm , not only \nwould reduce  the high prevalence of positive batches at slaughter age , but \nindirectly  would  also improve the overall san itary status of the farms. This would \nlower the need for the therapeutic use of antibiotics and would probably  lead to  a \nreduction in resistant strains.  \n \n \n \n \n \n   \nX \n RESUMEN  \nLa campilobacteriosis es la zoonosis de transmisi\u00f3n alimentaria m\u00e1s com\u00fanmente \nreportada  en la Uni\u00f3n Europea (UE)  desde 2005. La principal fuente de infecci\u00f3n \nes el consumo o manipulaci\u00f3n de carne de pollo contaminada con Campylobacter  \n(principalmente C. jejuni  y C. coli). La alta prevalencia de Campylobacter  en pollos \nde engorde en granja supone un elevado riesgo de contaminaci\u00f3n del producto \nfinal y por ende el riesgo de infecci\u00f3n para el consumidor. Es por ello que para la \nUE es prioritaria la prevenci\u00f3n y reducci\u00f3n del n\u00famero de lotes positivos a \nCampyloba cter en edad de sacrificio. De ah\u00ed la importancia de conocer en \nprofundidad el comportamiento y la epidemiologia de este pat\u00f3geno. De este \nmodo, en el marco de esta tesis (i) se estudi\u00f3 la diversidad y din\u00e1mica de cepas de \nCampylobacter de pollos de engord e en granja; (ii) se caracterizaron los aislados \ndesde el punto de vista de resistencia a un panel de antimicrobianos as\u00ed como de \ngenes de virulencia; (iii) se caracteriz\u00f3 en profundidad una selecci\u00f3n de aislados \nmediante secuenciaci\u00f3n masiva, analizando l os mecanismos de resistencia, \ndistribuci\u00f3n de genes de virulencia, genotipo y relaciones filogen\u00e9ticas. Los \naislados objeto de estudio proceden de un estudio longitudinal previo, realizado \ndurante dos a\u00f1os en cinco granjas de Catalu\u00f1a. De aquellos lotes po sitivos a \nCampylobacter se conservaron una serie de aislados al azar de diferentes \nindividuos a lo largo de cada crianza.  \nPara estudiar en profundidad la diversidad, estacionalidad y din\u00e1mica de cepas de \nCampylobacter  circulantes en las granjas, se realiz \u00f3 la tipificaci\u00f3n molecular de los \naislados utilizando las t\u00e9cnicas de electroforesis en campo pulsado (PFGE) y \nmultilocus  sequence  typing  (MLST). Mediante PFGE y utilizando dos enzimas de \nrestricci\u00f3n, se analizaron un total de 343 aislados (254 de  C. jejuni y 89 de C. coli ) y \nse identificaron un total de 92 perfiles diferentes de macrorestricci\u00f3n (de 12 a 24 \nperfiles por granja). Globalmente, detectamos  una gran diversidad genot\u00edpica, \nidentifica ndo mayoritariamente entre 1 y 2 genotipos diferentes p or crianza , pero \nque no se aislaron en crianzas sucesivas. Por otro lado, observamos persistencia   \nXI \n de algunos genotipos dentro de un mismo lote a lo largo de la crianza. Al comparar \nlos aislados de las diferentes granjas, encontramos genotipos comunes de C. jejuni  \nentre diferentes granjas. De los diferentes genotipos obtenidos mediante PFGE, \nseleccionamos un total de 127 aislados (93 de  C. jejuni y 34 de  C. coli ) que \nanalizamos mediante MLST, encontrando igualmente una gran diversidad \ngen\u00e9tica. Los aislados de C. jejuni  se agruparon en 15 complejos clonales (CC) \ndistribuidos en 34 secuencias tipo (ST), mientras que los aislados de  C. coli  se \nagruparon en su totalidad dentro del CC828 distribuidos en 12 STs. Adem\u00e1s, \nidentificamos cinco STs nuevos de C. jejuni  y dos de C. coli . Se observ\u00f3 cierta \nestacionalidad en determinados CC. Los CC21 y CC206 se encontraban a lo largo \ndel a\u00f1o, excepto  durante el trimestre m\u00e1s fr \u00edo, siendo m\u00e1s frecuentes en los meses \nm\u00e1s c\u00e1lidos. Por otro lado el CC48 se observ\u00f3 \u00fanicamente en  los meses m\u00e1s \nc\u00e1lidos.  \nEn el segundo estudio, evaluamos el perfil de susceptibilidad de 344 aislados \nfrente a un panel de 12 antimicrobianos de diferentes familias, utilizando el \nm\u00e9todo de difusi\u00f3n en disco. La resistencia a quinolonas (\u00e1cido nalid\u00edxico y \nciprofloxacina) fue la m\u00e1s prevalente, seguida de tetraciclinas. Esto representa un \nproblema de salud p\u00fablica importante puesto que \u00e9stos son los agentes m\u00e1s \nusados para tratar infecciones ent\u00e9ricas humanas. Por el contrario, las resistencias \na eritromic ina y gentamicina  fueron las menos prevalentes. Todos los aisla dos \nanalizados fueron sensibles a cloranfenicol, amoxicilina + clavulanato, imipenem y \nmeropenem.  Un 62,2 % de los aislados fueron multiresistentes, siendo el perfil de \nresistencia m\u00e1s frecuente : \u00e1cido nalidixico, ciprofloxacina, enrofloxacina, \ntetraciclina, doxiciclina y ampicilina. Por otro lado, analizamos 14 genes de \nvirulencia involucrados en la colonizaci\u00f3n e infecci\u00f3n, donde observamos una \ndistribuci\u00f3n heterog\u00e9nea de los mismos, en los ais lados analizados. Cabe destacar \nla detecci\u00f3n del gen wlaN en un 19% de aislados; este gen est\u00e1 relacionado con el \ns\u00edndrome de Guillain -Barr\u00e9, un s\u00edndrome neurol\u00f3gico grave que puede \ndesarrollarse tras una infecci\u00f3n por Campylobacter .   \nXII \n En el \u00faltimo estudio se realiz\u00f3 la secuenciaci\u00f3n del genoma completo, mediante la \nplataforma Illumina, de un total de 16 aislados de C. jejuni  y C. coli  para su \ncaracterizaci\u00f3n en profundidad. La tecnolog\u00eda de secuenciaci\u00f3n masiva se ha \nconvertido en una herramienta potente, r\u00e1pida y asequible para caracterizar \npat\u00f3genos de inter\u00e9s como  Campylobacter en estudios epidemiol\u00f3gicos.  \nLos datos obtenidos en esta tesis confirman la diversidad gen\u00e9tica de \nCampylobacter  en los pollos de engorde y la gran complejidad de la din\u00e1mica de \ncepas circulantes en granja. Ello probablemente sea el principal factor que dificulta \nconseguir estrategias eficaces de control de la bacteria en granja. Por otro lado, la \nelevada proporci\u00f3n  de cepas resistentes y multiresistentes  a antibi\u00f3ticos, aisladas \nde pollos de engorde ponen de relieve la importancia de concienciar a los \nproductores y/o encargados de la producci\u00f3n intensiva sobre el uso prudente de \nantimicrobianos. Unas medidas de bios eguridad efectivas para el control de \nCampylobacter  en granja, no s\u00f3lo conseguir\u00edan reducir la alta prevalencia de lotes \npositivos a edad de sacrificio, sino que indirectamente mejorar\u00edan el estatus \nsanitario general de la granja. Ello conllevar\u00eda una meno r necesidad del uso \nterap\u00e9utico de antibi\u00f3ticos y probablemente una reducci\u00f3n de cepas resistentes.  \n \n \n \n    \nXIII \n RESUM  \nLa campilobacteriosi \u00e9s la zoonosi de transmissi\u00f3 aliment\u00e0ria m\u00e9s comunament \nreportada a la Uni\u00f3 Europea (UE) des de 2005. La principal font d\u2019i nfecci\u00f3 \u00e9s el \nconsum o manipulaci\u00f3 de carn de pollastre contaminada amb Campylobacter  \n(principalment C. jejuni  i C. coli ). L\u2019alta prevalen\u00e7a de Campylobacter  en pollastres \nd\u2019engreix a granja suposa un elevat risc de contaminaci\u00f3 del  producte final i per \ntant el risc d\u2019infecci\u00f3 pel consumidor. \u00c9s per aix\u00f2, que per  a la UE \u00e9s priorit\u00e0ria la \nprevenci\u00f3 i reducci\u00f3 del nombre de lots positius a Campylobacter en edat de \nsacrifici. D\u2019aqu\u00ed la import\u00e0ncia de con\u00e8ixer en profunditat el comportament i \nl\u2019epidemiologia d\u2019aquest patogen. Aix\u00ed, en el marc d\u2019aquesta tesi, es va (i) estudiar \nla diversitat i din\u00e0mica de soques de Campylobacter  de pollastres d\u2019engreix a \ngranja; (ii) es van caracteritzar els a\u00efllaments des del punt  de vista de resist\u00e8ncia a \nun venta ll d\u2019antimicrobians aix\u00ed com de gens de virul\u00e8ncia; (iii) es va caracteritzar \nen profunditat una selecci\u00f3 d\u2019a\u00efllaments mitjan\u00e7ant seq\u00fcenciaci\u00f3 massiva, \nanalitzant els mecanismes de resist\u00e8ncia, distribuci\u00f3 de gens de viru l\u00e8ncia, genotip \ni relacions filogen\u00e8tiques. Els a\u00efllaments objecte d\u2019estudi procedien d\u2019un estudi \nlongitudinal previ, realitzat durant dos anys en cinc granges de Catalunya. D el \nconjunt de  lots positius a Campylobacter  es van conservar una s\u00e8rie d\u2019a\u00efllamen ts a \nl\u2019atzar de diferents individus al llarg de cada crian\u00e7a.  \nPer estudiar en profunditat la diversitat, estacionalitat i din\u00e0mica de soques de \nCampylobacter  circulants a les granges, es va realitzar la tipificaci\u00f3 molecular dels \na\u00efllaments utilitzant les  t\u00e8cniques d\u2019electroforesi en camp polsat (PFGE) i \nmultilocus  sequence  typing  (MLST). Mitjan\u00e7ant PFGE i utilitzant dos enzims de \nrestricci\u00f3, es van analitzar un total de 343  a\u00efllaments (25 4 de C. jejuni  i 89 de C. \ncoli) i es van identificar un total de 92 perfils diferents de macrorestricci\u00f3 (de 12 a \n24 perfils per granja). Globalment, v am detectar una gran diversitat genot\u00edpica, \nidentificant majorit\u00e0riament entre 1 i 2 genotips diferents per crian\u00e7a, per\u00f2 que no \nes van a\u00efllar  en criances successives. D\u2019altra banda, va m observar persist\u00e8ncia \nd\u2019alguns genotips dins d\u2019un mateix lot al llarg de la crian\u00e7a. En comparar els  \nXIV \n a\u00efllaments de les diferents granges, va m trobar genotips comuns de C. jejuni  entre \ngranges . Dels diferents genotips obtinguts mitjan\u00e7ant PFGE , vam seleccionar un \ntotal de 127 a\u00efllaments (93 de C. jejuni  i 34 de C. coli ) que va m analitzar mitjan\u00e7ant \nMLST, trobant igualment una gran diversitat gen\u00e8tica. Els a\u00efllaments de C. jejuni  es \nvan agrupar en 1 5 complexes clonals (CC) distribu\u00efts en 34 seq\u00fc \u00e8ncies tipus (ST), \nmentre que els a\u00efllaments de C. coli  es van agrupar en la seva totalitat dins del \nCC828 distribu\u00efts en 12 STs. A m\u00e9s, vam  identificar cinc STs no us per  aC. jejuni  i \ndos per a C. coli . Es va observar certa estacionalitat en determinats CC . Els CC21 i \nCC206 es trobaven al llarg de l\u2019any, excepte durant el trimestre m\u00e9s fred , sent m\u00e9s \nfreq\u00fcents en els mesos m\u00e9s c\u00e0lids. Per altra banda, el CC48 es va observar \n\u00fanicament en els mesos m\u00e9s c\u00e0lids.  \nEn el segon estudi, va m avaluar el perfil de sus ceptibilitat dels 344 a\u00efllaments \nenfront un panell de 12 antimicrobians de diferents fam\u00edlies, utilitzant el m\u00e8tode \nde difusi\u00f3 en disc. La resist\u00e8ncia a quinolones (\u00e0cid nalid\u00edxic i ci profloxacina) va \nser la m\u00e9s prevalent, seguida de  la resist\u00e8ncia a les  tetraciclines. Aquest fet \nrepresenta un problema de salut p\u00fablic a important donat  que aquests s\u00f3n els \nagents antimicrobians m\u00e9s utilitzats per tractar infeccions ent\u00e8riques humanes. \nPer contra, les resist\u00e8ncies a eritromicina i gentamicina van ser les men ys \nprevalents. Tots els a\u00efllaments analitzats van ser sensibles a cloramfenicol, \namoxicil\u00b7lina + \u00e0cid clavul\u00e0nic, imipenem i meropenem. Un 62,2 % dels a\u00efllaments \nvan ser multiresistents, sent el perfil m\u00e9s freq\u00fcent: \u00e0cid nalid\u00edxic, ciprofloxacina, \nenrofloxa cina, tetraciclina, doxiciclina i ampicil\u00b7lina. Per altra banda, va m analitzar \n14 gens de virul\u00e8ncia involucrats en la colonitzaci\u00f3 i infecci\u00f3, i vam observar una \ndistribuci\u00f3 heterog\u00e8nia dels mateixos en els a\u00efllaments analitzats. Cal destacar la \ndetecci\u00f3 del gen wlaN en un 19%  dels a\u00efllaments  analitzats ; aquest gen est\u00e0 \nrelacionat amb el s\u00edndrome de Guillain -Barr\u00e9, un a s\u00edndrome neurol\u00f2gic a greu que \nes pot desenvolupar despr\u00e9s d\u2019una infecci\u00f3 per Campylobacter .  \nEn l\u2019\u00faltim estudi es va realitzar la seq\u00fcencia ci\u00f3 del genoma complet, mitjan\u00e7ant la \nplataforma Illumina, d\u2019un total de 16 a\u00efllaments de C. jejuni  i C. coli  per a la seva   \nXV \n caracteritzaci\u00f3 en profunditat. La tecnologia de seq\u00fcenciaci\u00f3 massiva s\u2019ha \nconvertit en una eina potent, r\u00e0pida i assequible per car acteritzar pat\u00f2gens \nd\u2019inter\u00e8s com Campylobacter en estudis epidemiol\u00f2gics.  \nLes dades obtingudes en aquesta tesi confirmen la diversitat gen\u00e8tica de \nCampylobacter  en els pollastres d\u2019engreix i la gran complexitat de la din\u00e0mica de \nsoques circulants a granj a. Aix\u00f2 probablement sigui el principal factor que dificulta \naconseguir estrat\u00e8gies eficaces de control del bacteri a granja. Per altra banda, les \nelevades resist\u00e8ncies i multiresist\u00e8ncies a antibi\u00f2tics que presenten les soques de \nCampylobacter  a\u00efllades de  pollastres d\u2019engreix posen de manifest la import\u00e0ncia \nde conscienciar als productors i/o encarregats de la producci\u00f3 intensiva sobre l\u2019\u00fas \nprudent dels antimicrobians. Unes mesures de bioseguretat efectives pel control \nde Campylobacter  a granja, no nom\u00e9s a conseguirien reduir l\u2019alta prevalen\u00e7a de lots \npositius a edat de sacrifici, sin\u00f3 que indirectament millorarien l\u2019estatus sanitari \ngeneral de la granja. Aix\u00f2 comportaria una menor necessitat de l\u2019\u00fas d\u2019antibi\u00f2tics i \nprobablement una reducci\u00f3 de soques resist ents.    \n \n   \nXVII  \n PUBLICACIONES  \nLos resultados presenta dos en esta tesis se han enviado o est\u00e1n en preparaci\u00f3n \npara sumisi\u00f3n a revistas cient\u00edficas internacionales indexadas:  \nGuillermo Cantero, Florencia Correa -Fiz, Troels Ronco, Mikael  Strube, Marta \nCerd\u00e0 -Cu\u00e9llar, Karl Pederse n. 2017. Characterization of Campylobacter jejuni  \nand Cam pylobacter coli  broiler isolates by whole genome sequencing. \nFoodborne  Pathogens and Disease. Manuscrito submitido y bajo revisi\u00f3n.  \nGuillermo Cantero, Marta Cerd\u00e0 -Cu\u00e9llar . Long term dynamics and diversity of \nCampylobacter  strains in broiler farms . Manuscrito en p reparaci\u00f3n  para  su \nsubmisi\u00f3 n. \nGuillermo Cantero, Marta Cerd\u00e0 -Cu\u00e9llar . Antimicrobial resistance and virulence \nfactors of  C. jejuni  and C.  coli isolated  from broilers along a two -year period . \nManuscrito e n preparaci\u00f3n  para  su submisi\u00f3n   \n \n  \n    \n  \n \n \n \n \nPARTE I  \nIntroducci\u00f3n g eneral y Objetivos  \n   \n \n  \n    \n  \n \n \n \n \nIntroducci\u00f3n g eneral  \n   \n \n  \n  Introducci\u00f3n general  \n5 \n  1. Introducci\u00f3n general  \nLa campilobacteriosis (infecci\u00f3n por Campylobacter ) es la zoonosis de transmisi\u00f3n \nalimentaria m\u00e1s com\u00fanmente reportada en la Uni\u00f3n Europea (UE) en la \u00faltima \nd\u00e9cada (EFSA, 2016) , as\u00ed como en la mayor\u00eda de los pa\u00edses desarrollados y en v\u00edas \nde desarrollo (WHO, 2011) . Sin embargo, en los \u00faltimos a\u00f1os los casos de \nsalmonelosis hay ido disminuyendo debido al efecto de los programas de control \nimplementados, en contrapartida, los casos de campilobacteriosis siguen \naumentando. Desde 2005, Campylobacter ha superado  en n\u00famero a Salmonella \ncomo la causa m\u00e1s com\u00fanmente reportada de enfermedad diarreica bacteriana en \nhumanos en la UE (EFSA, 2014) . \nEl n\u00famero de casos confirmados en la UE ha ido en ascenso desde 2005 \nalcanzando en 2014 un total de 236.851 casos, seg\u00fan \u00faltimos datos de la \nAutoridad Europea de Seguridad Alimentaria (EFSA) y el Centro Europeo para la \nprevenci\u00f3n y el Control de Enfermedades (ECDC) (EFSA, 2016)  (Fig. 1). Sin \nembargo, se estima que la incidencia real de la enfermedad es entre 7,6 a 100 \nveces mayor que la reportada (Mead et al., 1999; Samuel et a l., 2004; Skirrow and \nBlaser, 1992) . Dada la importancia de la campilobacteriosis, la EFSA ha hecho \nhincapi\u00e9 en la importancia de realizar una vigilancia activa de esta zoonosis en \ntodos los estados miembros, intensificando los esfuerzos para determinar  y \ncomunicar todos los posibles casos de campilobacteriosis.  \n \n \n  Introducci\u00f3n genera l \n6 \n Figura 1.  Tasa de notificaci\u00f3n de zoonosis declaradas en casos humanos \nconfirmados en la UE, 2015. EFSA Journal 2016; 14(12):4634.  \n \nNota: Total de casos confirmados indicado en el extremo de cada barra.  \n \nFigura 2.  Evoluci\u00f3n de los casos humanos confirmados de campilobacteriosis en la \nUE/EEA, para el periodo 2008 -2015.  EFSA Journal 2016; 14(12):4634.  \n \n  \nN = 229213N = 94625N = 7202N = 5901N = 2206N = 1079N = 872N = 833N = 437N = 170N = 156N = 127N = 0\nCampilobacteriosisSalmonellosisYersiniosisSTEC infetionsListeriosisTularaemiaEchinococcosisQ feverBrucellosisTB caused by M. bobisTrichinellosisWest Nile fever Rabies\n10 20 30 40 50 60 70Z\no\no\nn\no\ns\ni\ns\nTasa de notificaci\u00f3n por 100.000 habitantes \n Introducci\u00f3n general  \n7 \n  2. Taxonom\u00eda de  Campylobacter  \nCampylobacter  spp., se asoci \u00f3 durante mucho tiempo como causa de enfermedades \nveterinarias, como la diarrea en el ganado bovino y los abortos s\u00e9pticos en bovinos \ny ovinos. En el a\u00f1o 1886, Theodor Escherich, observ\u00f3 unas bacterias no cultivables \nen forma de espiral en el contenido de c olon de neonatos y gatitos que hab\u00edan \nmuerto a consecuencia del c\u00f3lera infantum (Escherich, 1886) . \nEn 1913, McFadyean y Stockman realizaron la primera identificaci\u00f3n de \nCampylobacter  en asociaci\u00f3n con fetos abortados de ovinos (Crushell et al., 2004) . \nEn 1918 Smith descubri\u00f3 unas bacterias en forma de espiral en fetos de bovinos \nabortados, llegando a la conclusi\u00f3n que estas cepas y los vibriones de McFadyean y \nStockman pertenec\u00edan a la misma especie, por lo cual propuso el nombre de Vibrio \nfetus  (Smith, T ., Taylor, 1919) .  \nEn 1957, Elizabeth King  propuso dos tipos diferentes de  vibrios  implicados en \ninfecciones ent\u00e9ricas, denominando  a uno de ellos como Vibrio fetus y destacando  \nen el otro su caracter\u00edstica de vibrio term\u00f3filo ( V. jejuni y V. coli ), (King, 1957) . En \n1963,  bas\u00e1ndose en caracter\u00edsticas fenot\u00edpicas (composici\u00f3n de la base de ADN, \nrequerimientos de m icroaerofilia y metabolismo no fermentativo), se propuso la \ncreaci\u00f3n del g\u00e9nero Campylobacter , que deriva de dos palabras griegas que \nsignifican \u201cbast\u00f3n curvo\u201d (Veron, 1963) . Diez a\u00f1os m\u00e1s tarde, V\u00e9ron y Chatelain \nesclarecieron la taxonom\u00eda del g\u00e9nero reclasific \u00e1ndolo  en cuatro especies \ndistintas: Campylobacter fetus, Campylobacter coli, Campylobacter jejuni y \nCampylobacter sputorum . Desde entonces se desarrol laron diferentes m\u00e9todos y \nmedios de cultivos para su aislamiento (Chatelain, 1973) . \nLa dificultad y el fracaso de cultivar y aislar Campylobacter  de las heces se \natribu\u00edan al recrecimiento de las bacterias coliformes y los requerimient os \nnutricionales de este microorganismo. Posteriormente esta dificultad fue superada \nimplementando un m\u00e9todo de filtraci\u00f3n. Este m\u00e9todo implic\u00f3 el filtrado de heces Introducci\u00f3n genera l \n8 \n mediante filtros de 0,64 \u03bcm que dejaban pasar a las campilobacterias m\u00e1s \npeque\u00f1as y m\u00f3viles . Posteriormente el producto del filtrado se inoculaba en \nmedios selectivos (Butzler, J et al., 1973) . Este m\u00e9todo demostr\u00f3 ser demasiado \ncomplicado y en 1977, Martin Skirrow describi\u00f3 una t\u00e9cnica de siembra directa de \nheces en agar sangre suplementada con vancomicina, polimixina B y  trimetroprim, \nque facilitaba el examen de rutina de muestras fecales humanas (Skirrow, 1977) . \nDesde entonces, se han realizado varias modificaciones metodol\u00f3gicas, \npermitiendo as\u00ed la adopci\u00f3n universa l de tales m\u00e9todos y sus variantes en los \nlaboratorios de diagn \u00f3stico cl\u00ednico microbiol\u00f3gico para el aislamiento e \nidentificaci\u00f3n de Campylobacter  a partir de muestras fecales humanas. Los \nm\u00e9todos mejorados de aislamiento llevaron a la publicaci\u00f3n del primer informe \nsobre la frecuencia de la campilobacteriosis en asociaci\u00f3n con los seres humanos, \nlo que condujo a una avalancha de investigaciones epi demiol\u00f3gicas, y por \nconsiguiente, a la comprensi\u00f3n de que las campilobacterias eran un importante \nproblema de salud p\u00fablica para los pa\u00edses desarrollados y en v\u00edas de desarrollo  \n(On, 2013) . \nLas metodolog\u00edas de aislamiento desarrolladas permitieron el aislamiento de \nCampylobacter  a partir de diversas fuentes (humanas, animales y ambientales ), lo \ncual  condujo a proponer nuevas especies. A consecuencia de este hecho, la \ntaxonom\u00eda fue re -evaluada y se propus o una nueva familia bacteriana, \ndenominada Campylobacteraceae  (Vandamme and De ley, 199 1). Actualmente esta \nfamilia est\u00e1 constituida por cuatro g\u00e9neros diferentes: Campylobacter, Arcobacter, \nSulfurospirillum  y Dehalospirillum.   \n2.1 G\u00e9nero Campylobacter  \nLos miembros del genero Campylobacter  pertenecen a la Familia \nCampylobacteraceae , Orden Campylobacterales , Clase Epsilonproteobacteria , \nPhylum Proteobacteria. Aunque la estructura taxon\u00f3mica del g \u00e9nero  Introducci\u00f3n general  \n9 \n  Campylobacter  ha sufrido grandes cambios a lo largo del tiempo e incluso en la \nactualidad, la taxonom\u00eda del g\u00e9nero es un tema bastante controv ertido , que \nrequiere un mayor estudio (Debruyne et al., 2005; On, 2001) . Dentro del g\u00e9nero de \nCampylobacter  se han descrito 34 especies y 14 subespecies \n(http://www.bacterio.net ) (Tabla 1). Alguna s de estas bacterias son comensales, \npero las especies term\u00f3filas , principalmente  C. jejuni  (sub -especie jejuni ) y C. coli , \nson pat\u00f3genos ent\u00e9ricos de humanos y animales dom\u00e9sticos (Notermans, 1994) . \nAdem\u00e1s, se han aislado otras especies term\u00f3filas como C. lari  y C. upsaliensis  en \npacientes con enfermedades diarreicas, pero notificados con menor frecuenc ia \n(WHO, 2011) . \nTabla 1.  Especies descri tas y validadas dentro del g\u00e9nero Campylobacter.  \n \n Especies de Campylobacter Fuente A\u00f1o\nC. avium \u00a0 Aves de corral 2009\nC. butzleri \u00a0 Humanos, cerdos, bovinos 1991\nC. canadensis \u00a0 Aves silvestres 2007\nC. cinaedi \u00a0 Humanos 1988\nC. coli \u00a0 Cerdos, ovejas, ganado vacuno, aves \nde corral, aves silvestres1973\nC. concisus \u00a0 Humanos, mascotas 1981\nC. corcagiensis \u00a0 Primates 2014\nC. cryaerophilus \u00a0 Bovinos, porcinos, ovejas 1985\nC. cuniculorum \u00a0 Conejos 2009\nC. curvus \u00a0 Humanos 1991\nC.\u00a0fennelliae \u00a0 Humanos 1988\nC. fetus \u00a0 Bovinos 1963\n    C. \u00a0fetus \u00a0subsp.\u00a0 fetus \u00a0 Bovinos, ovejas y reptiles 1973\n    C. fetus \u00a0subsp.\u00a0 testudinum \u00a0 Reptiles 2014\n    C. fetus \u00a0subsp.\u00a0 venerealis \u00a0 Bovinos, ovejas 1973\nC. gracilis \u00a0 Humanos 1995\nC.\u00a0helveticus \u00a0 Perros, gatos 1993\nC. hominis \u00a0 Humanos 2001\nC. hyoilei \u00a0 Porcinos 1995\nC. hyointestinalis \u00a0 Porcinos 1985\n    C. hyointestinalis \u00a0subsp.\u00a0 hyointestinalis \u00a0 Bovinos, porcinos 1995\n    C. hyointestinalis \u00a0subsp.\u00a0 lawsonii \u00a0 Porcinos 1995\nC.\u00a0iguaniorum \u00a0 Reptiles 2015\nC.\u00a0insulaenigrae \u00a0 Mamiferos marinos 2004Introducci\u00f3n genera l \n10 \n Tabla 1.  Continuaci\u00f3n . Especies descriptas y validadas dentro del g\u00e9nero \nCampylobacter.  \n \n \n2.1.1 Caracter\u00edsticas microbiol\u00f3gicas y de cultivo  \nCampylobacter spp., son bacilos gram negativos, de aproximadamente 0,2 a 0,8 \u03bcm \nde ancho x 0,5 a 5 \u03bcm de largo, en su mayor\u00eda delgados, en forma de S o curvados \n Especies de Campylobacter Fuente A\u00f1o\nC.\u00a0jejuni \u00a0 Aves de corral, bovinos, ovejas, aves \nsilvestres, cerdos1973\n    C. \u00a0jejuni \u00a0subsp.\u00a0 jejuni \u00a0 Bovinos, ovejas, cerdos, aves de \ncorral, aves silvestres1988\n    C. \u00a0jejuni \u00a0subsp.\u00a0 doylei \u00a0 Humanos 1988\nC.\u00a0lari\u00a0 Aves de corral, gatos, aves silvestres, \nperros1984\n    C. \u00a0lari\u00a0subsp.\u00a0 concheus \u00a0 Mariscos 2009\n    C. \u00a0lari\u00a0subsp.\u00a0 lari\u00a0 Perros, gatos, aves de corral, aves \nsilvestres2009\nC.\u00a0lanienae\u00a0 Bovinos, porcinos 2000\nC.\u00a0mucosalis \u00a0 Porcinos 1985\nC. mustelae \u00a0 Hurones 1989\nC.\u00a0nitrofigilis\u00a0 Muestras de sedimentos asociadas a \nlas ra\u00edces1983\nC.\u00a0peloridis Mariscos 2009\nC.\u00a0pylori \u00a0 Humanos 1985\n    C. \u00a0pylori \u00a0subsp.\u00a0 Mustelae Hurones 1988\n    C. \u00a0pylori \u00a0subsp.\u00a0 Pylori Hurones 1988\nC.\u00a0rectus \u00a0 Humanos 1991\nC.\u00a0showae Humanos 1993\nC.\u00a0sputorum \u00a0 Bovinos 1973\n    C. sputorum \u00a0subsp.\u00a0 bubulus \u00a0 Bovinos 1973\n    C. \u00a0sputorum \u00a0subsp.\u00a0 mucosalis \u00a0 Bovinos 1981\n    C. \u00a0sputorum \u00a0subsp.\u00a0 sputorum \u00a0 Bovinos 1973\nC. subantarcticus Aves silvestres 2010\nC.\u00a0upsaliensis Perros, gatos 1991\nC.\u00a0ureolyticus \u00a0 Humanos 2010\nC.\u00a0volucris \u00a0 Aves silvestres 2010\nC. sputorum biovar faecalis Ovejas, toros -\nC. sputorum biovar  paraureolyticus Bovinos - \nC. sputorum biovar sputorum Bovinos, porcinos - Introducci\u00f3n general  \n11 \n  en espiral. Poseen un flagelo polar en uno (monotrico) o ambos extremos \n(anfitrico), que en con junto con su forma helicoidal genera un movimiento \ncaracter\u00edstico similar a un sacacorchos o en forma de tirabuz\u00f3n (Ferrero and Lee, \n1988) . Las \u00fanicas excepciones son C. gracilis  que no es m\u00f3vil y C. showae que posee \nm\u00faltiples flagelos (Debruyne et al., 2005) . La relaci\u00f3n de bases G y C del ADN oscila \nentre 27  y 47 %.  \nLas especies del g \u00e9nero Campylobacter  son no esporulad as y no sacarol\u00edticas, para \nsu crecimiento necesitan requerimientos nutricionales y ambientales \u00fanicos, esto \nse atribuye al tama\u00f1o relativamente peque\u00f1o de su genoma (Griffit hs and Park, \n1990) . Crecen en una atm\u00f3sfera microaer\u00f3bica (3 -5% de O2, 10% de CO2 y 85% \nde N) . Campylobacter  spp., poseen actividad oxidasa a excepci\u00f3n de C. gracilis ; no \nfermentan ni oxidan los carbohidratos, en su lugar obtienen energ\u00eda de \namino\u00e1cidos  o productos intermediarios del ciclo tricarboxilico (ciclo de Krebs) \n(Vandamme, 2000) , ade m\u00e1s no metabolizan la glucosa debido a que carecen de la \nenzima glucol\u00edtica 6 -fosfofructoquinasa (PFK) (Kelly, 2001; Velayudhan et al., \n2004) . C. jejuni  hidroliza el hipurato, el acetato de indoxilo y reduce el nitrato.  \nLas campilobacterias crecen a una temperatura \u00f3ptima de 30\u00b0 C a 37 \u00b0  C. Las \nespecies de Campylobacter  term\u00f3filas: C. jejuni, C. coli, C. lari , C. lanienae  y C. \nupsaliensis , son las responsables de ocasionar la campilobacteriosis en los \nhumano s, tienen la capacidad de crecer entre 37 \u00b0 C y 42\u00b0 C, pero son incapaces de \ncrecer por debajo de 30 \u00b0 C, debido a la au sencia de los genes de prote\u00ednas de \nchoque en fr\u00edo, importante s en la adaptaci\u00f3n a baja temperatura (Levin, 2007) .  \n2.1.2 Aislamiento, detecci\u00f3n, y confirmaci\u00f3n  \nLa sensibilidad al ox \u00edgeno y a los radicales oxidantes  que presenta Campylobacte r \nspp., condiciona la composici\u00f3n de los  medios selectivos para su aislamiento. Estos \nmedios selectivos generalmente contienen uno o m\u00e1s captadores de ox \u00edgeno y \nagentes selectivos, particularmente antibi\u00f3ticos. Para el aislamiento de Introducci\u00f3n genera l \n12 \n Campylobacter  spp., la mayor\u00eda de los m\u00e9todos incluyen un paso  previo de  pre-\nenriquecimiento en un medio l \u00edquido  selectivo , en funci\u00f3n  del tipo de muestra , \nseguido de un a siembra en agar selectivo . En la actualidad existen varios caldos \nselectivos, como  el caldo Bolton, el caldo Preston y el caldo de enriquecimiento \npara Campylobacter , as\u00ed como diversos agares selectivos , para aumentar la eficacia \ndel aislamiento de Campylobacter  de muestras cl\u00ednicas y de alimentos . Entre los \nagares selectivos  se encuentran el agar Preston, el agar carb\u00f3n  cefoperazona  \ndesoxicalato  mod ificado  (mCCDA), as\u00ed como el agar Skirrow, Blaser, Butzler y \nCampy -BAP; son medios comerciales que contienen agar brucela, base de agar \nsangre principalmente sangre de ovinos, bovinos o equinos, adem\u00e1s varios \naditivos antibi\u00f3ticos como bacitricina, novobio cina, trimetoprin, actidiona, \ncicloheximida, cefalotina y colistina, que inhiben el crecimiento de los \ncontaminantes y a su vez aumentan la eficacia de aislamiento. La utilizaci\u00f3n de \nmCCDA y la incubaci\u00f3n a 42 \u00b0 C en lugar de 37 \u00b0 C generalmente es la metodo log\u00eda \nde elecci\u00f3n  (ISO Standard 10272 -1:2006), ya que permite el aislamiento de m\u00e1s \ncepas de Campylobacter (Zanetti et al., 2009) . El agar mCCDA , que contiene como \nsuplemento antibi\u00f3tico  cefoperazona  y amfotericina B , es una modificaci\u00f3n del \nmedio original CCDA, que conten\u00eda \u00fanicamente cefazolin a.   \nAdem\u00e1s, se han desarrollado unos m\u00e9todos alternativos y r\u00e1pidos para la \ndetecci\u00f3n y confirmaci\u00f3n de Campylobacter  spp., por ejemplo aquellos q ue \nincluyen hibridaci\u00f3n in  situ  fluorescente (Lehtola MJ et al., 2006) , aglutinaci\u00f3n en  \nl\u00e1tex  y un m\u00e9todo de enriquecimiento mediante filtraci\u00f3n que permite la \nseparaci\u00f3n de Campylobacter  de otros organismos presentes en la matriz del \nalimento (Baggerman and T, 1992) . \nLos m\u00e9todos m\u00e1s eficaces de confirmaci\u00f3n de Campylobacter  son los basados en la \nt\u00e9cnica de la PCR, ya que las reacciones fenot\u00edpicas son a menudo at\u00edpicas y \ndif\u00edciles de interpretar, como en el caso de la prueba de la hidr\u00f3lisis del hipurato \n(hipO ) que se utiliza para diferenciar aislados  de C. jejuni  y C. coli . En la actualidad \nexisten diversos protocolos de PCR que se utilizan para la detecci\u00f3n y  Introducci\u00f3n general  \n13 \n  confirmaci\u00f3n de especies de Campylobacter  term\u00f3filos. Adem\u00e1s, recientemente se \nha dado paso hacia plataformas moleculares m\u00e1s sofisticadas como la PCR en \ntiempo real, que demuestra el potencial de un l\u00edmite de detecci\u00f3n de 1 ufc en \nmuestras de pollo en menos de dos horas (Debretsion et al., 2007) .  \n3. Signos cl\u00ednicos de la campilobacteriosis  \nLas especies de Campylobacter  constituyen un grupo de organismos de gran \ndiversidad biol\u00f3gica. En las infecciones humanas, las dos especies predominantes \nresponsables de trastornos gastrointestinales son C. jejuni  y C. coli . Las infecciones \npor lo general suelen ser leves, pero en oca siones pueden llegar a ser mortales \naunque muy poco frecuentes . La poblaci\u00f3n de mayor riesgo en humanos la \nconstituyen los ni\u00f1os menores de cinco a\u00f1os, los adolescentes y adultos j\u00f3venes \nentre 20 y 40 a\u00f1os, pero tambi\u00e9n puede afectar a adultos mayores de 7 5 a\u00f1os de \nedad  o individuos inmunosuprimidos (WHO, 2011) . A nivel mundial, C. jejuni causa \nentre el 5 % y el 10% de gastroenteritis  en los adultos y ha sido responsable de \nepidemias de diarrea en pa\u00edses en v\u00edas de desarrollo (Coker et al., 2002) . \nLos s\u00edntomas de la campilobacteriosis son variables, pudiendo aparecer entre dos \na cinco d\u00edas post infecci\u00f3n, sin embargo el periodo de incubaci\u00f3n oscila entre uno a \ndiez d\u00edas (WHO, 20 11). En general la dosis infectiva de Campylobacter  es baja ; en \nestudios experimentales en humanos, se han inducido infecciones con tan solo \n500 -800 bacterias (Skirrow and Bla ser, 1992) . La infecci\u00f3n ent\u00e9rica causada por \nCampylobacter puede cursar con una diarrea leve, acuosa, no inflamatoria a una \ndiarrea  inflamatoria severa (Butzler and Skirrow, 1979; van Vliet and Ketley, \n1991; Walker et al., 2011) . Los s\u00edntomas cl\u00ednicos m\u00e1s comunes de la infecci\u00f3n, por \nlo general cursan con dolor abdominal, a menudo con  fiebre, diarrea acuosa de \nleve a profusa, hematoquesia (puede aparecer sangre fresca en las heces al tercer \nd\u00eda), dolor de cabeza, n\u00e1useas y/o v\u00f3mitos y malestar general . Este proceso suele \nser autolimitante en el hombre (Humphrey et al., 2007) . Las complicaciones graves \nson poco frecuentes pero pueden producirse infecciones extra intestinales con Introducci\u00f3n genera l \n14 \n bacteriemia, hemorragias intestinales, hepatitis, pancreatitis, m egacolon t\u00f3xico y \ns\u00edndrome hemol\u00edtico ur\u00e9mico y en algunos casos adenitis mesent\u00e9rica (Humphrey \net al., 2007; Skirrow and Butzler, 2000) . As\u00ed mismo, aunque con una frecuencia \nreducida, entre las secuelas  de la infecci\u00f3n figura la artritis reactiva y los \ns\u00edndrome s de Guillain -Barr\u00e9 (SGB) y de Miller Fisher   (Moore, 2005; Nachamkin et \nal., 1998) . El SGB, es un trastorno a utoinmune grave del sistema nervioso \nperif\u00e9rico que se ha descrito en el 0,1  % de las infecciones humanas producidas \npor C. jejuni (Nachamkin et al., 1998) . El SGB, est\u00e1 asociado a un mimetismo \nmolecular de los lipo -oligosacaridos (LOS) de C. jejuni , que inducen reactividad \ncruzada de anticuerpos en gangli \u00f3sidos y tejido nervioso (Godschalk et al., 2004) . \nEsta complicaci\u00f3n est\u00e1 caracterizada  por una forma de par\u00e1lisis fl\u00e1cida semejante \na la poliomielitis, que puede ocasionar disfunci\u00f3n respiratoria y neurol\u00f3gica grave, \ne incluso la muerte (Nachamkin et al., 1998) . Las tasas de mortalidad de SGB se \nhan reducido de 2 a 3% en los pa\u00edses desarrollados, pero sigue siendo mayor en \npa\u00edses en v\u00edas de desarrollo (de Jager and Sluiter, 1991; Winer and Evans, 1993) . \nEl s\u00edndrome de Miller Fisher  es una variante no paral\u00edtica del SGB.  \n4. Aspectos epidemiol\u00f3gicos del Campylobacter  \nLas bacterias del g\u00e9nero Campylobacter se consideran microorganismos ubicuos \nen el medio ambiente y tienen una distribuci\u00f3n mundial. Las especies term\u00f3filas \nson las que se encuentran ampliamente distribuidas en la mayor\u00eda de los animales \nde sangre caliente y con una elevada prevalencia en los a nimales destinados al \nconsumo como las aves de corral, bovin o, porcino, ovino, avestruces y mariscos; \nlos animales de compa\u00f1\u00eda como perros y gatos tambi\u00e9n son considerados fuentes \nde infecci\u00f3n (Humphrey et al., 2007; WHO, 2011) .  \nSe considera que  las especies term\u00f3filas de Campylobacter forman parte de la \nmicrobiota intestinal natural de mam\u00edferos y aves (silvestres y dom\u00e9sticos), dado \nque aparentemente act\u00faan como portadores asi ntom\u00e1ticos. As\u00ed mismo, se  Introducci\u00f3n general  \n15 \n  encuentran en  fuentes ambientales, especialmente en el agua s superficiales \n(Gharst et al., 2013) . \nLa campilobacteriosis ha sido la zoonosis m\u00e1s com\u00fanmente notificada en los seres \nhumanos en la UE desde el 2005  con una tendencia al alza, a lo la rgo de los a\u00f1os, \naunque  en los \u00faltimos cinco a\u00f1os, la tasa de notificaci\u00f3n se ha mantenido  bastante \nestable (EFSA, 2016) . No obstante , un estudio basado en la serolog\u00eda en la \npoblaci\u00f3n de la UE/EEA, demostr\u00f3 que el n\u00famero de casos humanos notificados \nsolo representa una peque\u00f1a proporci\u00f3n de todas las infecciones cl\u00ednicas por \nCampylobacter spp. (Gibbons et al., 2014) . A pesar de ello , el aumento de los ca sos \nnotificados en algunos pa\u00edses en los \u00faltimos a\u00f1os puede no solo reflejar cambios \nen la exposici\u00f3n, si no tambi\u00e9n mejoras en los sistemas de vigilancia en los Estados \nMiembros (EM) (Emborg et al., 2015) .  \nEn la actualidad no existe una vigilancia armonizada de Campylobacter  en la UE, al \ninterp retar los datos sobre este pat\u00f3geno  en alimentos y animales debido a que \nexiste una variaci\u00f3n en los pa\u00edses que informan sobre los datos del monitoreo de \nCampylobacter  cada a\u00f1o y por otro lado, debido a las diferencias en las estrategias \nde muestreo y los m\u00e9todos de diagn\u00f3 stico en cada pa\u00eds (EFSA, 2016) .   \n4.1. Transmisi\u00f3n de Campylobacter  \n4.1.1 Fuentes y transmisi\u00f3n en humanos  \nLa camp ilobacteriosis es una infecci\u00f3n de origen alimentario . La principal fuente \nde transmisi\u00f3n de Campylobacter  en las personas  se atribuye a la manipulaci\u00f3n y \nconsumo de alimentos contaminados, principalmente carne cruda de pollo  \n(Deckert et al., 2014; Friedman et al., 2004; Kang et al., 2006) , y en menor medida, \nde otros productos alimenticios de origen animal (EFSA, 2 016) . Esto se debe a que \na edad de sacrificio  la mayor\u00eda de los lotes de pollos son positivos a Campylobacter  \ny con una carga bacteri ana elevada.  Los niveles de Campylobacter  en el intestino Introducci\u00f3n genera l \n16 \n de los pollos pueden alcanzar las  109 UFC/gr  de contenido cecal . Si durante el \nprocesado en el matadero se produce una rotura del paquete intestinal, toda la \ncanal se contamina muy f\u00e1cilmente, y con niveles elevados de la bacteria (Shanker \net al., 1990) . \nAs\u00ed pues, c asi todas las partes de la canal de las aves de corral, ya sean frescas, \nrefrigeradas o congeladas est\u00e1n frecu entemente contaminadas con Campylobacter \n(Butzler, 2004) . No obstante, mediante la congelaci\u00f3n se eliminan las bacterias \nviables y por tanto el riesgo de infecci\u00f3n. Se ha estimado que la manipulaci\u00f3n, \npreparaci\u00f3n y consum o de carne de pollo es responsable del 20 al 30% de los \ncasos de campilobacterios is en la UE, mientras que el 50 \u201380% del total de los \ncasos se atribuyen al reservorio en conjunto  (EFSA, 2010) . Por ot ro lado, la \ncontaminaci\u00f3n cruzada de los alimentos supone un factor de riesgo importante \npara contraer la infecci\u00f3n (EFSA, 2013) . \nOtras fuentes de infecci\u00f3n para el humano, incluyen consumir agua no potable \n(Eberhart -Phillips et al. , 1997; Schorr et al., 1994) , el contacto frecuente con \nperros y/o gatos , derivados l\u00e1cteos y leche no pasteurizada, marisco de aguas \ncontaminadas con Campylobacter ,  contacto con aguas contaminadas durante \nactividades recreativas y viajes al extranjero  (Figura 3)  (Altekruse et al., 1999; \nYoung et al. , 2007) . \nLa EFSA, describi\u00f3 algunos factores de riesgo que influyen en las infecciones por \nCampylobacter : la edad (mayores tasas de ocurrencia en ni\u00f1os menores de 5 a\u00f1os), \nla temporada (un mayor n\u00famero de casos de campilobacteriosis se informa \ndurante los meses de verano), la inmunidad del hu\u00e9sped, los viajes y los factores \ndemogr\u00e1ficos (situaci\u00f3n socio -econ\u00f3 mica)  (EFSA, 2007) . \n  Introducci\u00f3n general  \n17 \n    \nFigura 3. Fuentes y consecuencias  de la i nfecci\u00f3n por C. jejuni . Diferentes fuentes \nambientales conducen a la infecci\u00f3n por C. jejuni . Adaptado de Young, Davis, and \nDirita (2007) . \n \n4.1.2 Transmisi\u00f3n horizontal en aves  \nLas especies term\u00f3filas de Campylo bacter son consideradas microorganismos \nubicuos en el medio ambiente, siendo  la transmisi\u00f3n horizontal desde el medio \nambiente la principal v\u00eda de colonizaci\u00f3n en pollos de engorde . Es por ello que  los \nanimales dom\u00e9sticos  presentes en el entorno de las gra njas , los animales silvestres \ny el ambiente externo de la granja  juegan un papel relevante  en la transmisi\u00f3n de \nla Campylobacter  (Humphrey et al., 2007) . En producci\u00f3n intensiva (naves \ncerradas), una vez introducido el pat\u00f3geno dentro de las naves , se disemina \nr\u00e1pidamente por todo el lote y la mayor\u00eda de las aves son colonizadas (Evans and \nSayers, 2000; Gregory et al., 1997; Horrocks et al., 2009) . Estudios recientes \ndemuestran que dicha diseminaci\u00f3n se puede producir  en tan s\u00f3lo 2 -3 d\u00edas \n(Urdaneta, 2016) . \nIntroducci\u00f3n genera l \n18 \n Por lo general , durante las 2 \u20133 primeras sem anas de vida l os pollos de engorde se \nmantienen libres de Campylobacter  (Evans and Sayers, 2000) . A partir de esta \nedad, la resistencia a la colonizaci\u00f3n va disminuyendo, pero se desconocen los \nmotivos de este periodo refractario. Est\u00e1 demostrado que los anticuerpos \nmaternales protegen parcialmente de la infecci\u00f3 n en este periodo, pero estos \nanticuerpos maternales van disminuyendo progresivamente en el tiempo y \ndesaparecen en la tercera semana de edad (S. Cawthraw and Newell 2010) . \nEntre los factores de riesgo de introducci\u00f3n, colonizaci\u00f3n y diseminaci\u00f3n de \nCampylobacter  dentro de las naves de pollos, incluyen la transferencia de la \nbacteria desde los lotes anteriores  (Kapperud et al., 1993; Pearson et al., 1993) , \nedad del  lote, el vaciado parcial (aclarado) , la presencia de m\u00faltiples naves de \npollos en la misma granja, granjas vecinas alrededor  (de aves u otros animales de \nproducci\u00f3n), presencia de animales de compa\u00f1\u00eda en el recinto de la granja,  y \ncharcos alrededor de la nave o granja (Bull et al., 2008; Johnsen et al., 2006) , un \ngran tama\u00f1o del lote, el origen del  agua y fuentes de agua en e l medio ambiente  de \nla granja , basuras, aves silvestres, roedores, tran sporte de equipos, personal de la \ngranja (Horrocks et al., 2009) , la yacija , el pienso (van de Giessen et al., 1996) . \nAdem\u00e1s,  la entrada de insectos, como moscas (Rosef and Kapperud, 1983; Shane \net al., 1985; Urdaneta, 2016) , el calzado contaminado con heces o yacija \ncontaminada  (Ridley et al., 2011) , son considerados como factores de riesgo para \nla coloniza ci\u00f3n por Campylobacter  en pollos de engorde. Por otro lado, el \ntranspor te de las aves de la granja al matadero tambi\u00e9n supone un riesgo de \ncontaminaci\u00f3n de las mismas a trav\u00e9s  de las jaulas y m\u00f3dulos de transporte y \notros equipamientos (Hansson et al., 2005) . \n   Introducci\u00f3n general  \n19 \n  4.1.3 Transmisi\u00f3n vertical en aves  \nLa principal v\u00eda de transmisi\u00f3n  de Campylobacter  en las aves de corral es \nhorizontal, mientras que hace m\u00e1s de una d\u00e9cada que se debate sobre si existe  \ntransmisi\u00f3n vertical  (Agunos et al., 2014; Cox et al., 2012) . Se  ha detectado \nCampylobacter en ambos oviductos de gallinas ponedoras (Buhr et al., 2002; Cox et \nal., 2012; Hiett et al., 2002; Jacobs -Reitsma, 1997)  y en semen de pollos de engorde \ncomerciales (Hiett et al., 2003) . Newell and Fearnley (2003) , demostraron otra \nposible v\u00eda de transmisi\u00f3n vertical de Camp ylobacter , desde la gallina a trav\u00e9s de la \nc\u00e1scara del huevo . Otros estudios han demostrado la presencia de ADN de \nCampylobacter  en las pelusas de la incubadora y tracto intestinal de embriones en \ndesarrollo y pollitos reci\u00e9n nacidos, que apoyan la evidenc ia molecular de que el \npat\u00f3geno puede estar presente en pollitos antes de ser entregados a la granja  \n(Chuma et al., 1997, 1994; Hiett et al., 2003; Idris et al., 2006) . En cambio  otros \nautores no han apoyado la hip\u00f3tesis de que la transmisi\u00f3n vertical contribuya \nsignificativamente a la diseminaci\u00f3n de la bacteria en las granjas av\u00edcolas   (Bull et \nal., 2006; Callicott et al., 2006; O n et al., 2003) . En un estudio reciente realizado en \nEspa\u00f1a, detectaron ADN de Campylobacter  en pollitos de un d\u00eda  de edad  mediante \nla t\u00e9cnica de qPCR, demostrando de esta manera la posibilidad de una transmisi\u00f3n \nvertical, sin embargo por m\u00e9todo de cultivo bacteriano convencional (ISO 10272 -\n2) todos los pollitos muestreados resultaron negativos.  Por otro lado, \nrecientemente Battersby ( 2016)  durante un estudio de evaluaci\u00f3n de patrones de \ncontaminaci\u00f3n por Campylobacter  spp., en granjas de pollos, no detect \u00f3 \ntransmisi\u00f3n ve rtical utilizando la t\u00e9cnica de qPCR.  Adem\u00e1s, otros estudios han \ndemostrado la ausencia de Campylobacter  en huevos f\u00e9rtiles de lotes de gallinas \npositivas, a pesar de haberse recuperado C. jejuni  del intestino y de las heces. Sin \nembargo, se ha demostrado la presencia de Campylobacter  en la c \u00e1scara interna y \nlas membranas del huevo, revelando de esta manera una posible v\u00eda de exposici\u00f3n \npara los pollos incubados (Doyle, 1984) .  \n Introducci\u00f3n genera l \n20 \n 4.2 Estacionalidad de la campilobacteriosis  \nCampylobacter  spp. , presenta una  estacionalidad caracter\u00edstica, con un elevado \naumento de la prevalencia de pollos colonizad os por C. jejuni  y/o C. coli en los \nmeses de verano y principios de oto\u00f1o. En muchos pa\u00edses europeos se ha \nobservado esta misma  estacionalidad en las infecciones por Campylobacter , con un \npico de casos confirmados en los meses de verano (junio - agosto) (Jore et al., \n2010; Nylen et al., 2002) . Curiosamente, en un estudio de caso control realizado en \nSuiza  detectaron picos de campilobacteriosis en  invierno, estos casos se \natribuyeron al consumo de una comida tradicional (fondue de carne, \nespecialmente si se sirve con carne de pollo)  (Bless et al., 2014) . \nPor otro lado, se cree que los cambios en el comportamiento recreat ivo humano, \ncomo hacer barbacoa  y la participaci\u00f3n en actividades al aire libre que resulten en \nla exposici\u00f3n ambiental contribuyen a una mayor incidencia durante el verano \n(Eberhart -Phillips et al., 1997; Nylen et al., 2002) . Los picos estacionales de la \ncampilobacteriosis en humanos, se observan com\u00fanmente en los pa\u00edses \noccidentales con climas templados, mientras que esto es menos marcado en \nAustralia, N ueva Zelanda  y en los pa\u00edses tropicales.  \nPor otro lado, estudios de supervivencia de C. jejuni  en carcasas de pollos expuesta \npara la venta en supermercados, donde se analizaba el efecto d e la temperatura \nambiental sobre el crecimiento de C. jejuni  en diferentes \u00e9poc as del a\u00f1o  \ndemostraron que Campylobacter  spp.  presentaba un pico de positividad  \nprincipalmente durante los meses m\u00e1s c\u00e1lidos (mayo a octubre)  y la prevalencia \nm\u00e1s baja fue durante los meses m\u00e1s  fr\u00edos (diciembre -enero)  (Willis y Murray \n1997) . \n   Introducci\u00f3n general  \n21 \n  4.3 Campilobacteriosis: el papel de la carne de aves de corral  \nLa carne de pollo comprende una fuente sustancial de prote\u00ednas, vitaminas y \nminerales de alta calidad . El pollo magro contiene m\u00e1s prote\u00ednas que la carne \nasada magra y comparativamente el precio de la carne de pollo es m\u00e1s bajo que el \nde la carne de res o de cerdo . Adem\u00e1s, los sub -productos de pollo requieren de un  \ncorto tiempo para su preparaci\u00f3n.  Por todo  ello, tanto la carne de pollo como los \nsubproductos del pollo se  consume n ampliamente . \nSin embargo dichos productos c\u00e1rnicos han estado implicado s durante los \u00faltimos \na\u00f1os en un gran n\u00famero de brotes de campilobacteriosis aguda a nivel mundial, \ntanto en l os pa\u00edses industrializados como en pa\u00edses en v\u00edas de desarrollo, \nespecialmente en ni\u00f1os, ancianos y pacientes inmunodeprimidos (Corry and \nAtabay, 2001; Skirrow and Blaser, 1992; Tauxe, 1992) . La mayor\u00eda de los casos de \ncampilobacteriosis humana se asocian con el consumo de carne insuficientemente \ncocida  de aves de corral o por contaminaci\u00f3n cruzada de alimentos crudos de \norigen animal con alimentos cocinados (Corry and Atabay, 2001; Jean -Paul and \nJohannes, 1991; Nadeau et al., 2002 ). \nEn un estudio  realizado  en Inglaterra y Gales, C. jejuni  fue responsable de hasta \nm\u00e1s de 12 veces el n\u00famero de casos de campilobacteriosis en comparaci\u00f3n con C. \ncoli (Friedman et al. 2000) . Sin embargo, se sabe que C. coli  es tambi\u00e9n \nresponsable de campilobacteriosis en humanos, aunque los factores de riesgo \nasociados sean diferentes, revelando de esta manera la problem\u00e1tica social que \ntienen ambas especies d e Campylobacter  sobre la salud de la poblaci\u00f3n.  \nAs\u00ed pues, dada  la asociaci\u00f3n que existe entre la presencia de Campylobacter en las \naves de corral y la campilobacteriosis, y el consiguiente problema que  supone  a \nnivel de salud p\u00fablica, se hace necesario actuar a nivel de toda la cadena \nalimentaria, de la granja a la mesa, para conseguir reducir el riesgo de infecci\u00f3n en \nlas personas. Para ello, el  primer paso es el control de Campylobacter  en granjas de Introducci\u00f3n genera l \n22 \n pollos de engorde , debido a la alta prevalencia en l os lotes a edad de sacrificio.  \nActualmente la \u00fanica herramienta disponible es la implementaci\u00f3n de unas \nestrictas medidas de bioseguridad, tanto a nivel de granja como a nivel de nave, a \nfin de evitar la transmisi\u00f3n de la bacteria del medio ambiente exteri or de las \ngranjas a las aves de la explotaci\u00f3n que se encuentran confinadas en naves \ncerradas.  Dichas medidas han demostrado ser efectivas tanto en pa\u00edses de clima \nm\u00e1s fr\u00edo (Hald et al., 2008) como en pa\u00edses de clima c\u00e1lido, como Espa\u00f1a (Cerd\u00e0 -\nCu\u00e9llar et al., 2015) . \nAlgunos pa\u00edses que adoptaron estrategias espe c\u00edficas a nivel de producci\u00f3n \nprimaria para reducir la prevalencia de Campylobacter  en las aves de corral, han \nobservado una reducci\u00f3n similar en los casos en humanos  (Hald et al., 2008) . Por \notro lado, las estrategias que han tenido \u00e9xito en el control de la infecci\u00f3n \nocasionada por Salmonella  en gallinas ponedoras y reproductoras,   en el q ue las \naves se mantienen durante meses a diferencia de la producci\u00f3n de pollos de \nengorde, que el periodo de vida es muy corto (m\u00e1ximo de seis semanas ), estas \nestrategias son generalmente ineficaces contra Campylobacter  (New ell and \nWagenaar, 2000) . \n5. Patog\u00e9nesis de la campilobacteriosis  \nLa severidad de Campylobacter  spp., depende principalmente de la virulencia de la \ncepa, as\u00ed como del estado inmunitario del hospedador. Los mecanismos espec\u00edficos \nde virulencia no est\u00e1n  claramente definidos a\u00fan para esta bacteria, probablemente \ndebido  a la falta de similitud entre Campylobacter  y otros pat\u00f3genos ent\u00e9ricos   \n(Dasti et al., 2010; Guerry, 2007) . A pesar del conocimiento l imitado sobre el \nmodus operandi  de Campylobacter , es bien sabido que los flagelos son necesarios \npara la colonizaci\u00f3n del intestino delgado, para luego moverse al colon  (Poly and \nGuerry, 2008; van Vliet and Ketley, 2001) . La invasi\u00f3n,  que ocasiona inflamaci\u00f3n \ncelular, es probab lemente el resultado de la producci\u00f3n de citotoxinas, seguida por \nla reducci\u00f3n de la capacidad de absorci\u00f3n del intestino. Se piensa que   Introducci\u00f3n general  \n23 \n  Campylobacter  posee una resistencia a los \u00e1cidos g\u00e1stricos y a las sales biliares, y \nesto le confiere la capacidad para  alcanzar el tracto intestinal  (Van Deun et al., \n2007) . \nEn las aves el sitio de colonizaci\u00f3n primaria es el ciego, pudiendo alcanzar 106 a \n109 UFC/gr de heces (Allen et al., 2007; Meade et al., 2009) . Sin embargo, en los \nhumanos, la colonizaci\u00f3n ocurre predominantemente en el intestino delgado. \nVarios estudios experimentales han reportado una mayor capacidad de \ncolonizaci\u00f3n y virulencia de Campylobacter  aislados en heces de humanos, una vez \npasado a tra v\u00e9s de las aves de corral  (Cawthraw et al., 1996) . Se cree que los \nmecanismos de invasi\u00f3n en las l\u00edneas celulares de aves y humanos son similares \npero no id\u00e9nticos, como es el caso de C. jejuni que puede sobrevivir \nintracelularmente en las c\u00e9lulas epiteliales T84 en el humano, sin embargo no \npuede  sobrevivir en enterocitos primarios de pollos (Van Deun et al., 2007) . Para \nque se produzca la colonizaci\u00f3n a nivel intestinal se requiere que la bacteria tenga \nla capacidad de producir motilidad, adhesi\u00f3n, invasi\u00f3n y producci\u00f3n de t oxinas \n(Bang et al., 2003) . \n5.1 Factores de virulencia  \n5.1.1 Motilidad  \nCampylobacter  spp., se caracterizan por poseer una motilidad r\u00e1pida y din\u00e1mica \nmediada por flagelos polares. La motilidad aumenta bajo condiciones altamente \nviscosas para poder producirse la colonizaci\u00f3n del intestino delgado (Guerry, \n2007; Jagannathan, A. Penn, 2005) . El rol de los flagelos bajo diferentes \ncondic iones quimiot\u00e1cticas es esencial para la supervivencia de la bacteria en los \ndiversos nichos ecol\u00f3gicos con que se encuentra dentro del tracto gastrointestinal \n(Jagannathan, A. Penn, 2005) . Introducci\u00f3n genera l \n24 \n C. jejuni  y C. coli poseen flagelos que est\u00e1n compuest os de dos flagelinas que \ncomparten un alto grado de homolog\u00eda, flaA  considerada la m\u00e1s importante y flaB  \n(Guerry, 2007) . Tanto flaA  como flaB , est\u00e1n codificadas por dos genes de flagelina \ndispuestos en t\u00e1ndem. El gen flaA  est\u00e1 regulado por el promotor de la flagelina \ncl\u00e1sica \u03c328, mientras que el gen flaB  se encuentra regulado por el promotor \ndependiente \u03c354 (Jagannathan, A. Penn, 2005) . En la  Tabla 2 se muestran otros \nfactores de virulencia asociados con la motilidad.  \nEl gen flaA  parece ser esencial para que se produzca la invasi\u00f3n de las c\u00e9lulas \nepiteliales. Algunos autores han reportado que una mutaci\u00f3n del flaA  en la regi\u00f3n \nVC167 dio como r esultado la s\u00edntesis de un filamento flagelar truncado y \ncompuesto exclusivamente de flaB , provocando de esta manera una reducci\u00f3n \nsevera en su motilidad, reduciendo notablemente la capacidad del organismo para \ncolonizar el tracto gastrointestinal (Guerry,  2007; Wassenaar, 2000) . Sin embargo, \nuna mutaci\u00f3n en el flaB  en la misma regi\u00f3n, dio como resultado un filamento \nflagelar que era indistinguible en longitud de la cepa de campo ( wild type) , aunque \nla motilidad se redujo ligeramente (Guerry, 2007) . \nAs\u00ed, la expresi\u00f3n de ambas flagelinas parece ser necesaria para la m\u00e1xima \nmotilidad de Campylobacter . Adem\u00e1s, el gen flaA es el responsable de la expresi\u00f3n \nde adherencia, colonizaci\u00f3n del tracto gastrointestinal e invasi\u00f3n de las c\u00e9lulas del \nhospedador (Jain et al., 2008) . Por otro lado , se cree que los flagelos poseen la \ncapacidad de segregar prote\u00ednas no flagelares que  podr\u00edan estar asociad as a la \nvirulencia (Poly and Guerry, 2008) . \nDe esta manera se puede pensar que la actividad de los flagelos en la patog\u00e9nesis \nde Campylobacter  es multifuncional y compleja, considerando que est\u00e1n \ninvolucrados no solo en la motilidad y la quimiotaxis, si no tambi\u00e9n en la secreci\u00f3n \nde prote\u00ednas de virulencia, la autoaglutinaci\u00f3n, la formaci\u00f3n de micro -colonias y la \ninhibici\u00f3n de la respuesta innata.   Introducci\u00f3n general  \n25 \n  Tabla 2.  Factores de virulencia en Campylobacter  asociados a la motilidad.  \n \n \n5.1.2  Quimiotaxis   \nLa quimiotaxis es un mecanismo por el cual las bacterias m\u00f3viles detectan y se \nmueven hacia condiciones m\u00e1s favorables para invadir a su hospedador. Es sabido \nque C. jejuni  es un comensal del intestino de las aves, colonizando espec\u00edficamente \nlas criptas d el ciego, utilizando el mecanismo de la quimiotaxis para localizar estos \nsitios primarios de colonizaci\u00f3n (Chang and  Miller, 2006) . Durante este proceso, \nlos quimioatrayentes primarios son las mucinas y las glicoprote\u00ednas, considerados \ncomponentes primarios del mucus (Hermans et al., 2012) . La quimiotaxis ha sido \nampliamente estud iada en E. coli y todas las pruebas realizadas hasta la fecha \nsugieren un mecanismo de funcionamiento similar en Campylobacter  (Hendrixson \nand DiRita, 2004; Yao et al., 1997) . En la Tabla 3 se  detallan los diferentes genes \nrelacionados con la quimiotaxis identificados en Campylobacter . \n \nFactores de VirulenciaGen \ncodificanteReferencias\nFlaA ,  prote\u00edna mayor de \nla flagelinaflaANachamkim et al., 1993; Wassenaar et al., \n1993; Sommerlad and Hendrixson, 2007; \nFlaB , prote\u00edna menor de la \nflagelinaflaBNachamkim et al., 1993; Wassenaar et al., \n1993; Sommerlad and Hendrixson, 2007; \nEl promotor \u03c328 que \nregula la expresi\u00f3n del gen fliA Hendrixson, 2006\nEl promotor que \u03c354 \nregula la expresi\u00f3n del gen rpoN Hendrixson, 2006\nFliF , prote\u00edna del codo del \ncuerpo basal fliF Carrillo et al., 2004\nFliM  & FliY , prote\u00ednas \nmotoras flagelaresfliM & fliYNachamkim et al., 1993; Wassenaar et al., \n1993; Sommerlad and Hendrixson, 2007; \nFlgl , P-anillo del \npeptidoglicanoflglNachamkim et al., 1993; Wassenaar et al., \n1993; Sommerlad and Hendrixson, 2007; \nFlgH , anillo L de la \nmembrana externaflgHNachamkim et al., 1993; Wassenaar et al., \n1993; Sommerlad and Hendrixson, 2007; \nFlgE  & FliK , componentes \nmenores del codoflgE & fliKNachamkim et al., 1993; Wassenaar et al., \n1993; Sommerlad and Hendrixson, 2007; \nProte\u00ednas implicadas en la \nO-glicosilaci\u00f3n de la \nflagelinacj1321-\ncj1325/6Champion et al., 2005MotilidadIntroducci\u00f3n genera l \n26 \n Tabla 3 . Factores de virulencia en Campylobacter  asociados a la quimiotaxis.  \n \n \n5.1.3 Adhesi \u00f3n   \nLa adhesi\u00f3n de las bacterias del g \u00e9nero Campylobacter  a las c\u00e9lulas epiteliales del \nintestino del hu\u00e9sped es un requisito previo para la colonizaci\u00f3n  que est\u00e1 mediada \npor varias adhesinas sobre la superficie bacteriana  (Jin et al., 2001) . Los genes \nasociados a la adhesi\u00f3n en Campylobacter  se detallan en la Tabla 4.  Se destacan la  \nPEB1 (un hom \u00f3logo de l sistema de transporte ABC en bacterias Gram -negativ as) \n(Pei and Blaser, 1993) , CadF  (prote\u00edna de membrana externa) (Konkel et al., \n1997) , y lipooligosac \u00e1ridos  (LPS)  (Wassenaar et al., 2000 ). Sin embargo, parece \nque la adherencia de C. jejuni  a las c\u00e9lulas del hu\u00e9sped es un proceso de varios \npasos que implica tanto interacciones adhesina -receptor espec\u00edficas como no \nespec \u00edficas  (Crushell et al., 2004) . \n  \nFactores de VirulenciaGen \ncodificanteReferencias\nProte\u00ednas de quimiotaxis; \nCheA, B, R, V, W , & ZcheA, cheB, \ncheR, cheV, \ncheW & cheZHamer et al., 2010\nLas prote\u00ednas de \nquimiotaxis aceptoras de \nmetilo (MCP) tambi\u00e9n \ndenominadas prote\u00ednas tlp1, tlp4, tlp10 Marchant et al., 2002\nCheY , regulador de \nrespuesta que controla la \nrotaci\u00f3n flagelarcheY Hermans et al., 2011\nSistema de prote\u00ednas CetA \n(Tlp9) y CetB  (Aer2)  \ninvolucradas en el \ntactismo energ\u00e9ticocetA & cetB Golden and Acheson, 2002\nEnzima de bios\u00edntesis de \nAI-2luxS Quinones et al., 2009; Hermans et al., 2011\nAfcB , la prote\u00edna MCP \nnecesaria para la \npersistencia en el ciegoacfB Golden and Acheson, 2002Quimiotaxis Introducci\u00f3n general  \n27 \n  Tabla 4 . Factores de virulencia en Campylobacter  asociados a la adhesi\u00f3n.  \n \n \n5.1.4 Invasi\u00f3n  \nAdem\u00e1s de la motilidad que confieren los flagelos a la bacteria, se cree que \u00e9stos \ntienen una segunda funci\u00f3n, actuando como un aparato trasportador (T3SS) en la \nsecreci\u00f3n de prote\u00ednas no flagelares  durante la invasi\u00f3n del hu\u00e9sped (Poly and \nGuerry, 2008) . Algunos autores han sugerido que Campylobacter  no puede \npenetrar eficientemente en la c\u00e9lula hu\u00e9sped a trav\u00e9s de la membrana apical  \n(Monteville and Konkel, 2002) . Una evidencia reciente apoya esta afirmaci\u00f3n de \nque C. jejuni  preferen temente penetra en las c\u00e9lulas epiteliales a trav\u00e9s de la \nmembrana baso lateral (Monteville and Konkel, 2002) . En la Tabla 5 se detallan los \ndiferentes genes implicados en la invasi\u00f3n identificados en Campylobacter . Muchos \npat\u00f3g enos invasivos alteran las estructuras citoesquel\u00e9ticas del hu\u00e9sped para \nFactores de VirulenciaGen \ncodificanteReferencias\nCadF , prote\u00edna de \nmembrana externacadF Konkel et al., 1997\nCapA , prote\u00edna A de \nadhesi\u00f3n de \nCampylobactercapA Jin et al., 2001\nFosfolipasa A  pldA Ziprin et al., 2001; Dekker, 2000\nLipoprote\u00edna jlpA Jin et al., 2001\nPeb1, prote\u00edna de uni\u00f3n \nperiplasm\u00e1ticapeb1A Pei and Blaser, 1993\nPeb3 , prote\u00edna de \ntransportepeb3 Min et al., 2009\nPeb4 , chaperona que \ndesempe\u00f1a un papel \nimportante en la \nexportaci\u00f3n de prote\u00ednas a \nla membrana externapeb4 kale et al., 2011\nFlpA , prote\u00edna A de la \nfibronectinaflpA Flanagan et al., 2009\nSistema de secreci\u00f3n de \ntipo IV posiblemente \nimplicada en la adhesi\u00f3nvirB11 Bacon et al., 2000; Dasti et al., 2010\nJlpA , lipoprote\u00edna de 42-\nkDa implicada en la \nadhesi\u00f3n a c\u00e9lulas hep-2jlpA Jin et al., 2001Adhesi\u00f3nIntroducci\u00f3n genera l \n28 \n producir la invasi\u00f3n de las c\u00e9lulas epiteliales intestinales. En el caso de C. jejuni  se \nha descrito que la invasi\u00f3n de las c\u00e9lulas en ocasiones depende de los \nmicrot\u00fabulos y microfil amentos  (Crushe ll et al., 2004) .  \nTabla 5 . Factores de virulencia en Campylobacter  asociados a la invasi\u00f3n.  \n \n \n5.1.5  Producci\u00f3n de t oxin as  \n Campylobacter  produce una gran variedad de citotoxinas (McFarland and Neill, \n1992; Schulze et al., 1998) , de las cuales solo se ha estudiado con profundidad la \ncitotoxina de distensi\u00f3n  (CDT , cytolethal distending toxin ) (Pickett and \nWhitehouse, 1999) . Muchas bacterias Gram -negativas tienen la capacidad de \nproducir CDT (Ge et al., 2008 ), una toxina tripartita compuesta de tres \nFactores de VirulenciaGen \ncodificanteReferencias\nFlhA, FlhB, FliO, FliP, FliQ \n& FliR , componentes del \nT3SS flagelarflhA, flhB, fliQ, \nfliP, fliO & fliRCarrillo et al., 2004\nFlaC  prote\u00edna secretada en \nlas c\u00e9lulas hu\u00e9sped y \nesenciales para la \ncolonizaci\u00f3n y la invasi\u00f3nflaC Carrillo et al., 2004; Konkel et al., 2004\nCiaB , prote\u00edna de 73 kDa \nimplicada en la adhesi\u00f3nciaB Konkel et al., 2004\nCiaC , prote\u00edna necesaria \npara la invasi\u00f3n completa \nde las c\u00e9lulas INT-407ciaCChristensen et al., 2009; Euker and Kpnkel, \n2012\nCiaI , descrita en la \nsupervivencia intracelularciaI Buelow et al., 2011\nIamA , prote\u00edna asociada a \nla invasi\u00f3niamACarvalho et al., 2001; Rivera-Amill et al., \n2001\nHtrA , chaperona \nimplicada en el correcto \nplegado de adhesinashtrA Baek et al., 2011\nVirK , puede tener un papel \nen la protecci\u00f3n contra las \nprote\u00ednas antimicrobianasvirK Novik et al., 2009\nFspA , prote\u00edna con un \npapel en la apoptosisfspA Poly et al., 2007Invasi\u00f3n  Introducci\u00f3n general  \n29 \n  subunidades codificadas por los genes cdtA, cdtB  y cdtC , que en conjunto son \nnecesarios para que la toxina sea funcionalmente activa  (Asakura et al., 2008) . \nCdtA y cdtC  son subunidades heterodim\u00e9ricas , responsables de la uni\u00f3n de la \ntoxina a la membrana celular y del trasporte del producto del gen cdtB , que es la \nsubunidad enzim\u00e1ticamente activa . Esta prote\u00edna ingr esa al n\u00facleo de la c\u00e9lula del \nhu\u00e9sped y act\u00faa como una enzima desoxirribonucleasa, bloqueando la prote\u00edna  \nCDC2  (cell division control protein  2), una prote\u00edna  clave en la regulaci\u00f3n del ciclo \ncelular.  Ello provoca en las c\u00e9lulas eucariot as la detenci\u00f3n en  fase G2  (periodo de \nr\u00e1pido crecimiento celular antes de la mitosis) del ciclo celular, evitando que  \u00e9stas \nentren en mitosis, lo cual conduce  a la muerte celular  (Bang et al., 2001; Pickett \nand Whitehouse, 1999) .  \nLos lipooligosacaridos (LOS), adem\u00e1s de jugar un papel en la adhesi\u00f3n presentan \nuna actividad endot\u00f3xica, como otras bacterias. Por otro lado, son responsables de \ndesencadenar la respuesta inmune en la que se basa las neuropat\u00edas de  los \ns\u00edndrome s de Guillain -Barr\u00e9  (SGB)  y de Miller Fisher, despu\u00e9s de la infecci\u00f3n por \nC. jejuni . La estructura del  ant\u00edgeno \u201cO\u201d del L OS contiene \u00e1cido si\u00e1lico, semejante  a \nla que se observa en los gangli\u00f3sidos humanos.  La mayor\u00eda de los pacientes que \ndesarrollan el  SGB despu\u00e9s de una enteritis por C. jejuni  lo desarrollan debido a la \nproducci\u00f3n de anticuerpos IgG  que reaccionan con los glangli\u00f3 sidos GM1, GD1a  y \nGQ1b  (Janssen et al., 2008; Willison, 2005) . En la Tabla 6 se describen los genes \nque se encuentran asociados a la producci\u00f3n de toxina, adem\u00e1s del gen wlaN  que \nest\u00e1 implicado en el des arrollo del SGB.  \n \n \n Introducci\u00f3n genera l \n30 \n Tabla 6 . Factores de virulencia en Campylobacter  asociados a la producci\u00f3n de \ntoxinas.  \n \n \n5.1.6 Resistencia a sales  biliares y a antimicrobianos  \nLa resistencia a los agentes antimicrobianos, a las sales biliares y a los metales \npesados en Campylobacter , est\u00e1 mediada por la bomba de eflujo de m\u00faltiples \nf\u00e1rmacos (CME), codificada por el oper\u00f3n cmeABC y cuya expresi\u00f3n est \u00e1 modulada \npor un represor tra nscripcional (CmeR). El CME est\u00e1 compuesto de una prote\u00edna \nperiplasm\u00e1tica (CmeA), un transportador de eflujo de membrana interna (CmeB) y \nuna prote\u00edna de membrana externa (CmeC) (Lin et al., 2002) . Se ha  descrito que \nuna mutaci\u00f3n en el CmeR podr\u00eda alterar la capacidad de C. jejuni  para colonizar los \npollos de engorde  (Guo et al., 2008) .  \n5.1.7 Respuesta al estr\u00e9s y supervivencia  \n Es sabido que Campylobacter  spp., carece de muchas respuestas adaptativas a \ndiferencia de otras bacterias (Parkhill et al., 2000) . Adem\u00e1s, presenta una \ndiversidad gen\u00e9tica inusual y una alta frecuencia de recombinaci\u00f3n intragen\u00f3mica . \nEllo  podr\u00eda alterar el fenotipo y el genotipo, aumentando su capacidad de \nsupervivencia y virulencia en un rango de condiciones adversas (Ridley et al., \n2008) . Por lo general las campilobacterias son muy sensibles a la desecaci\u00f3n y \nestr\u00e9s oxidativo, exposici\u00f3n al ox \u00edgeno, tempe ratura s elevadas , pH \u00e1cido y tambi\u00e9n \npueden experimentar estr\u00e9s por falta de nutrientes , observ\u00e1ndose una \ndisminuci\u00f3n de la actividad metab\u00f3lica, aumentando la producci\u00f3n de enzimas \ndegradativas (Chaveerach et al., 2003; Humphrey et al., 1995) . \nFactores de VirulenciaGen \ncodificanteReferencias\nSubunidades de citotoxina \n(CDT)cdtA, cdtB & \ncdtCAsakura et al., 2008\n1,3 galactosiltransferasas \nimplicadas en la \nproducci\u00f3n de \nlipopolisac\u00e1ridoscgtB & wlaN Gilbert et al., 2000; Linton et al., 2000Producci\u00f3n \nde toxinas Introducci\u00f3n general  \n31 \n  6. Tratamiento  \nGeneralmente la enteritis causada por Camp ylobacter  tiene un pron\u00f3stico muy \nbueno, la mayor\u00eda de los pacientes infectados por esta bacteria se recuperan sin \nning\u00fan tratamiento espec\u00edfico, pero en pacientes deshidratados (reci\u00e9n nacidos y \nni\u00f1os) a causa de C. jejuni  es necesario la reposici\u00f3n de l\u00edquidos. El uso de \nantibi\u00f3ticos es controve rtido  y solo tiene un beneficio marginal durante el curso \nde la infecci\u00f3n y no debe ser utilizado de forma rutinaria (Ternhag et al., 2007) . Sin \nembargo, el tratamiento antimicrobiano est\u00e1 recome ndado para suprimir la \ncondici\u00f3n de portador y en casos invasivos (cuando las bacterias invaden las \nc\u00e9lulas de la mucosa intestinal y da\u00f1an los tejidos; en pacientes que cursan con \nfiebre persistente, diarrea sanguinolenta y pacientes inmunodeprimidos) \n(Crushell et al., 2004; WHO, 2011) . Por lo tanto , el uso de antibi\u00f3ticos depender\u00e1 \nde la gravedad de los s\u00edntomas.  \nEn los casos m\u00e1s graves, el tratamiento de elecci\u00f3n generalmente son macr \u00f3lidos, \ntetraciclinas, fluoroquinolonas y cefalosporinas. Sin embargo, la resistencia \ncreciente a f luoroquinolonas, tetraciclina y a la eritromicina de las cepas de C. \njejuni  y C. coli , podr\u00eda comprometer la eficacia de estos antimicrobianos (Aarestrup \nand Engberg, 2001; Alfredson and Korolik, 2007; Gibreel and Taylor, 2006) . Por \notro lado, la gentamicina podr\u00eda ser una buena alternati va para tratar las \ninfecciones sist\u00e9micas causadas por Campylobacter  spp. (Aarestrup and Engberg, \n2001) . Otros autores recomiendan el uso del cloramfenicol y kanamicina, debido a \nque las campilobacterias han mostrado bajos porcentajes de resistencia frente a \nestos f\u00e1rmacos.  \nLa resistencia a los antibi\u00f3ticos en Campylobacter  est\u00e1 emergiendo a nivel mundial \ny es reconocida por la OMS como un problema de importancia para la salud \np\u00fablica a nivel mundial  (Greig, 2003; Moore et al., 2006; WHO, 1996) . \n Introducci\u00f3n genera l \n32 \n 7. Tipificaci\u00f3n de Campylobacter   \nEn la actualidad existe una amplia variedad de sistemas de tipificaci\u00f3n bacteriana \nque difieren entre s\u00ed  en la capacidad de discriminar entre las cepas bacterianas, en \nsu fiabilidad, en el esfuerzo requerido y en el coste. La t\u00e9cnica elegida para \ndeterminado estudio depender\u00e1 del dise\u00f1o y de los objetivos de la investigaci\u00f3n, \nconsiderando que ninguna t\u00e9cnica  es \u00f3ptima para todas las formas de \ninvestigaci\u00f3n. Los m\u00e9todos de tipificaci\u00f3n se dividen en dos grandes categor\u00edas, \nm\u00e9todos fenot\u00edpicos y genot\u00edpicos.  \n7.1 M\u00e9todos fenot\u00edpicos  \nExisten diferentes m\u00e9todos de tipificaci\u00f3n para las campilobacterias, basados \nfundam entalmente en el fenotipo tales como serotipo, biotipo, fagotipo o perfiles \nde susceptibilidad antimicrobiana.  Estos m\u00e9todos permiten discriminar entre \nbacterias de una misma especie, ya que implican la expresi\u00f3n de genes. Las \npropiedades fenot\u00edpicas tiene n una tendencia a variar, en funci\u00f3n de los cambios \nen las condiciones de crecimiento, fase crecimiento y mutaci\u00f3n espont\u00e1nea \n(Pfaller, 1999) . \n7.2 M\u00e9todos genot\u00edpicos  \nEn los \u00faltimos a\u00f1os los m\u00e9todos de tipificaci\u00f3n molecular han contribuido a \nmejorar los estudios epidemiol\u00f3gicos que buscan identificar y rastrear las fuentes \nde infecciones ocasionadas por Campylobacter  spp., proporcionando los subtipos \ngen\u00e9ticos que se encuentran en circulaci\u00f3n. Los m\u00e9todos genot\u00edpicos \nproporcionan una diferenciaci\u00f3n m\u00e1s sensible y niveles m\u00e1s altos de \nestandarizaci\u00f3n, reproducibilidad, capacidad de tipificaci\u00f3n y poder \ndiscriminatorio en c omparaci\u00f3n con los m\u00e9todos de tipificaci\u00f3n fenot\u00edpica  \n(Wassenaar, 2000) . Las t\u00e9cnicas m\u00e1s utilizadas para la tipificaci\u00f3n molecular de  Introducci\u00f3n general  \n33 \n  Campylobacter  son flaA -RFLP, PFGE y MLST. Mientras que la secuenciaci\u00f3n masiva \nest\u00e1 tomando cada vez m\u00e1s fuerza (Eberle and Kiess, 2012) .  \nLa tipificaci\u00f3n y caracterizaci\u00f3n de los agentes microbianos es importante desde el \npunto de vista del diagn\u00f3stico y tratamiento de la enfermedad, en la vigilancia \nepidemiol\u00f3gica de las infecciones y en estudios de la din\u00e1mica de las poblaciones \nbacterianas. Por otro lado, los nuevos m\u00e9todos y herramientas moleculares \ncumplen un papel muy importante para determinar la diversidad bacteriana y \nobtener una gran cantidad d e informaci\u00f3n en menor tiempo, obten iendo de este \nmodo  una visi\u00f3n amplia de los diferentes procesos y cambios de las poblaciones \nmicrobianas.  En la Tabla 8 se resume una breve c omparaci\u00f3n de las t\u00e9cnicas \ncomunes de tipificaci\u00f3n m\u00e1s utilizadas en la actuali dad.  \n7.2.1  Pulsed -field gel electrophoresis  (PFGE)  \nLa electroforesis en gel de campo pulsado (PFGE), es un m\u00e9todo basado en patr\u00f3n \nde bandas de ADN, que clasifican a las bacterias de acuerdo con el tama\u00f1o de los \nfragmentos generados por la digesti\u00f3n enzim\u00e1tica del ADN gen\u00f3mico, embebido \nen una matriz de ge l de agarosa aplicando un campo el\u00e9ctrico que peri\u00f3dicamente \nva cambiando de direcci\u00f3n (Schwartz and Charles R, 1984) . Fue desarrollado en el \na\u00f1o 1984 y desde entonces se ha convertido en el m\u00e9todo de referencia o gold \nstandard  de los m\u00e9todos de caracterizaci\u00f3n molecular, y ha sido ampliamente \nutilizado para tipificar pat\u00f3genos transmitidos por los alimentos . Fue la base para \nla implementaci\u00f3n de PulseNet en los Estados Unidos para  ayudar en la detecci\u00f3n \nr\u00e1pida de brotes (Ribot et al., 2001) .  \nPFGE fue uno de los primeros m\u00e9todos basados en ADN ideado para la tipificaci\u00f3n \npara Campylobacter  spp. (Foley et al., 2009; Ribot et al., 2001) . Aunque la \nsensibilidad del PFGE depe nde de la elecci\u00f3n de enzima de restricci\u00f3n, \ngeneralmente es considerado como uno de los m\u00e9todos de tipificaci\u00f3n genot\u00edpica \nde alto poder discriminatorio (On et al., 1998) . El procedimiento consiste en la Introducci\u00f3n genera l \n34 \n incorporaci\u00f3n de una susp ensi\u00f3n bacteriana mezclada con una proteasa y un \ndetergente (SDS) en agarosa fundida y haciendo bloques ( plugs ) de agarosa en \nmoldes reutilizables. La mezcla de proteasa -SDS desnaturaliza las prote\u00ednas de la \nmembrana celular formando los poros en la c\u00e9lula  que permiten la liberaci\u00f3n del \nADN cromos\u00f3mico.  \nPosteriormente, se realiza n varios lavados del plug  para eliminar restos celulares y \nproteasas. Una parte del plug se utiliza para la digesti\u00f3n enzim\u00e1tica, se a\u00f1ade a una \nmezcla de endonucleasa de restricci \u00f3n que corta el ADN en diana s espec\u00edfic as, \ngenerando en el caso de  Campylobacter  spp., entre 10 a 30 fragmentos de ADN de \n0,5 a 100 kb . Las enzimas utilizadas son Sma I y KpnI. Los fragmentos de ADN se \nseparan electrofor\u00e9ticamente en funci\u00f3n al tama\u00f1o, los m\u00e1s peque\u00f1os se mueven \nm\u00e1s r\u00e1pido a trav\u00e9s de la agarosa que los fragmentos m\u00e1s grandes (Ribot et al., \n2001) .  \nEl patr\u00f3n de PFGE obtenido de los aislado s se compara con un patr \u00f3n de \nreferencia cuyo peso molecular es conocid o. Este patr\u00f3n es el DNA de  Salmonella \nBraenderup . Los geles se ti\u00f1en con un colorante fluorescente como el bromuro de \netidio , los patrones electrofor\u00e9ticos se visualizan bajo la iluminaci\u00f3n UV y se  \nfotograf\u00eda n para posteriormente ser analizados con un software comercial (Olive \nand Bean, 1999; Tenover et al., 1995) .  \nEl PFGE ha sido aplicado con \u00e9xito en la producci\u00f3n av\u00edcola para el seguimiento de \nCam pylobacter spp. (Melero et al., 2012 ; Miller et al., 2010; Oyarzabal et al., 2013) . \nAdem\u00e1s, esta t\u00e9cnica permiti\u00f3  la detecci\u00f3n de un clon altamente virulento de C. \njejuni  en humanos en los Estados Unidos (Sahin et al., 2012) . No obstante, e sta \nt\u00e9cnica es costosa y laboriosa, especialmente por el equipo necesario, lo cual \npuede suponer una limitaci\u00f3n importante para la implementaci\u00f3n de la t\u00e9cnica en \nmuchos laboratorios (Matushek et al., 1996) .   Introducci\u00f3n general  \n35 \n  Tabla 8 . Comparaci\u00f3n de las t\u00e9cnicas de tipificaci\u00f3n molecular m\u00e1s utilizadas en la actualidad. Adaptada por Foxman  (2005 ). \nT\u00e9cnica de \ntipificaci\u00f3n    Poder \nrelativo de \ntipificaci\u00f3n    Repetibilidad \nrelativa    Reproducibilidad \nrelativa    Parte \ndispersa o \nfocal del \ngenoma    D\u00edas \nrequeridos \npost cultivo    Costo relativo  \nWhole genomic \nsequencing  (WGS)    Elevado    Elevado    Elevado    Genoma \nentero    Meses o a\u00f1os    Muy elevado  \nMultiloocus \nsequence typing  \n(MLST)    Moderado o \nelevado \n(depende del \ngen de \nelecci\u00f3n)    Elevado    Elevado    Dispersa    3+   Equipo : medio \na elevado. \nTrabajo y \nsuministro : \nElevado  \nPulsed -field gel \nelectrophoresis  \n(PFGE)    Moderado a \nelevado \n(depende el \nnumero de \nbandas \nobservadas)    Medio \n=>elevado (en \nfunci\u00f3n de las \nespecies)    Medio =>elevado    Dispersa    3   Equipo : \nelevado \nTrabajo y \nsuministro : \nElevado  \nRestriction \nfragment length \npolymorphism  \n(RFLP)    Moderado a \nelevado \n(depende el \nnumero de \nbandas \nobservadas)    Medio \n=>elevado    Medio    Dispersa    1- 3    Medio  Introducci\u00f3n genera l \n36 \n 7.2.2  Multilocus Sequence Typing  (MLST)  \nEn los \u00faltimos a\u00f1os el MLST se ha convertido en uno de los m\u00e9todos m\u00e1s \nampliamente utilizado para la tipificaci\u00f3n molecular de cepas de Campylobacter  \nspp. (Miller et al., 2012; M\u00fcllner et al., 2010) . Dentro de las especies de \nCampylobacter  spp., el primer esquema del MLST fue desarrollado para C. jejun i y \nC. coli . La t\u00e9cnica consiste en  la secuenciaci\u00f3n de fragmentos cortos de siete genes \nconservados (aspA, glnA, gltA, glyA, pgm, tkt  y uncA ) (Dingle et al., 2001a) . Una vez \nsecuenciado s los productos de PCR para cada locus , se le asigna un n\u00famero de \nalelo bas ado en una coincidencia completa con un alelo en la base de datos \nPubMLST. A esta combinaci\u00f3n de siete alelos diferentes (perfil al\u00e9lico) se le asigna \nun tipo de secuencia (ST) \u00fanico de acuerdo con la base de datos. Los ST que \ncomparten como m\u00ednimo cuatro o m\u00e1s alelos pertenecen al mismo complejo clonal \n(CC) (Dingle et al., 2001a) . Debido a la transferencia horizontal y la recombinaci\u00f3n \nintramolecular, Campylobacter  spp., tiene una poblaci\u00f3n d\u00e9bilmente clonal (Dingle \net al., 2005, 2001a) . \nEl MLST posee un elevado poder discriminatorio, altamente reproducible y se ha \nconvert ido en la t\u00e9cnica gold standard  de genotipado, permitiendo la comparaci\u00f3n \nmundial de forma precisa y sencilla entre diferentes cepas (Dingle et al., 2001a) . \nSin embargo a pesar de las ventajas, la t\u00e9cnica sigue siendo costosa y laboriosa, \npor lo cual no es factible para una prueba de rutina . MLST por s \u00ed sola proporciona \ninformaci\u00f3n excelente sobre la epidemiologia global y la estructura poblacional de \nCampylobacter , pero parece ser menos discriminatoria en estudios \nepidemiol\u00f3gicos a corto plazo (Sails et al., 2003) , aunque Dingle (2002 y  2008 ), \nrecomienda n el uso de la t\u00e9cnica para estudios epidemiol\u00f3gicos de corto y largo \nplazo. En el momento de la escritura de esta tesis se han descri to 8859  STs de C. \njejuni y C. coli  en la base de datos de PubMLST \n(http://pubmlst.org/campylobacter/ ).  Introducci\u00f3n general  \n37 \n  El MLST proporciona una valiosa informaci\u00f3n y comprensi\u00f3n sobre la ecolog\u00eda, la \nestructura de la poblaci\u00f3n y la evoluci\u00f3n de Campylobacter  a trav\u00e9s de la \ntransferencia gen\u00e9 tica y v\u00edas evolutivas (Sheppard et al., 2011) . Adem\u00e1 s, mide las \nvariaciones que ocurren de forma relativamente lenta y sin presi\u00f3n selectiva, por \nlo que pueden ser apropiadas para estudios filogen\u00e9ticos (Sails et al., 2003) , \npudiendo determinar tambi\u00e9n la transferencia horizontal de genes (McCarthy et \nal., 2007) . El MLST se utiliza principalmente como herramienta para describir la \ndin\u00e1mica de las poblaciones en varias regiones geogr\u00e1ficas y en diferentes \ntiempos.  \n7.2.3  Whole genomic secuencing  (WG S) \nHace poco m \u00e1s de 20 a\u00f1os, la publicaci\u00f3n de la primera secuencia del genoma \nbacteriano de Haemophilus influenzae  sacudi\u00f3 el mundo de la bacteriolog\u00eda . \nDurante este periodo, la poderosa combinaci\u00f3n de la secuenciaci\u00f3n del genoma y \nel an\u00e1lisis bioinform\u00e1t ico de la secuencia de datos, ha hecho que podamos \ncomprender claramente c\u00f3mo funcionan las bacterias, c\u00f3mo evolucionan e \ninteract\u00faan entre s\u00ed, con sus hospedadores y con su entorno. Los an\u00e1lisis basados \nen las secuencias han aportado informaci\u00f3n inesperad a sobre la diversidad \nmicrobiana y la oportunidad de explorar las diferentes comunidades microbianas, \nadem\u00e1s estos enfoques han permitido rastrear la propagaci\u00f3n de la infecci\u00f3n y han \nayudado a dise\u00f1ar nuevos f\u00e1rmacos y vacunas (Loman and Pallen, 2015) . \n El proceso de secuenciaci\u00f3n ha experimentado una notable innovaci\u00f3n en la \ninvestigaci\u00f3n, por lo que los trabajos de investigaci\u00f3n que sol\u00eda n llevar a\u00f1os y un \nalto cost e, en la actualidad con esta herramienta se puede reducir el tiempo y el \ncost e del proyecto (Loman and Pallen, 2015) . El WGS mediante plataformas de \nnext -generation sequencing  (NGS ) como la plataforma Illumina ha reducido \nnotablemente el co ste de secuenciaci\u00f3n masiva siendo actualmente de 0,10 $ por \ncada 1Mpb.  Introducci\u00f3n genera l \n38 \n Los datos obtenidos a partir del WGS, pueden en principio definir los aislamientos \nbacterianos que difieren en un solo par de bases, proporcionando de esta manera \nel nivel m\u00e1s alto de poder discriminatorio para el genotipa do. Los datos de WGS de \nalta calidad proporcionan informaciones m\u00e1s completa  que otras t\u00e9cnicas de \ntipificaci\u00f3n molecular para inferir las relaciones gen\u00e9ticas y filogen\u00e9ticas  (Laing et \nal., 2011) . La reducci\u00f3n del coste y facilidad de obtenci\u00f3n de  secuencias de un \nelevado n\u00famero de aislados ha dado lugar a aumento de los estudios \nepidemiol\u00f3gicos que aprovechan la potencia de esta tecnolog\u00eda. Es de prever que \nen un futuro cercano el WGS ser\u00e1 la herramienta m\u00e1s com\u00fan de tipificaci\u00f3n \nmolecular.  \nAdem\u00e1s , Campylobacter  spp.,  fue una de las primeras bacterias a ser analizada con \nesta tecnolog\u00eda NGS (Hofreuter et al., 2006; Pearson et al., 2007) . Se han realizado \ny publicado varios estudios con el objeto de examinar la estructura de la poblaci\u00f3n \nde C. jejuni  y C. coli , utilizando NGS como herramienta  de trabajo (Gripp et al., \n2011; Lef\u00e9bure et al., 2010; Sheppard et al., 2013) . Sin embargo, los \nconocimientos, la experiencia y las herramientas necesarias para un r\u00e1pido \nan\u00e1lisis bioinform\u00e1tico de los datos obtenidos a partir del WGS s iguen siendo un \ndesaf\u00edo, lo cual es probable que impida el uso de datos de WGS para el genotipado \nrutinario de Campylobacter  spp. (Pendleton et al., 2013) . \n8. Antimicrobianos  \nLos antimicrobianos se definen como medicamentos que destruyen los \nmicroorganismos o impiden su multiplicaci\u00f3n o desarrollo. Los antimicrobianos se \ndividen en diferentes grupos, antibacterianos o antibi\u00f3ti cos, antivirales, \nantimic\u00f3ticos, an timicobacterianos, antiparasitarios y antirretrovirales (Whalter \nIv\u00e1n, 2008) . Los antibi\u00f3ticos son sustancias qu\u00edmicas producidas por diferentes \nmicroorganismos o derivados s int\u00e9ticos, que act\u00faan inhibiendo el crecimiento de \nlas bacterias (bacteriost\u00e1tico), y/o eventualmente destruirlas (bactericida). Estos \ncompuestos difieren marcadamente en sus propiedades f\u00edsicas, qu\u00edmicas y  Introducci\u00f3n general  \n39 \n  farmacol\u00f3gicas, as\u00ed como en su mecanismo de acci\u00f3 n y espectro antimicrobiano \n(Martinez et al., 2015) . \nNormalmente los antibi\u00f3ticos  presentan \u201c toxicidad selectiva\u201d  (actividad selectiva \nfrente a microorganismo, pero no frente a c\u00e9lulas humanas, animal o plantas), \nsiendo  la toxicidad  muy superior para los organismos invasores que para los \nhospedadores, aunque ocasionalmente puede produc irse un efecto secundario, no \ndeseado o una reacci\u00f3n adversa medicamentosa (Manrique, 2012) . Los \nantibi\u00f3ticos se utilizan para el tratamiento, control y prevenci\u00f3n de las \nenferme dades infecciosas en humanos y animales, ocasionadas por bacterias . \nAdem\u00e1s, ayudan a las defensas del sistema inmune del individuo hasta que las \nrespuestas locales sean suficientes para controlar la infecci\u00f3n (Martinez et al., \n2015) .  \nDesde la d\u00e9cada de 1950, los antibi\u00f3ticos tambi\u00e9n se utilizaban en animales como \npromotor de crecimien to, especialmente en aves y cerdos de engorde, aunque este \nuso est\u00e1 totalmente prohibido en toda la Uni\u00f3n Europea desde el a\u00f1o 2006 . Sin \nembargo, todav\u00eda se sigue utilizando con este fin en otros continentes (Manrique, \n2012) .  \n8.1 Resistencia antimicrobiana  \nEl alarmante incremento de la resistencia bacteriana a los antibi\u00f3ticos es sin duda, \nuno de los mayores problemas actuales de la salud p\u00fablica ya que estos \ncompuestos constituyen una de las principales herramientas para controlar y \ntratar las infecciones bacterianas, tanto en medicina humana como en veterinaria. \nLa emergencia de bacterias resistentes a los antibi\u00f3ticos ha ido de una forma \nparalela a la incorporaci\u00f3n de los mismos a l arsenal terap\u00e9utico. Sin embargo, la \nindustria farmac\u00e9utica fue modificando la estructura qu\u00edmica de las mol\u00e9culas de \nantibi\u00f3ticos ya conocidos y busc\u00f3 nuevos antibi\u00f3ticos que fuesen capaces de Introducci\u00f3n genera l \n40 \n esquivar los mecanismos de resistencias adquiridas por las b acterias (Manrique, \n2012) . \nLa resistencia a los antimicrobianos es un problema emergente a nivel mundial. En \nmuchas bacterias de inter\u00e9s cl\u00ednico se han producido cambios importan tes en los \nfenotipos de resistencia a los antibi\u00f3ticos y este fen\u00f3meno ha sido especialmente \nrelevante en los \u00faltimos a\u00f1os para algunas asociaciones bacteria -antibi\u00f3tico.  \nDesde el punto de vista pr\u00e1ctico, se considera que una bacteria es sensible a un  \nantibi\u00f3tico, cuando \u00e9sta es capaz de inhibir su crecimiento y ayuda a eliminar y \ncontrolar la infecci\u00f3n, por el contrario, una bacteria es resistente cuando su \ncrecimiento solo puede ser inhibido a concentraciones superiores a las que el \nf\u00e1rmaco puede alcanza r en el lugar de la infecci\u00f3n (Garc\u00eda de Lomas and Gimeno, \n1997) . \nUna de las pruebas de sensibilidad antimicrobiana cualitativa m\u00e1s utilizada en la \npr\u00e1ct ica es el test de susceptibilidad antimicrobiana o antibiograma (difusi\u00f3n en \ndisco), cuyo objetivo es evaluar la respuesta de un microorganismo frente a uno o \nvarios antimicrobianos y traducir en una primera aproximaci\u00f3n, su resultado \ncomo factor predictiv o de la eficacia cl\u00ednica. Este m\u00e9todo clasifica directamente al \nmicroorganismo como sensible o resistente frente al antibi\u00f3tico (Cant\u00f3n, 2010; \nTaroco R  and Vignoli, 2008) . \nPor otro lado, existe un m\u00e9todo cuantitativo, la concentraci\u00f3n m\u00ednima inhibitoria \n(MIC), que permite medir la m\u00ednima concentraci\u00f3n de antibi\u00f3tico que en un \nperiodo de tiempo determinado, es capaz de inhibir el crecimiento in vitro  de un \nin\u00f3culo bacteriano previamente estandarizado. Esta t\u00e9cnica se puede realizar por \nmicro o macro diluci\u00f3n en caldo, diluc i\u00f3n en agar o en test comercial (Taroco R \nand Vignoli, 2008) .  Introducci\u00f3n general  \n41 \n  El Clinical and Laboratory Standards Institute  (CLSI) en Estados Unidos, as\u00ed como el \nEuropean Committee on Antimicrobial Susceptibility Testin g (EUCAST), en Europa, \nhan establecido puntos de corte, bien en valores o en halos de inhibici\u00f3n \n(antibiograma) o de MIC, para separar estas categor\u00edas en: sensible, intermedio y \nresistente (Rafael Cant\u00f3n , 2010) . Para la interpretaci\u00f3n de lo s resultados de las \npruebas de sensibilidad, algunos pa\u00edses utilizan puntos de corte cl\u00ednicos, conforme \na lo dispuesto por CLSI o una combinaci\u00f3n de puntos cl\u00ednicos de CLSI y EUCAST, \ndependiendo del antimicrobiano. Algunos pa\u00edses utilizan otros criterios c omo \nvalores de corte epidemiol\u00f3gicos (ECOFFs) proporcionados por EUCAST (EFSA, \n2013) . \n8.2 Tipo s de resistencia antimicrobiana  \n8.2.1 Natural o intr\u00ednseca:  se produce cuando la bacteria carece de diana siendo \npropia de cada familia, especie o grupo bacteriano (Daza -Perez, 1998).  \n8.2.2 Adquirida:  es variable y obtenida \"a posteriori\" por una cepa de una especie \nbacteriana. Es la resistencia m\u00e1s importante desde el punto de vista cl\u00ednico, se \nproduce por una modificaci\u00f3n de la carga gen\u00e9tica de la bacteria, por mutaci\u00f3n \ncromos\u00f3mica o por mecanismo d e transferencia gen\u00e9tica (transmisi\u00f3n vertical) \n(Daza -Perez, 1998), pero la  resistencia transmisible , es la m\u00e1s importante, esta \nmediado por pl\u00e1smidos, trasposones, o integrones que pueden pasar de una \nbacteria a otra (transmisi\u00f3n horizontal) (Garc\u00eda de Lo mas, 1998).  \n8.3 Mecanismo de  resistencia  \nDurante mucho tiempo, el principal objetivo en investigaci\u00f3n en el \u00e1rea de la \nresistencia a los antibi\u00f3ticos estaba relacionado con la emergencia de pat\u00f3ge nos \nhumanos y su epidemiologia. S in embargo, en la actualidad la  presencia de genes \nde resistencia en las bacterias pat\u00f3genas se ha convertido en el foco principal en la \ninvestigaci\u00f3n, considerando que un n\u00famero cada vez mayor de microorganismos Introducci\u00f3n genera l \n42 \n presentan resistencia a los diferentes tipos de antimicrobianos. El origen  de l os \ngenes de resistencia est\u00e1 en  los propios microorganismos productores de \nantibi\u00f3ticos que los pose en como mecanismo de defensa frente a estos \ncompuestos que ellos mismos sintetizan . Dichos genes  fueron  posteriormente \ntransferidos a las bacterias pat \u00f3genas (Manrique, 2012) . \nDiversos estudios han demostrado que las bacterias ambientales (especialmente \nlas que provienen del suelo), contienen una gran diversidad de genes de \nresistencia, algunos similares a los detectados en las bacterias pat\u00f3genas y otr os \nnuevas (Cant\u00f3n, 2009; D\u2019Costa et al., 2007; Forsberg et al., 2012) . \n Por otro lado, s e han observado grandes semejanzas estructurales entre algunos \nantibi\u00f3ticos y otras mol\u00e9culas que participan en el metabolismo microbiano, por \nello es posible que algunos genes de resistencia tengan una doble funci\u00f3n: \ninactivar a los antibi\u00f3ticos y actuar en procesos celulares (Mart\u00ednez et al., 2011; \nWright, 2007) .  \n8.4 Principales mecanismos de resistencia antimicrobiana  \n8.4.1 Modificaci\u00f3n enzim\u00e1tica del antibi\u00f3tico:  las bacterias expresan enzimas \ncapaces de crear cambios  en la estructura del antibi\u00f3tico haciendo que \u00e9ste pierda \nsu funcionalidad. (Tafur, 2008).  \n8.4.2 Bombas de eflujo:  operan tomando el antibi\u00f3tico del espacio peripl\u00e1smico y \nexpuls\u00e1ndolo al exterior, con lo cual evitan que llegue a su sitio de acci\u00f3n. Este \nmecanismo es frecuentemente utilizado por las bacterias Gram negativas . Figura 3 \n(Vila, J. 2007).  \n8.4.3 Cambios en la permeabilidad de la membrana externa de la bacteria:  \nlas bacterias pueden generar cambios de la bicapa lip\u00eddica, aunque de \npermeabilidad d e la membrana se ve alterada, principalmente por las porinas \n(prote\u00ednas), forman canales de agua embebidos en la membrana externa que  Introducci\u00f3n general  \n43 \n  regulan la entrada de algunos elementos, entre ellos, antibi\u00f3ticos. Los cambios en \nsu conformaci\u00f3n pueden llevar a que la membrana externa no permita el paso de \nestos agentes al espacio peripl\u00e1smico (Vila, J. 2007; Tafur, 2008).  \n8.4.4 Alteraciones de las dianas del antibi\u00f3tico:  las bacterias pueden alterar el \nsitio donde el antibi\u00f3tico se une a la bacteria para interrumpir una funci\u00f3n vital de \n\u00e9sta. Este mecanismo es, principalmente, utilizado por las bacterias Gran positivas \n(Cavaco et al., 2008).  En la figura tres se detalla l os principales mecanismos de \nresistencia a los antimicrobianos en Campylobacter .   \n \nFigura 3 . Resumen de los principales mecanismos de resistencia a las diferentes \nfamilias de antibi\u00f3ticos en Campylobacter.  Adaptado de Iovine (2013) .  \n8.5. Mecanismos de Resistencia en Campylobacter  \n8.5.1 Resistencia a  fluoroquinolonas (FQ)  \nEn Campylobacter  existen dos mecanismos de resistencia bien descritos: la \ninactivaci\u00f3n de  la diana de las FQ y el sistema de bombas de eflujo. Las dos dianas \nenzim\u00e1ticas intracelulares de las FQ son  la ADN girasa , codificada por gyrA  y gyrB ; \ny la topoisomeras a IV, codificada por parC  y parE  (Drlica and Zhao, 1997) . Estas \nenzimas act\u00faan en la replicaci\u00f3n del ADN bacterian o, la transcripci\u00f3n, la \nrecombinaci\u00f3n y la reparaci\u00f3n del ADN (Jacoby, 2005) . Sin embargo, varios \nIntroducci\u00f3n genera l \n44 \n estudios han demostrado que C. jejuni  y C. coli  carecen de los genes parC  y parE \npor lo tant o no pueden ser fuente de resistencia a las FQ  (Iovine, 2013; Parkhill et \nal., 2000) . \nLa resistencia a FQ en C. jejuni  y C. coli  ocurre a trav\u00e9s  de mutaciones puntuales \nespecificas en la regi\u00f3n determinant e de la resistencia a las quinolonas (QRDR) del \ngen gyrA , siendo la mutaci\u00f3n Thr -86-IIe la m\u00e1s com\u00fan. Esta mutaci\u00f3n en gyrA  \nconduce a una elevada resistencia al \u00e1cido nalidixico y FQ (Iovine, 2013; \nWieczorek et al., 2013) . Adem\u00e1s de esta mutaci\u00f3n, se han descripto varias otras \nmutaciones puntuales en gyrA  en el mismo cod\u00f3n -Thr86Val  (Piddock et al., 2003) , \nThr86Lys y Thr86Ala  (Wang et., 1993), as\u00ed como otros codones: Ala87Pro , \nAsp90His y Asp90Tyr . Estas otras mutaciones confieren resistencia a quinolonas \ncon diferentes valores de MICs . Los polimorfismos en el gen gyrB  han sido \ndescartados como causa de resistencia a quinolonas en Campylobacter  spp. (Payot \net al., 2006)  \nEl segundo mecanismo de resistencia,  caracterizad o por la disminuci\u00f3n de la \npermeabilidad de la membrana externa , es mediado  por un sistema de eflujo de \nm\u00faltiples f\u00e1rmacos , la bomba de eflujo  CmeABC , codificada cromos\u00f3micamente y \nque reduce la concentraci\u00f3n de FQ y otros antibi\u00f3ticos (Lin et al., 2002; Pumbwe \nand Piddock, 2002) . \n8.5.2 Resistencia a m acr\u00f3lidos  \nLos macr \u00f3lidos inhiben la s\u00edntesis de prote \u00ednas uni\u00e9ndose reversiblemente al sitio \nP en la sub -unidad 50S de ribosomas bacterianos. Campylobacter  utiliza d iferentes \nmecanismos de resistencia  frente a los macr \u00f3lidos: 1) modificaci\u00f3n de  la diana; 2) \nmecanismo de eflujo y 3) alteraci\u00f3n de la permeabilidad de la membrana, \ncodificada cromos\u00f3micamente por porA . Los dos primeros act\u00faan sin\u00e9rgicamente \npara conferir un nivel alto de resistencia a macr\u00f3lidos (Cagliero et al., 2006; Iovine, \n2013; Lin et al., 2007) .   Introducci\u00f3n general  \n45 \n  Al igual que otras bacterias, mutaciones puntuales en el dominio V de la regi\u00f3n que \ncodifica para el p\u00e9ptido del gen 23S rRNA, en las posic iones 2074 y 2075, \nconfieren resistencia de alto nivel, siendo la sustituci\u00f3n 2075 la m\u00e1s frecuente \n(Iovine, 2013) . C. jejuni  y C. coli  llevan tres copias del gen 23S rRNA , de las cuales  \ndos o tres est\u00e1n mutadas en cepas resistente s a macr\u00f3lidos (Fouts et al., 2005; \nIovine, 2013; Parkhill et al., 2000; P\u00e9rez -Boto et al., 2014a) . Otros mecanismos de \nresistencia menos frecuentes son debidos  a mutaciones  en  los genes  rplD  y rplV , \nque codifican para las prote\u00ednas ribos\u00f3micas  L4 y L22, respectiv amente  (Caldwell \net al., 2008) . \nLa bomba de eflujo CmeABC, tambi\u00e9n contribuye a la resistencia frente a \nmacr\u00f3lidos y funcio na de forma sin\u00e9rgica con las mutaciones del 23S rRNA para \nproducir una resistencia elevada a los macr\u00f3lidos (Cag liero et al., 2006; Kurin\u010di\u010d et \nal., 2007) .  \n8.5.3 Resistencia a \u03b2-lact\u00e1mico s \nExisten tres mecanismos que median la resistencia a  antibi\u00f3ticos  \u03b2-lact\u00e1 micos en \nCampylobacter  spp. 1) Inactivaci\u00f3n enzim\u00e1tica por \u03b2 -lactamasas codificadas \ncromos\u00f3micamente; 2 ) reducci\u00f3n de la absorci\u00f3n debido a alteraciones en l os \nporos de la membrana externa y 3) bomba de eflujo. No obstante , algunos \nmecanismos de resistencia frente a algun os \u03b2-lact\u00e1mico s a\u00fan  no est\u00e1n muy bien \ndefinidos (Iovine, 2013) . Generalmente, con la excepci\u00f3n de alguno s carbapene n, \nla mayor\u00eda de las cepas de Campylobacter  se consideran resistentes a los agentes \nantimicrobianos \u03b2 -lact\u00e1micos, especialmente las penicilinas y las cefalosporinas de \nespectro reducido . No obstante, presentan susceptibilidad  a la amoxicilina y la \nampicilina.  \n8.5.4 Resistencia a t etraciclinas  \nEn Campylobacter  spp., la resistencia a las tetraciclinas es conferida por el gen  \nTetO , que se encuentra presente en C. jejuni  y C. coli  (Conne ll et al., 2003; Taylor et \nal., 1983) . Las tetraciclinas se unen a los cationes Mg+ para pasar a trav\u00e9s de las Introducci\u00f3n genera l \n46 \n porinas de la membrana externa y luego, en el espacio peripl\u00e1smico, se disocia del \nMg+ y se mueve pasivamente hacia el citoplasma para unirse a los sitios discretos \nen la subunidad 30S ribosomal (Chopra and Roberts, 2001) . Se ha demostrado que \nel gen TetO confiere niveles extremadamente altos de resistencia a la tetraciclina \n(Gibreel et al., 2004) . TetO puede estar codificada en el cromosoma o m\u00e1s \ncom\u00fanmente en el pl\u00e1smido pTet en C. jejuni  y pCC31 en C. coli  (Iovine, 2013) . \n8.5.5 Resistencia a a minogluc\u00f3sidos  \nEl principal mecanismo de la resistencia a los aminogluc\u00f3sidos en Campylobacter  \nes a trav\u00e9s de enzimas modificadoras de aminogluc\u00f3sidos, que suelen ser \ntransmitid os por pl\u00e1smidos. La resistencia a los aminogluc\u00f3sidos se detect\u00f3 por \nprimera vez  en cepas de C. coli  y fue mediada por una 3' -aminoglycoside \nphosphotransferase , codificada por el gen aphA -3. Este gen sigue siendo la fuente \nm\u00e1s com\u00fan de resistencia a los aminogluc\u00f3sidos en Campylobacter  (Gibreel et al., \n2004) .  \nLa contribuci\u00f3n de la bomba de eflujo a la resistencia frente a los aminogluc\u00f3sidos \nen Campylobacter  no est\u00e1 completamente clara, pero es probable que sea menos \nimportante que las enzimas modi ficadoras de f\u00e1rmacos presentes en pl\u00e1smidos \n(Iovine, 2013) . \n8.5.6  Resistencia a c lora nfenicol  \nEl clora nfenicol act\u00faa inhibiendo la s\u00edntesis de prote\u00ednas bacterianas al impedir  la \nelongaci\u00f3n  de la cadena pept\u00eddica ; se une de forma reversible a la subunidad 50S \ndel ribosoma . El principal mecanismo de  resistencia bacteriana al clonranfenicol \nes mediante la inactivaci\u00f3n enzim\u00e1tica por acetilaci\u00f3n v\u00eda diferentes tipos de \nacetiltransferasas (CAT, chloramphenicol acetyltransferases ). Estos enzimas est\u00e1n \ncodificados por el gen cat que puede tener una localizaci\u00f3n cromos\u00f3mica o \nplasm\u00eddica (Schl\u00fcnzen et al., 2001; Schwarz e t al., 2004) . Aunque la resistencia al \nclora nfenicol es infrecuente en Campylobacter , se ha descrito  un gen plasm\u00eddico de \nresistencia al clora nfenicol en cepas de C. coli  (Ying and Diane E, 1990) .   Introducci\u00f3n general  \n47 \n  9. Utilizaci\u00f3n de antimicrobianos en la industria av\u00edcola  \nEn los \u00faltimos a\u00f1os la comunidad cient\u00edfica ha manifestado una gran preocupaci\u00f3n \npor el alarmante incremento de la resistencia a antibi\u00f3ticos debido al problema \nque esto supone en el tratamiento de las enfermedades infecciosas. \nHist\u00f3ricamente los antimicrobianos han sido utilizados en la ganader\u00eda tanto para \nel tratamiento de infecciones como promotores del crecimiento. La utilizaci\u00f3n de \nantimicrobianos en la industria av\u00ed cola se utiliza principalmente como tratamiento \nmetafil\u00e1ctico y terap\u00e9utico. Por otro lado, l a pr\u00e1ctica de administrar promotores \ndel crecimiento que contienen antimicrobianos an\u00e1logos a los utilizados en \nmedicina humana fue prohibida en los pa\u00edses de la U E en 2003 y en 2006 se \nprohibi\u00f3 el uso de todos los promotores de crecimiento antimicrobianos en la UE . \nSin embargo, en aves de corral, algunos  antimicrobianos espec\u00edficos est\u00e1n \nautorizados para uso terap\u00e9utico  (Wimalarathna et al., 2013) . Actualmente en la \nUE est\u00e1  prohibido el uso de antibi\u00f3ticos que producen fotosensibilizaci\u00f3n , \ncloranfenicol, quinolonas de segunda generaci\u00f3n (Olaquindox), cefalosporinas de \ntercera y cuarta generaci\u00f3n (excepto ceftiofur) y tilosina a dosis de promotores de \ncrecimiento. En Espa\u00f1a, l a red espa\u00f1ola de vigilancia de la resistencia  a \nantibi\u00f3ticos en animales , tendr\u00eda un importante papel en el seguimiento  de las \ntasas de resistencia que pudiesen indicar desv\u00edos  en los patrones de uso de los \nantibi\u00f3ticos. Este hecho, hizo que se buscara nuevas alternativas al uso de los \nantibi\u00f3ticos en la alimentaci\u00f3n a nimal, en este contexto , est\u00e1 el uso de probi\u00f3ticos  \n(bacterias que compiten con los pat\u00f3genos y mantienen  el equilibrio de la flora \nintestinal), enzimas que  mejoran la digesti\u00f3n de los alimentos o la adici\u00f3n de  \nciertos \u00e1cidos org\u00e1nicos, entre otras.   \n \n  \n    \n \n   \n \n \n \nObjetivos  \n  \n \n  Objetivos  \n51 \n El control de Campylobacter  en el primer eslab\u00f3n de la cadena alimentaria (granjas \nde pollos de engorde) es fundamental para reducir la incidencia de la \ncampilobacteriosis. Profundizar en el conocimiento de Campylobacter en \navicultura de carne tanto desde el aspecto de la diversidad  gen\u00e9tica, como de la \ncirculaci\u00f3n de cepas resistentes a antimicrobianos o de la potencial virulencia de \nlas mismas, contribuir\u00e1 a establecer o mejorar mecanismos de control del \npat\u00f3geno, para minimizar el riesgo de infecci\u00f3n en humanos. De este modo los \nobjetivos planteados en esta tesis son:  \n1. Estudiar la diversidad gen\u00e9tica y la din\u00e1mica de circulaci\u00f3n de cepas de \nCampylobacter  en granjas de pollos de engorde.  \n2. Determinar la susceptibilidad antimicrobiana de los aislados de Campylobacter \ncirculantes e n granja a lo largo del tiempo.  \n3. Identificar la presencia de genes asociados a la virulencia en dichos aislados.  \n4. Caracterizar en profundidad una selecci\u00f3n de aislados de Campylobacter  \nmediante secuenciaci\u00f3n masiva.  \n \n   \n \n    \n  \n \nPART II  \nStudies  \n   \n \n  \n   \n  \n \n \n \nStudy I  \nLong -term dynamics and diversity of Campylobacter  strains in \nbroiler farms  \n   \n \n  Study I  \n57 \n ABSTRACT  \nA long -term longitudinal study was performed in five conventional broiler farms \nduring a two -year period, with the aim of determining the Campylobacter  strain \ndynamics, diversity and seasonality. In total 343 isolates (254 C. jejuni  and 89 C. \ncoli) were first analysed by pulsed field gel electrophoresis (PFGE), using Sma I and \nKpn I restriction enzymes. A great genotypic diversity was observed with an overall \n92 macrorestriction profiles (12 to 24 profiles per farm). A succession of \ngenotypes was obs erved along the rearing cycles, with usually one or two \ngenotypes per crop in all farms. Additionally, we detected some persistent \ngenotypes within the same crop, but not between consecutive rearing cycles. A low \nproportion of common C. jejuni  genotypes we re observed among farms. Multilocus \nsequence typing (MLST) was performed in a selection of isolates (93 C. jejuni and \n34 C. coli ), from the different macrorestriction profiles obtained by PFGE. Sixteen \nclonal complexes (CC) distributed in 34 sequence types  (STs) were detected in \ntotal in C. jejuni  isolates, whereas C. coli  isolates were all grouped within the CC828 \ndistributed in 12 STs. Overall seven novel ST s were isolated. C. jejuni  CC21 and \nCC206 were observed throughout the year and more frequently dur ing the \nwarmer months, while absent during the coldest trimester; CC48 was only \nobserved during the warmest months. The large diversity of genotypes with no or \nlittle common genotypes between consecutive crops, points to a diversity of \nsources of Campyloba cter in the external environment of the farms, and an \nefficient downtime that eliminates Campylobacter  present in the broiler houses by \nthe end of the rearing cycles.  \n  Study I  \n58 \n INTRODUCTION  \nCampylobacteriosis is a major food -borne zoonosis in developed countries (WHO, \n2011)  and in the European Union (EU) it has outnumbered the cases of Salmonella  \ninfections since 2005  (EFSA, 2014) .The majority of Campylobacter  infections are \ncaused  by C. jejuni  and to a lesser  extent  C. coli  (Gillespie et al., 2002) , producing a \nself-limiting gastroenteritis  (Butzler, 2004) . However, in rare cases (1 in 1000),  \ncampylobacteriosis can lead to a number of severe  immune reactive  neuropathies  \nsuch as Guillain -Barr\u00e9 and Miller \u2013Fisher syndromes  (Skirrow and Butzler, 2000) . \nThe main source of infection in humans is associated with the handling and \nconsumption of contaminated raw or under  cooked  poultry products, mainly \nchicken meat and its by  products (Friedman et al., 2004; Humphrey et al., 2007) . \nAn Expert Opinion  Assessment  by the European  Food Safety Authority has \nestimated  that  chicken meat  consumption  accounts for 20% \u201330% of \ncampylobacteriosis in the EU, whereas 50% \u201380% may be attributed to the  chicken  \nreservoir as a whole  (EFSA, 2011) . In most EU countries, the  majority of broiler  \nbatches  are Campylobacter -positive at slaughter. The lowest  Campylobacter flock  \nprevalence  is seen in Nordic countries (Denmark, Finland, Norway and Sweden) \nwhich  range  from 0.6% to 13.1%, whilst in the rest of the EU the  prevalence is \nrather  high (up to74.2% \u201380%)  (EFSA, 2015) .  \nCampylobacter  are excreted into the environment in large numbers and are \nefficient colonizers of poultry (Newell and Fearnley, 2003) . However, this \npathogen is not usually detected in broilers until 2 -3 weeks of life, when birds \nbecame more susceptible to colonization (Evans and Sayers, 2000) . This seems to \nbe due to a steady decrease of materna l antibodies, that disappear completely by \nthe third week and which provide partial protection at an early age (Cawthraw \nand Newell, 2010) . Despite over 30 years of research,  the origin of the infection \nremains unclear.  Nevertheless, since Campylobacter  are ubiquitous in most \nenvironments,  the colonization of intensively grown broilers is likely the result of \na combination of factors for horizontal transmission from the environment. In this Study I  \n59 \n context, domestic and wild animals, vectors and the external environment have a \nfundamental role to play in the bacterial transmission (Humphrey et al., 2007) . \nThere have been multiple risk factors described for the introduction,  colonization \nand dissemination of the pathogen  into broiler farms.  The most important include \nthe maintenance of bacteria from previous flocks which can infect new ones \n(Pearson et al., 1993) , the age of the flock,  the practice of partial depopulation on \nthe same or neighbouring farms, the presence of multiple broiler houses, farm  \nworkers and other livestock on the farm  (Bull et al. 2008; Johnsen, Kruse and \nHofshagen 2006) , water sources, rodents, fomites, transportation of equipment \nand farm personnel (Horrocks et al., 2009) . In contrast, vertical transmission of \nCampylobacter spp. remains unclear and questionable (Agunos et al., 2014; \nBattersby et al., 2016) . \nCampylobacter spp. shows a high degree of genetic diversity, which makes it \ndifficult to trace the source of infections. The lack of adequate and easily available \nmethods for identification, typification, tracing and following up of Campylobacter \nstrains that cause dise ase in humans has further aggravated this difficulty \n(Wassenaar, 2000) . Different methods of molecular typing have been developed in \norder to elucidate the possible infection sources of Campylobacter . Pulsed -field gel \nelectrophoresis (PFGE) is currently one of the most discriminatory methods of \nmolecular  typing for outbreak investigation, especially when two restriction \nenzymes are used (Rivoal et al. 2005) . Multilocus Sequence Typing (MLST), \ndisplays a high discriminatory power and is c onsidered the gold standard \ntechnique for genotyping during long term epidemiological studies (Dingle et al., \n2001a) , providing information about global epidemiology and population \nstructure of Campylobacter spp. These two methods have also proven valuable in \non farm studies.  \nThe aim of thi s study was to determine the dynamics, temporal trends and \ndiversity of Campylobacter isolates  in Spanish broiler farms, by molecular typing Study I  \n60 \n of those isolates recovered from all  flocks raised during a two year -period in five \nfarms.  \nMATERIALS AND METHODS  \nStudy design  \nA total of 343 isolates (254 of C. jejuni and 89 of C. coli ) from a longitudinal 2 -year \nstudy in five farms were analyzed (Urdaneta, 2016) . These farms (identified as \nfarm A, B, C, D and E), each located and belonging to one of the main broiler \ncompanies in Catalonia (northeastern Spain), had a breed integrated system with \nan \u201call in, all out\u201d management system. The downtime between flocks  lasted 10 \ndays on average. All farms had one or two broiler houses and distances from farm \nto farm ranged from 15km to 200 km. Characteristics of each farm are shown on \nFigure 1 and Table 1.  Six to seven flocks per farm were monitored each year, with \na weekly sampling (visits to farms each 2 to 5 days).  \nFrom each Campylobacter -positive sampling, five isolates from five different birds \nrandomly selected among up to 30 positive birds per sampling were preserved at -\n80\u00baC in brain heart infusion broth with 20% glycerol. Two to three samplings per \nflock were performed. Isolates were  identified at species level by PCR (Urdaneta, \n2016) . For the molecular typing of th e isolates, fresh cultures were prepared from \nthe -80 \u00b0C frozen stocks by plating each isolate onto blood agar plates (bioM\u00e9rieux, \nMarcy -l\u2019Etoile, France), and incubated at 37 \u00b0C for 48 h under microaerobic \nconditions, using a microaerobic atmosphere gener ator (Anaerocult\u00ae C, Merck, \nDarmstadt, Germany).  \n Study I  \n61 \n  \nFigure 1.  Locat ion of sampled farms in Catalonia (northeastern Spain).  \n \nTable1. Characteristics of the broiler farms included in the study.  \n \na) Size of each broiler house; b) capacity of each broiler house; c) forced = \ntransversal forced ventilation.  \n \nPulsed -field gel electrophoresis (PFGE)  \n Campylobacter  isolates were typed by PFGE according to the standard operating \nprocedure of PulseNet ( www.pulse netinternational.org ). Genomic DNA was \ndigested with Sma I and Kpn I (Roche Applied Science, Indianapolis, IN). Salmonella \nenterica serovar Braenderup H9812 was used as size marker. Restriction \nfragments were separated by electrophoresis in a CHEF -DR III System (Bio -Rad, \nHercules, CA, USA) and the resulting PFGE patterns were analyzed using  \nFingerprinting II Informatix sofware  (Applied Maths, Saint -Martens -Latem, \nBelgium). Similarity matrices were calculated using the Dice coefficient (1% \noptimization and 1% tolerance) and cluster analysis was performed by the \nC\nD AB\nE\nCapacity \nMax.          Min.\nA 2 >15 1.120 m2 15.500  - 12.900 natural Straw / Shaving\nB 1 10-15 940 m2 15.000  - 13.000 forced Straw / Shaving (pine)\nC 1 6-10 1.428 m2 25.596  - 20.200 forced Shaving (rec)\nD 2 5-5 2.900 m2 46.200  - 40.000 forced Shaving (graim)\nE 2 >15 2.190 m2 28.500  - 24.052 natural Rice husksBed type Farm Ventilation Num HouseHouse age \n(Year)Sizea cbStudy I  \n62 \n unweighted -pair group method with arithmetic average. A cut -off of 9 0% was \nused for the determination of the different macrorestriction profiles . \nMultilocus sequence typing (MLST)  \nGenomic DNA extraction was performed from a bacterial suspension in PBS using \nInstaGene Matrix (Bio -Rad Laboratories, Hercules, CA, USA) followi ng the \nmanufacturer instructions. MLST was performed as described previously by Miller \net al. (2005) . Briefly,  internal fragments of seven housekeeping genes: aspA  \n(aspartate ammonia -lyase), glnA  (glutamine synthetase), gltA  (citrate synthase), \nglyA  (serine hydroxy methyl transferase), uncA  (or atpA , ATP synthase alpha \nsubunit), glmM  (or pgm , phosphoglucosamine mutase) and tkt (transketolase), \nwere PCR amplified and sequenced. When no amplification product was obtained \n(this happened for pgm  and tkt genes only), the reaction was repeated by using the \nprimers described by Korczak et al. (2009)  instead. The oligonucleotide primers \nset are described in Table 2.  The sequence types (ST) and clonal compleses (CC) \nwere determined according to the scheme provided on  the MLST data base \n(http://pubmlst.org/campylobacter/ ). Novel alleles and STs were submitted to \nthe C. jejuni  and C. coli pubMLST data bases.  \n  Study I  \n63 \n Table 2. Campylobacter  MLST primer sets.  \n \n \nRESULTS  \nA 0,87 % (3/343) of isolates were not typeable with Kpn I, and thus were not \nincluded in the analyses.  Ninety -two different profiles were obtained from the 340 \nisolates analysed by PFGE after digestion with the two restriction enzymes. The \nnumber of fragments gene rated per isolate with each enzyme ranged from 5 to 13 \nand their sizes varied from 33.3 to 1135 kb. Overall, 12 to 24 macrorestriction \nprofiles were identified per farm and between one to six genotypes per crop \n(Table 3).  \nOn farm A, with an overall Campylo bacter  prevalence of 53,85% (7 positive \ncrops/13 crops), 55 isolates were analyzed (27 C. jejuni  and 28 C. coli ). Overall 18 \ndifferent macrorestriction profiles (genotypes) were obtained, two of them (P8, \nP16) were predominant (with 9 and 8 isolates, respe ctively) and were found in \ntwo crops (Figure 2). The same genotype was found within the same crop in \nconsecutive weekly samplings (crops L1, L12) and in non -consecutive reared \nGene Primer Sequence 5'- 3 'Amplicon \nSize (bp)Reference\naspAF1 GAGAGAAAAGCWGAAGAATTTAAAGAT\naspAR1 TTTTTTCATTWGCRSTAATACCATC\nglnAF TGATAGGMACTTGGCAYCATATYAC\nglnAR ARRCTCATATGMACATGCATACCA\ngltAF GARTGGCTTGCKGAAAAYAARCTTT\ngltAR TATAAACCCTATGYCCAAAGCCCAT\nglyAF ATTCAGGTTCTCAAGCTAATCAAGG\nglyAR GCTAAATCYGCATCTTTKCCRCTAAA\npgm F1 CATTGCGTGTDGTTTTAGATGTVGC\npgm R1 AATTTTCHGTBCCAGAATAGCGAAA\ntkt_Cjc-L GCAAAYTCAGGMCAYCCAGGTGC\ntkt_Cjc-R TTTTAATHAVHTCTTCRCCCAAAGGT\natpAF GWCAAGGDGTTATYTGTATWTATGTTGC\natpAR TTTAADAVYTCAACCATTCTTTGTCC\nglmM_Cjc-L GCTTATAAGGTAGCWCCKACTG \nglmM_Cjc-R AATTTTCHGTTCCAGAATAGCG\ntkt_Cjc-L AAAYCCMACTTGGCTAAACCG\ntkt_Cjc-R TGACTKCCTTCAAGCTCTCCMiller et al., 2005\nMiller et al., 2005\nKorczak et al., 2009\nKorczak et al., 2009Miller et al., 2005Miller et al., 2005\nMiller et al., 2005706\n716\n685\n606700720\n730gltA\nglyA\npgm\ntktatpApgm\ntkt676 Miller et al., 2005 aspA\nglnA 751 Miller et al., 2005Study I  \n64 \n crops (L1, L7). Two isolates, one C. jejuni  and one C. coli  from the same (L7) o r \ndifferent (L1 and L7) crops showed >90% similarity (Figure 2).   \nOn farm B, with an overall Campylobacter  prevalence of 69,23% (9  positive \ncrop s/13 crop s), 76 isolates were analyzed (53 C. jejuni  and 23 C. coli ). Altogether \n24 different genotypes were obtained, three of them (P28, P33, P34) were \npredominant (with 9 to 11 isolates each) and were found in four flocks (Figure 3). \nThe same genotype was found within the same crop in consecutive weekly \nsamplings (crop s L1, L6, L9, L11 and L12) and in non -consecutive reared crops \n(L2-L13 and L5 -L6).  \nOn farm C, with an overall Campylobacter  prevalence of 66,66% ( 8 positive \ncrop s/12  crop s), 73 isolates were analyzed (53 C. jejuni  and 20 C. coli ). In total 12 \ndifferent ge notypes were obtained, three of them (P43, P46, P50) were \npredominant (with 10 to 18 isolates each) and were found in three crops. The \nsame genotype was found within the same crop in consecutive weekly samplings \n(crops L5, L7, L9) and in non -consecutive re ared crops (L10, L12) (Figure 4).  \nOn farm D, with an overall Campylobacter  prevalence of 38,46% ( 5 positive \ncrop s/13  total crop s), 55 isolates were analyzed (49 C. jejuni  and 6 C. coli ). This \nfarm showed the lowest prevalence among the five farms studied. In total 14 \ndifferent genotypes were obtained, three of them (P55, P62 and P63) were \npredominant (with 8 to 11 isolates each) and were found in five  crop s. The same \ngenotype was found within the same crop in consecutive weekly samplings (crops \nL1 and L12) and in non -consecutive reared crops (L2 -L8 and L5 -L8) (Figure 6).  \nFinally, farm E was the one with the highest Campylobacter  prevalence,  83% (10 \npositive crops/12 crop s), and a total of 81 isolates were analyzed (69 C. jejuni  and \n12 C. coli ). Overall, 24 d ifferent genotypes were identified and only two of them \n(P69 and P89) were predominant, with 21 and 9 isolates, respectively and were \nfound in five crops (Figure 6). Despite this high genetic diversity, the same Study I  \n65 \n genotype was found in consecutive samplings from three crops (L1, L9 and L10). \nThe same genotype was also isolated in two occasions from different non -\nconsecutive positive crops (L2, L4, L7 and L9).  \nGlobally, among the five farms studied we have detected a great genotypic \ndiversity. Mostly, one or t wo different genotypes were identified per crop; in this \nway, a succession of genotypes per crop was observed. A great genotypic diversity \nwas observed in four of the five farms (A , B, D and E), with up to five or six \ndifferent genotypes per crop in up to two crops per farm. The lowest genotypic \ndiversity per crop was observed in farm C, with a maximum of one or two \ngenotypes. On the other hand, we usually found one or two persistent genotypes \nper crop with the exception of L4 from farm E in which three dif ferent genotypes \nwere observed. No persistent genotype that originated in a previous crop was \nidentified. However, when comparing all isolates, same C. jejuni  genotypes were \nfound among different farms, specifically between farms A and B, B and D, and C \nand D (Table 3 and Figure 7).  Study I  \n66 \n Table 3. Total number of genotypes identified per crop and farm . \n \nFlocks \n numN\u00ba of \ngenotypesProfiles per ageb Flocks \n numN\u00ba of \ngenotypesProfiles per ageFlocks \nnumN\u00ba of \ngenotypesProfiles per age\nL1 234d (P15,P16)/37d \n(P15,P16)L1 4 27d (P23)/34d (P23,P42) L1   \u0336   \u0336\nL2 426d (P1,P2,P4)/30d \n(P3,P4)L2 514d (P20,P33)/20d \n(P19,P40)/34d (P24)L2 2 21d (P47)/25d (P47, P54 )\nL3 1 35d L3   \u0336   \u0336 L3 1 21d  \nL4 1 14d\nL4  \u0336   \u0336 L4   \u0336   \u0336\nL5   \u0336a  \u0336 L5 2 39d L5 1 14d (P50)/17d (P50)\nL6 2 30d L6 628d (P21, P37 ,P38)/33d \n(P22 ,P27, P31 ,P38)L6   \u0336   \u0336\nL7 628d (Cj:P5,P7,P17,P18; \nCc:P5) 32d (Cj:P6; Cc:P14)L7 2 21d L7 229d (P34)/34d (P34)/37d \n(P34)\nL8   \u0336   \u0336 L8   \u0336   \u0336 L8 1 31d\nL9   \u0336   \u0336 L9 2 18d (P34)/22d (P34,P36) L9 1 14d (P53)/17d (P53)\nL10   \u0336   \u0336 L10 -   \u0336 L10 2 13d\nL11   \u0336   \u0336 L11 2 36d (P25,P26)/39d (P26) L11   \u0336   \u0336\nL12 2 19d ( P8,P9)/22d ( P8) L12 2 22d (P28, P35)/24d (P28) L12 221d (P46)/27(P46)/30d \n(P46)/33d (P46,P51,P52)\nL13   \u0336   \u0336 L13 1 21d (P33)/26d (P33)Farm A Farm B Farm CStudy I  \n67 \n Table 3. Continuated.  \n \na) Negative  flocks  \nb) Age per day  \nFlocks \nnumN\u00ba of \ngenotypesProfiles per ageFlocks \nnumN\u00ba of \ngenotypesProfiles per age\nL1 1 29d ( P62 )/31d ( P62 )L1 523d (P84,P86)/27d \n(P73,P84,P85,P92)\nL2 414d (P63, P64 )/21d \n(P56,P61)L2 428d\nL3   \u0336   \u0336 L3 2 33d\nL4   \u0336   \u0336 L4 422d \n(P69,P78,P81)/28d \n(P69,P78,P79,P81)\nL5 1 14d (P55)/20d (P55) L5 2 21d\nL6   \u0336   \u0336 L6   \u0336   \u0336\nL7   \u0336   \u0336 L7 120d (P69)/25d \n(P69)/29d (P69)\nL8 327d (P57)/30d \n(P55,P63)L8   \u0336   \u0336\nL9   \u0336   \u0336 L9 423d (P77)/28d \n(P69,P77,P90,P91)\nL10   \u0336   \u0336 L10 221d (P89)/25d \n(P74,P89)\nL11   \u0336   \u0336 L11 1 31d\nL12 610d (P65,P67)/14d \n(P58,P60,P66)/18d \n(P59,P60,P68)L12 325d \n(P80,P82,P83)/ \n29d (P80)\nL13   \u0336   \u0336Farm D Farm EStudy I  \n68 \n  \nFigure 2. PFGE combined dendrogram of Sma I and Kpn I patterns of Campylobacter  isolates from farm A. Profiles = \nP1 to P18, with total number of isolates per profile in brackets. Profiles with a simila rity > 90% were considered the \nsame genotype. Isolates from the same crop clustering to a similarity > 90% are highlighted with green  boxes and \nthose form different crops, with blue boxes.  ST, MLST sequence type; CC, MLST clonal complex.  Campylobacter -negative \ncrops: L5, L8, L9, L10, L11.  \nSma I Kpn I\nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.ES193-13-L4-C1\nES193-8-C1\nES193-H10-C1\nES193-3-L6-C1\nES193-10-L7-C1\nES193-3-C1\nES193-21-C1\nES193-26-C2\nES193-HC12-C1\nES193-30-L7-C1\nES193-26-L7-C1\nES193-24-L7-C1\nES193-11-L12-19d\nES193-2-C1\nES193-6-C1\nES193-H23-C1\nES193-C7-C1\nES193-12-L7-C1\nES193-14-L7-C1\nES193-8-L6-C1\nES193-23-L12-19d\nES193-1-L12-22dC. coli\nC.coli\nC. coli\nC. coli\nC. jejuni\nC. coli\nC. coli\nC. coli\nC. coli\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. jejuni\nC. coli\nC. jejuni\nC. jejuni.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.14d, L4\n32d, L7\n35d, L3\n30d, L6\n28d, L7\n34d, L1\n37d, L1\n34d, L1\n37d, L1\n28d, L7\n32d, L7\n28d, L7\n19d, L12\n26d, L2\n26d, L2\n26d, L2\n30d, L2\n28d, L7\n28d, L7\n30d, L6\n19d, L12\n22d, L12894\n8778\n894\n7108\n5396\n854\n1044\n1044\n122\n5908\n50\n50\n50\n50\n854\n1044\n7108\n5908\n122828\n828\n828\n353\n828\n658\n658\n206\n353\n21\n21\n21\n21\n828\n658\n353\n206A7\nA13\nA6\nA8\nA45\nA20\nA27\nA19\nA1\nA11\nA12\nA10\nA14\nA2\nA3\nA4\nA5\nA16\nA18\nA9\nA15\nA17\nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.ES193-13-L4-C1\nES193-8-C1\nES193-H10-C1\nES193-3-L6-C1\nES193-10-L7-C1\nES193-3-C1\nES193-21-C1\nES193-26-C2\nES193-HC12-C1\nES193-30-L7-C1\nES193-26-L7-C1\nES193-24-L7-C1\nES193-11-L12-19d\nES193-2-C1\nES193-6-C1\nES193-H23-C1\nES193-C7-C1\nES193-12-L7-C1\nES193-14-L7-C1\nES193-8-L6-C1\nES193-23-L12-19d\nES193-1-L12-22dC. coli\nC.coli\nC. coli\nC. coli\nC. jejuni\nC. coli\nC. coli\nC. coli\nC. coli\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. jejuni\nC. coli\nC. jejuni\nC. jejuni.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.14d, L4\n32d, L7\n35d, L3\n30d, L6\n28d, L7\n34d, L1\n37d, L1\n34d, L1\n37d, L1\n28d, L7\n32d, L7\n28d, L7\n19d, L12\n26d, L2\n26d, L2\n26d, L2\n30d, L2\n28d, L7\n28d, L7\n30d, L6\n19d, L12\n22d, L12894\n8778\n894\n7108\n5396\n854\n1044\n1044\n122\n5908\n50\n50\n50\n50\n854\n1044\n7108\n5908\n122828\n828\n828\n353\n828\n658\n658\n206\n353\n21\n21\n21\n21\n828\n658\n353\n206A7\nA13\nA6\nA8\nA45\nA20\nA27\nA19\nA1\nA11\nA12\nA10\nA14\nA2\nA3\nA4\nA5\nA16\nA18\nA9\nA15\nA17 Isolate Profile Species Age, Flock Year ST CC\nA7 P11 (5) C. coli 14d, L4 2012 894 828\nA13 P14 (2) C. coli 32d, L7 2012 8778 828\nA6 P12 (5) C. coli 35d, L3 2011 894 828\nA8 P13 (4) C. coli 30d, L6 2012 7108 UC\nA45 P18 (1) C. jejuni 28d, L7 2012 - -\nA20 P15 (2) C. coli 28d, L7 2012 - -\nA27 C. coli 37d, L1 2011 - -\nA19 P16 (8) C. coli 34d, L1 2011 854 828\nA1 C. coli 37d, L1 2011 854 828\nA11 P17 (1) C. jejuni 28d, L7 2012 1044 658\nA12 P6 (3) C. jejuni 32d, L7 2012 1044 658\nA10 P7 (1) C. jejuni 28d, L7 2012 122 206\nA14 P9 (1) C. jejuni 19d, L12 2013 5908 353\nA2 P2 (1) C. jejuni 26d, L2 2011 50 21\nA3 P1 (3) C. jejuni 26d, L2 2011 50 21\nA4 P4 (2) C. jejuni 26d, L2 2011 50 21\nA5 P3 (4) C. jejuni 30d, L2 2011 50 21\nA16 P5 (2) C. coli 28d, L7 2012 854 828\nA18 C. jejuni 28d, L7 2012 1044 658\nA9 P10 (1) C. coli 30d, L6 2012 7108 UC\nA15 P8 (9) C. jejuni 19d, L12 2013 5908 353\nA17 C. jejuni 22d, L12 2013 122 206Study I  \n69 \n  \nFigure 3. PFGE combined dendrogram of Sma I and Kpn I patterns of Campylobacter  isolates from farm \nB. Profiles = P19 to P42, with total number of isolates per profile in brackets. Profiles with a \nsimilarity > 90% were considered the same genotype. Isolates from the same crop clustering to a \nsimilarity > 90% are highlighted with green  boxes and those form different crops, with blue boxes.  \nST, MLST sequence type; CC, MLST clonal complex.  Campylobacter -negative crops: L3, L4, L8, L10.  \nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n100908070605040PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.ES156-27-L12\nES156-2-L12\nES156-27-L5-C1\nES156-14-L11\nES156-2-L11\nES156-26-L11\nES156-22-L6-C1\nES156-4-L6-C1\nES156-24-L6-C1\nES156-5-L6-C1\nES156-HC5-C1\nES156-H20-C1\nES156-H3-C2\nES156-H3-C1\nES156-11-L6-C1\nES156-16-L7-C1\nES156-18-L7-C1\nES156-14-22d-L9-C1\nES156-HC6-C1\nES156-H2-C1\nES156-24-L13\nES156-28-L13\nES156-23-18d-L9-C1\nES156-1-L9-C1\nES156-23-L12\nES156-11-L6-C1\nES156-24-L6-C1\nES156-HC12-C1\nES156-HC1-C1\nES156-12-L5-C1\nES156-15-L6-C1\nES156-C2-C1\nES156-HC14-C1C. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.Casallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2013\n2013\n2012\n2013\n2013\n2013\n2012\n2012\n2012\n2012\n2011\n2011\n2011\n2011\n2012\n2012\n2012\n2013\n2011\n2011\n2013\n2013\n2013\n2013\n2013\n2012\n2012\n2011\n2011\n2012\n2012\n2011\n201122d, L12\n24d, L12\n39d, L5\n36d, L11\n39d, L11\n36d, L11\n28d, L6\n33d, L6\n28d, L6\n33d, L6\n34d, L1\n20d, L2\n20d, L2\n14d, L2\n33d, L6\n21d, L7\n21d, L7\n22d- L9\n34d, L1\n14d, L2\n21d, L13\n26d, L13\n18d, L9\n22d, L9\n22d, L12\n28d, L6\n33d, L6\n27d, L1\n34d, L1\n39d, L5\n28d, L6\n34d, L1\n34d, L1824\n824\n46\n827\n3097\n827\n1016\n1016\n1016\n1016\n854\n5150\n2097\n2097\n8780\n19\n21\n257\n122\n257\n824\n122\n257\n257\n8041\n8780\n572\n572\n572\n8779\n854\n854257\n257\n206\n828\n828\n828\n828\n828\n828\n828\n828\n828\n828\n48\n21\n21\n257\n206\n257\n257\n206\n257\n257\n464\n61\n48\n206\n206\n206\n206\n828\n828B32\nB23\nB9\nB31\nB21\nB30\nB12\nB13\nB28\nB14\nB2\nB7\nB5\nB27\nB15\nB17\nB18\nB20\nB3\nB4\nB33\nB24\nB29\nB19\nB22\nB10\nB16\nB25\nB26\nB8\nB11\nB1\nB6\nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n100908070605040PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.ES156-27-L12\nES156-2-L12\nES156-27-L5-C1\nES156-14-L11\nES156-2-L11\nES156-26-L11\nES156-22-L6-C1\nES156-4-L6-C1\nES156-24-L6-C1\nES156-5-L6-C1\nES156-HC5-C1\nES156-H20-C1\nES156-H3-C2\nES156-H3-C1\nES156-11-L6-C1\nES156-16-L7-C1\nES156-18-L7-C1\nES156-14-22d-L9-C1\nES156-HC6-C1\nES156-H2-C1\nES156-24-L13\nES156-28-L13\nES156-23-18d-L9-C1\nES156-1-L9-C1\nES156-23-L12\nES156-11-L6-C1\nES156-24-L6-C1\nES156-HC12-C1\nES156-HC1-C1\nES156-12-L5-C1\nES156-15-L6-C1\nES156-C2-C1\nES156-HC14-C1C. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.Casallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch\nCasallarch.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2013\n2013\n2012\n2013\n2013\n2013\n2012\n2012\n2012\n2012\n2011\n2011\n2011\n2011\n2012\n2012\n2012\n2013\n2011\n2011\n2013\n2013\n2013\n2013\n2013\n2012\n2012\n2011\n2011\n2012\n2012\n2011\n201122d, L12\n24d, L12\n39d, L5\n36d, L11\n39d, L11\n36d, L11\n28d, L6\n33d, L6\n28d, L6\n33d, L6\n34d, L1\n20d, L2\n20d, L2\n14d, L2\n33d, L6\n21d, L7\n21d, L7\n22d- L9\n34d, L1\n14d, L2\n21d, L13\n26d, L13\n18d, L9\n22d, L9\n22d, L12\n28d, L6\n33d, L6\n27d, L1\n34d, L1\n39d, L5\n28d, L6\n34d, L1\n34d, L1824\n824\n46\n827\n3097\n827\n1016\n1016\n1016\n1016\n854\n5150\n2097\n2097\n8780\n19\n21\n257\n122\n257\n824\n122\n257\n257\n8041\n8780\n572\n572\n572\n8779\n854\n854257\n257\n206\n828\n828\n828\n828\n828\n828\n828\n828\n828\n828\n48\n21\n21\n257\n206\n257\n257\n206\n257\n257\n464\n61\n48\n206\n206\n206\n206\n828\n828B32\nB23\nB9\nB31\nB21\nB30\nB12\nB13\nB28\nB14\nB2\nB7\nB5\nB27\nB15\nB17\nB18\nB20\nB3\nB4\nB33\nB24\nB29\nB19\nB22\nB10\nB16\nB25\nB26\nB8\nB11\nB1\nB6Sma I Kpn I Isolate Profile Species Age, Flock Year ST CC\nB32 P28 (9) C. jejuni 22d, L12 2013 824 257\nB23 C. jejuni 24d, L12 2013 824 257\nB9 P29 (1) C. jejuni 39d, L5 2012 46 206\nB31 P26 (7) C. coli 36d, L11 2013 827 828\nB21 C. coli 39d, L11 2013 3097 828\nB30 P25 (2) C. coli 36d, L11 2013 827 828\nB12 P27 (2) C. coli 28d, L6 2012 1016 828\nB13 C. coli 33d, L6 2012 1016 828\nB28 P38 (3) C. coli 28d, L6 2012 1016 828\nB14 C. coli 33d, L6 2012 1016 828\nB2 P39 (1) C. coli 34d, L1 2011 854 828\nB7 P40 (4) C. coli 20d, L2 2011 5150 UC\nB5 P19 (1) C. coli 20d, L2 2011 2097 828\nB27 P20 (1) C. coli 14d, L2 2011 2097 828\nB15 P31 (1) C. jejuni 33d, L6 2012 8780 48\nB17 P30 (4) C. jejuni 21d, L7 2012 19 21\nB18 P32 (1) C. jejuni 21d, L7 2012 21 21\nB20 P36 (1) C. jejuni 22d, L9 2013 257 257\nB3 P24 (1) C. jejuni 34d, L1 2011 122 206\nB4 P33 (11) C. jejuni 14d, L2 2011 257 257\nB33 C. jejuni 21d, L13 2013 824 257\nB24 C. jejuni 26d, L13 2013 122 206\nB29 P34 (9) C. jejuni 18d, L9 2013 257 257\nB19 C. jejuni 22d, L9 2013 257 257\nB22 P35 (1) C. jejuni 22d, L12 2013 ND 464\nB10 P21 (1) C. jejuni 28d, L6 2012 8041 61\nB16 P22 (1) C. jejuni 33d, L6 2012 8780 48\nB25 P23 (6) C. jejuni 27d, L1 2011 572 206\nB26 C. jejuni 34d, L1 2011 572 206\nB8 P37 (6) C. jejuni 39d, L5 2012 572 206\nB11 C. jejuni 28d, L6 2012 8779 206\nB1 P41 (1) C. coli 34d, L1 2011 854 828\nB6 P42 (1) C. coli 34d, L1 2011 854 828Study I  \n70 \n  \nFigure 4. PFGE combined dendrogram of Sma I and Kpn I patterns of Campylobacter  isolates from farm C. Profiles = P43 to \nP54, with total number of isolates per profile in brackets. Profiles with a similarity > 90% were considered the same \ngenot ype. Isolates from the same crop clustering to a similarity > 90% are highlighted with green  boxes and those form \ndifferent crops, with blue boxes.  ST, MLST sequence type; CC, MLST clonal complex.  Campylobacter -negative crops: L1, L4, L6, \nL11.  \nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.C. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2012\n2012\n2013\n2013\n2013\n2013\n2013\n2013\n2013\n2011\n2013\n2012\n2012\n2012\n2012\n2012\n2013\n2013\n2013\n2013\n201117d, L5\n14d, L5\n31d, L8\n27d, L12\n30d, L12\n13d, L10\n21d, L12\n33d, L12\n21d, L12\n21d, L2\n13d, L10\n29d, L7\n34d, L7\n37d, L7\n21d, L3\n37d, L7\n33d, L12\n33d, L12\n14d, L9\n17d, L9\n25d, L26788\n6788\n704\n21\n21\n48\n21\n21\n21\n1710\n5821\n854\n854\n854\n827\n854\n354\n5402\n257\n8781\n17101332\n1332\n21\n21\n48\n21\n21\n21\n48\n828\n828\n828\n828\n828\n354\n354\n257\n257C4\nC14\nC7\nC20\nC21\nC18\nC10\nC22\nC19\nC13\nC9\nC5\nC15\nC16\nC3\nC6\nC11\nC12\nC17\nC8\nC2\nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.C. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli\nC. coli\nC. coli\nC. coli\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2012\n2012\n2013\n2013\n2013\n2013\n2013\n2013\n2013\n2011\n2013\n2012\n2012\n2012\n2012\n2012\n2013\n2013\n2013\n2013\n201117d, L5\n14d, L5\n31d, L8\n27d, L12\n30d, L12\n13d, L10\n21d, L12\n33d, L12\n21d, L12\n21d, L2\n13d, L10\n29d, L7\n34d, L7\n37d, L7\n21d, L3\n37d, L7\n33d, L12\n33d, L12\n14d, L9\n17d, L9\n25d, L26788\n6788\n704\n21\n21\n48\n21\n21\n21\n1710\n5821\n854\n854\n854\n827\n854\n354\n5402\n257\n8781\n17101332\n1332\n21\n21\n48\n21\n21\n21\n48\n828\n828\n828\n828\n828\n354\n354\n257\n257C4\nC14\nC7\nC20\nC21\nC18\nC10\nC22\nC19\nC13\nC9\nC5\nC15\nC16\nC3\nC6\nC11\nC12\nC17\nC8\nC2Sma I Kpn I Isolate Profile Species Year Flock, Age ST CC\nC4 P50 (10) C. jejuni 17d, L5 2012 6788 1332\nC14 C. jejuni 14d, L5 2012 6788 1332\nC7 P49 (5) C. jejuni 31d, L8 2013 704 UC\nC20 P46 (18) C. jejuni 27d, L12 2013 21 21\nC21 C. jejuni 30d, L12 2013 21 21\nC18 C. jejuni 13d, L10 2013 48 48\nC10 C. jejuni 21d, L12 2013 21 21\nC22 C. jejuni 33d, L12 2013 21 21\nC19 C. jejuni 21d, L12 2013 21 21\nC13 P47 (6) C. jejuni 21d, L12 2011 1710 UC\nC9 C48 (4) C. jejuni 13d, L10 2013 5821 48\nC5 P43 (14) C. coli 29d, L7 2012 854 828\nC15 C. coli 34d, L7 2012 854 828\nC16 C. coli 37d, L7 2012 854 828\nC3 P44 (5) C. coli 21d, L3 2012 827 828\nC6 P45 (1) C. coli 37d, L7 2012 854 828\nC11 P52 (1) C. jejuni 33d, L12 2013 354 354\nC12 P51 (2) C. jejuni 33d, L12 2013 5402 354\nC17 P53 (6) C. jejuni 14d, L9 2013 257 257\nC8 C. jejuni 17d, L9 2013 8781 257\nC2 P54 (1) C. jejuni 25d, L2 2011 1710 UCStudy I  \n71 \n  \nFigure 5. PFGE combined dendrogram of Sma I and Kpn I patterns of Campylobacter  isolates from farm D. Profiles = \nP55 to P68, with total number of isolates per profile in brackets. Profiles with a similarity > 90% were considered the \nsame genotype. Isolates from the sa me crop clustering to a similarity > 90% are highlighted with green  boxes and \nthose form different crops, with blue boxes.  ST, MLST sequence type; CC, MLST clonal complex.  Campylobacter -negative \ncrops: L3, L4, L6, L7, L9, L10, L11, L13.  \nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.C. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli\nC. coli.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2012\n2012\n2012\n2011\n2012\n2013\n2012\n2013\n2012\n2011\n2011\n2011\n2011\n2012\n2011\n2011\n2013\n2013\n2013\n201214d, L5\n20d, L5\n30d, L8 \n21d, L2\n27d, L8 \n14d, L12\n18d, L12\n14d, L12\n18d, L12\n21d, L2\n29d, L1\n31d, L1\n31d, L1\n30d, L8\n14d, L2\n14d, L2\n10d, L12\n14d, L12\n10d, L12\n18d, L12572\n572\n572\n381\n2254\n2254\n2642\n2254\n572\n572\n572\n572\n2254\n2642\n2642206\n206\n206\n21\n257\n257\n828\n257\n21\n206\n206\n206\n206\n21\n21\n257\n828\n828D1\nD13\nD14\nD32\nD6\nD9\nD17\nD8\nD19\nD5\nD11\nD2\nD12\nD15\nD4\nD3\nD51\nD10\nD7\nD18\nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.C. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli\nC. coli.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2012\n2012\n2012\n2011\n2012\n2013\n2012\n2013\n2012\n2011\n2011\n2011\n2011\n2012\n2011\n2011\n2013\n2013\n2013\n201214d, L5\n20d, L5\n30d, L8 \n21d, L2\n27d, L8 \n14d, L12\n18d, L12\n14d, L12\n18d, L12\n21d, L2\n29d, L1\n31d, L1\n31d, L1\n30d, L8\n14d, L2\n14d, L2\n10d, L12\n14d, L12\n10d, L12\n18d, L12572\n572\n572\n381\n2254\n2254\n2642\n2254\n572\n572\n572\n572\n2254\n2642\n2642206\n206\n206\n21\n257\n257\n828\n257\n21\n206\n206\n206\n206\n21\n21\n257\n828\n828D1\nD13\nD14\nD32\nD6\nD9\nD17\nD8\nD19\nD5\nD11\nD2\nD12\nD15\nD4\nD3\nD51\nD10\nD7\nD18Isolate Kpn I Sma I Species Age, Flock Year Profile ST CC\nD1 P55 (11) C. jejuni 14d, L5 2012 572 206\nD13 C. jejuni 20d, L5 2012 572 206\nD14 C. jejuni 30d, L8 2012 572 206\nD32 P56 (1) C. jejuni 21d, L2 2011 - -\nD6 P57 (5) C. jejuni 27d, L8 2012 381 21\nD9 P58 (1) C. jejuni 14d, L12 2013 2254 257\nD17 P59 (1) C. jejuni 18d, L12 2013 2254 257\nD8 P60 (6) C. jejuni 14d, L12 2013 2642 828\nD19 C. jejuni 18d, L12 2013 2254 257\nD5 P61 (4) C. jejuni 21d, L2 2011 ND 21\nD11 P62 (10) C. jejuni 29d, L1 2011 572 206\nD2 C. jejuni 31d, L1 2011 572 206\nD12 C. jejuni 31d, L1 2011 572 206\nD15 P63 (8) C. jejuni 30d,L8 2012 572 206\nD4 C. jejuni 14d, L2 2011 ND 21\nD3 P64 (1) C. jejuni 14d, L2 2011 ND 21\nD51 P65 (1) C. jejuni 10d, L12 2013 - -\nD7 P67 (4) C. coli 10d, L12 2013 2642 828\nD18 P68 (1) C. coli 18d, L12 2013 2642 828\nD10 P66 (1 ) C. coli 14d, L12 2013 2254 257Study I  \n72 \n  \nFigure 6. PFGE co mbined dendrogram of Sma I and Kpn I patterns of Campylobacter  isolates from \nfarm E . Profiles = P69 to P92, with total number of isolates per profile in brackets. Profiles with a \nsimilarity > 90% were considered the same genotype. Isolates from the same crop  clustering to a \nsimilarity > 90% are highlighted with green  boxes and those form different crops, with blue boxes.  \nST, MLST sequence type; CC, MLST clonal complex.  Campylobacter -negative crops: L6, L8.  \nE17 P69 (21) C. jejuni 20d, L7 2012 ND 257\nE31 C. jejuni 25d, L7 2012 ND 257\nE32 C. jejuni 29d, L7 2012 8782 UC\nE12 C. jejuni 22d, L4 2012 627 354\nE65 C. jejuni 28d, L9 2013 - -\nE40 C. jejuni 28d, L2 2011 - -\nE16 P70 (1) C. jejuni 21d, L5 2012 222 206\nE7 P71 (1) C. jejuni 28d, L2 2011 257 257\nE8 P72 (1) C. jejuni 28d, L2 2011 824 257\nE4 P73 (1) C. jejuni 27d, L1 2011 8586 21\nE23 P74 (1) C. coli 25d, L10 2013 8578 828\nE6 P75 (1) C. jejuni 28d, L2 2011 824 257\nE15 P76 (3) C. jejuni 21d, L5 2012 222 206\nE18 P77 (6) C. jejuni 23d, L9 2013 772 443\nE33 C. jejuni 28d, L9 2013 772 443\nE9 P88 (1) C. jejuni 33d, L3 2012 1301 692\nE10 P87 (4) C. jejuni 33d, L3 2012 1301 692\nE25 P80 (7) C. jejuni 29d, L12 2013 5268 464\nE11 P78 (2) C. jejuni 22d, L4 2012 47 21\nE13 P79 (1) C. jejuni 28d, L4 2012 47 21\nE14 P81 (2) C. jejuni 28d, L4 2012 2324 UC\nE2 P84 (6) C. jejuni 23d, L1 2011 8586 21\nE26 C. jejuni 27d, L1 2011 8586 21\nE3 P85 (1) C. jejuni 27d, L1 2011 8586 21\nE1 P86 (1) C. jejuni 23d, L1 2011 8586 21\nE74 P82 (6) C. jejuni 31d, L11 2013 - -\nE24 P83 (2) C. jejuni 25d, L12 2013 45 45\nE34 P89 (9) C. coli 21d, L10 2013 8578 828\nE22 C. coli 25d, L10 2013 8578 828\nE20 P90 (1) C. coli 28d, L9 2013 832 828\nE21 P91 (1) C. coli 28d, L9 2013 832 828\nE5 P92 (1) C. jejuni 27d, L1 2011 8586 21Sma I Kpn I Isolate Species Year Flock, Age ST CC Profile\nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.C. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli\nC. coli\nC. coli\nC. jejuni.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2012\n2012\n2012\n2012\n2013\n2011\n2012\n2011\n2011\n2011\n2013\n2011\n2012\n2013\n2013\n2012\n2012\n2013\n2012\n2012\n2012\n2011\n2011\n2011\n2011\n2013\n2013\n2013\n2013\n2013\n2013\n201120d, L7\n25d, L7\n29d, L7\n22d, L4\n28d, L9\n28d, L2\n21d, L5\n28d, L2\n28d, L2\n27d, L1\n25d, L10\n28d, L2\n21d, L5\n23d, L9\n28d, L9\n33d, L3\n33d, L3\n29d, L12\n22d, L4\n28d, L4\n28d, L4\n23d, L1\n27d, L1\n27d, L1\n23d, L1\n31d, L11\n25d, L12\n21d, L10\n25d, L10\n28d, L9\n28d, L9\n27d, L18782\n627\n222\n257\n824\n8586\n8578\n824\n222\n772\n772\n1301\n1301\n5268\n47\n47\n2324\n8586\n8586\n8586\n8586\n45\n8578\n8578\n832\n832\n8586257\n257\n354\n206\n257\n257\n21\n828\n257\n206\n443\n443\n692\n692\n464\n21\n21\n21\n21\n21\n21\n45\n828\n828\n828\n828\n21E17\nE31\nE32\nE12\nE65\nE40\nE16\nE7\nE8\nE4\nE23\nE6\nE15\nE18\nE33\nE9\nE10\nE25\nE11\nE13\nE14\nE2\nE26\nE3\nE1\nE74\nE24\nE34\nE22\nE20\nE21\nE5\nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.C. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. coli\nC. coli\nC. coli\nC. coli\nC. jejuni.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2012\n2012\n2012\n2012\n2013\n2011\n2012\n2011\n2011\n2011\n2013\n2011\n2012\n2013\n2013\n2012\n2012\n2013\n2012\n2012\n2012\n2011\n2011\n2011\n2011\n2013\n2013\n2013\n2013\n2013\n2013\n201120d, L7\n25d, L7\n29d, L7\n22d, L4\n28d, L9\n28d, L2\n21d, L5\n28d, L2\n28d, L2\n27d, L1\n25d, L10\n28d, L2\n21d, L5\n23d, L9\n28d, L9\n33d, L3\n33d, L3\n29d, L12\n22d, L4\n28d, L4\n28d, L4\n23d, L1\n27d, L1\n27d, L1\n23d, L1\n31d, L11\n25d, L12\n21d, L10\n25d, L10\n28d, L9\n28d, L9\n27d, L18782\n627\n222\n257\n824\n8586\n8578\n824\n222\n772\n772\n1301\n1301\n5268\n47\n47\n2324\n8586\n8586\n8586\n8586\n45\n8578\n8578\n832\n832\n8586257\n257\n354\n206\n257\n257\n21\n828\n257\n206\n443\n443\n692\n692\n464\n21\n21\n21\n21\n21\n21\n45\n828\n828\n828\n828\n21E17\nE31\nE32\nE12\nE65\nE40\nE16\nE7\nE8\nE4\nE23\nE6\nE15\nE18\nE33\nE9\nE10\nE25\nE11\nE13\nE14\nE2\nE26\nE3\nE1\nE74\nE24\nE34\nE22\nE20\nE21\nE5Study I  \n73 \n  \nFigure 7. PFGE combined dendrogram of Sma I and Kpn I patterns  common to different farms (similarity \u2265 90% ). \nSame PFGE profile of isolates from different farms have different profile code (e.g. P54 = P64).  \nC + D\nA + B\nB + D\nA + B\nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.C. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2011\n2011\n2013\n2013\n2012\n2011\n2011\n2012\n2011\n2011\n2013\n2012\n201225d, L2\n14d, L2\n19d, L12\n22d, L12\n33d, L6\n29d, L1\n31d, L1\n33d, L6\n31d, L1\n29d, L1\n19d, L12\n28d, L6\n39d, L51710\n5908\n122\n8780\n572\n572\n8780\n572\n572\n5908\n8779\n57221\n353\n206\n48\n206\n206\n48\n206\n206\n353\n206\n206C2\nD3\nA15\nA17\nB15\nD11\nD12\nB16\nD2\nD21\nA14\nB11\nB8\nPFGE SmaI+PFGE KpnI\nSmaI&KpnI\n1009080706050PFGE SmaI PFGE KpnI\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.C. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni\nC. jejuni.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n..\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.2011\n2011\n2013\n2013\n2012\n2011\n2011\n2012\n2011\n2011\n2013\n2012\n201225d, L2\n14d, L2\n19d, L12\n22d, L12\n33d, L6\n29d, L1\n31d, L1\n33d, L6\n31d, L1\n29d, L1\n19d, L12\n28d, L6\n39d, L51710\n5908\n122\n8780\n572\n572\n8780\n572\n572\n5908\n8779\n57221\n353\n206\n48\n206\n206\n48\n206\n206\n353\n206\n206C2\nD3\nA15\nA17\nB15\nD11\nD12\nB16\nD2\nD21\nA14\nB11\nB8\nC2 P54 C. jejuni 25d, L2 2011 1710 UC\nD3 P64 C. jejuni 14d, L2 2011 ND 21\nA15 P8 C. jejuni 19d, L12 2013 5908 353\nA17 P8 C. jejuni 22d, L12 2013 122 206\nB15 P31 C. jejuni 33d, L6 2012 8780 48\nD11 P62 C. jejuni 29d, L1 2011 572 206\nD12 P62 C. jejuni 31d, L1 2011 572 206\nB16 P22 C. jejuni 33d, L6 2012 8780 48\nD2 P62 C. jejuni 31d, L1 2011 572 206\nD21 P62 C. jejuni 29d, L1 2011 572 206\nA14 P9 C. jejuni 19d, L12 2013 5908 353\nB11 P37 C. jejuni 28d, L6 2012 8779 206\nB8 P37 C. jejuni 39d, L5 2012 572 206Sma I Kpn I Isolate Species Flock, Age ST Year CC ProfileStudy I  \n74 \n MLST  \nA total of 127 isolates ( 93 of C. jejuni and 34 of C. coli ), were selected for the MLST \nanalysis from the 92 different PFGE profil\u00b7les, according to differnt bird age and \ncrop per farm. Complete MLST profile was obtained for 121 of them. For the \nremaining six (all C. jejuni  isolates), the STs could not be determined, since one or \ntwo genes in each of them could not be PCR -amplified and sequenced (Table 4).   \nA high diversity of CC among the C. jejuni  isolates (n=93) was found with 16 CC in \ntotal and CC21, CC206, CC257 being the most frequent.  CC 21 comprised 23 \nisolates (24,7%) distributed in seven STs and two undetermined STs with ST 21 \nand ST 8586 being the most frequent. CC 206 included 18 isolates (19,3%) \ndistrib uted in five different STs including the most abundant ST 572. Finally, CC \n257 with 17 isolates (20,4%) was distributed in four STs (Table 3). By contrast, all \nbut three C. coli  isolates (n=34), belonged to the same clonal complex (CC 828). \nThese four CC p redominated and represent 74% of all the studied isolates.  \nIn total, 46 different STs were found out of which 34 corresponded to C. jejuni \nisolates and 12 to C. coli isolates (Tables 5 and 6). Nineteen unique STs \nheterogeneously distributed among the five  farms  were identified (16 C. jejuni , 3 C. \ncoli); the remaining STs were detected in more than one occasion, being the most \nfrequent with 10 isolates each, ST572 ( C. jejuni, 10,7%) and ST854 ( C. coli, 29,4%) \nand were found in two and three farms, respectiv ely. Overall, 41 ST out of the 46 \nSTs identified were assigned to 16 previously described  clonal complexes (CC) \nwhile the remaining five STs belonged to undefined CC (Tables 5 and 6).  \n  Study I  \n75 \n Table 4.  Allele profiles of C. jejuni  isolates that could not be assigned to a ST.   \n \na) ND, not determined  \n \nAdditionally, several novel STs were identified: five novel STs in 11 C. jejuni  \nisolates and two novel STs in four C. coli  isolates, all of them belonging to \npreviously described CC (CC 21, CC 48, CC 52, CC 206 and CC 257 for C. jejuni ; CC \n828 for C. coli ). Those new STs were found in all farms but not farm D, and were \nmost frequent in farm E, with three novel ST and one of them (ST 8586 with six \nisolates) being the third most common C. jejuni  ST together with the widespread \nST 21. These novel STs were due mostly to new allele combinations (six ST) or to a \nnew allele sequence for the pgm  (865) loci that corresponded to the above \nmentioned ST8586.  \n \nThe overall high diversity of genotypes e ncountered in the five farms is also \nreflected by the few ST found in more than one farm (2 -3 farms): six C. jejuni  ST \n(ST21, ST50, ST122 ST257, ST572, ST824) and two C. coli  ST (ST827, ST854).  \n \n \n \n  \naspA glnA gltA glyA pgm tkt uncA ST CC\nB22 C. jejuni 22d 12 24 2 2 2 10 3 ND - 464\nD4 C. jejuni 14d 2 2 1 ND 3 ND 1 5 - 21\nD5 C. jejuni 21d 2 2 1 12 3 ND 1 5 - 21\nE17 C. jejuni 20d 7 9 2 2 2 ND 5 102 - 257\nE31 C. jejuni 25d 7 9 2 2 2 ND 5 6 - 257\nE35 C. jejuni 25d 12 24 2 2 2 132 3 ND - 464Isolate Species Age FlockSeven housekeeping genesStudy I  \n76 \n Table 5. Allele profiles, sequenc e types (ST), and clonal  complex es (CC) of  C. jejuni  \nisolates (n= 93).  \n \na) Novel STs are indicated in bold. UC, undefined CC.  \nb) In brackets, number of isolates per farm.  \n  \naspA glnA gltA glyA pgm tkt atpA\nCC 21 19 2 1 5 3 2 1 5 1 B\n21 2 1 1 3 2 1 5 6 B (1), C (5)\n47 2 1 1 5 2 1 5 2 E\n50 2 1 12 3 2 1 5 5 A (4), D (1)\n381 2 1 1 3 11 1 5 1 D\n8586 2 1 12 3 865 1 5 6 E\nCC 45 45 4 7 10 4 1 7 1 1 E\nCC 48 48 2 4 1 2 7 1 5 1 C\n5821 2 4 1 2 11 1 5 1 C\n8780 62 4 5 2 22 1 5 2 B\nCC 52 8782 9 2 2 2 113 3 6 1 E\nCC 61 8041 33 4 2 301 10 3 5 1 B\nCC 206 122 6 4 5 2 2 1 5 4 A (3), B (1)\n222 2 21 5 2 59 1 5 2 E\n46 2 21 5 3 2 1 5 1 B\n572 62 4 5 2 2 1 5 10 B (3), D (7)\n8779 62 4 5 2 118 1 5 1 B\nCC 257 257 9 2 4 62 4 5 6 7 B (5), C (1), E (1)\n8781 9 2 4 62 7 5 6 1 C\n824 9 2 2 2 11 5 6 5 B (3), E (2)\n2254 8 2 4 62 4 5 6 4 D\nCC 353 5908 7 2 5 2 104 3 6 2 A\nCC 354 5402 8 10 2 2 2 12 6 1 C\n354 8 10 2 2 11 12 6 1 C\n627 2 2 2 2 11 5 6 1 E\nCC 443 772 7 17 2 15 132 3 12 3 E\nCC 464 5268 24 2 2 2 23 3 1 1 E\nCC 607 904 24 2 5 53 23 3 1 3 E\nCC 658 1044 2 10 2 4 19 3 6 3 A\nCC 692 1301 2 115 57 26 127 29 35 2 E\nCC 1332 6788 2 1 4 28 58 29 58 2 C\nUC 704 2 29 4 27 7 25 57 1 C\nUC 1710 2 71 5 62 22 67 6 3 C\nUC 2224 7 112 5 62 11 67 6 1 EST a AllelesNo. of isolates Farm bCCStudy I  \n77 \n Table 6.  Allele profiles, sequence types (ST), and clonal complexes (CC) of C. coli  \nisolates (n= 34).  \n \na) Novel STs are indicated in bold. UC, undefined CC.  \nb) In brackets, number of isolates per farm.  \nDISCUSSION  \nIn order to study in depth the diversity and population dynamics of Campylobacter  \ngenotypes colonizing broiler flocks, molecular typing was conducted of isolates \nrecovered along all Campylobacter -positive crops reared during an extended \nperiod  in five farms. The genetic instability reported for Campylobacter  spp. makes \nit difficult to interpret its molecular epidemiology (Dingle et al., 2008) . For this \nreason, it is recommended to use more than one typing method. Here, for the \ntyping of C. jejuni  and C. coli  isolates, PFGE and MLST were used.  \nCampylobacter  isolates were first characterized by PFGE using two restriction \nenzymes, which allows for a higher discriminatio n among genotypes (H\u00e4nninen et \nal., 2003; Ribot et al., 2001) . Next, subsets of isolates from all f arms, representing \ndifferent PFGE genotypes from the different crops, were further typed by MLST.  \nThe PFGE and MLST analysis showed the high genetic diversity of Campylobacter  \nisolates that can be found in broilers, demonstrating the genetic instability of  \nCampylobacter  within a crop and between crops from the same farm. This genetic \naspA glnA gltA glyA pgm tkt atpA\nCC 828 827 33 39 30 82 104 56 17 3 B (2), C (1)\n832 33 39 30 79 113 43 17 2 E\n854 33 38 30 82 104 43 17 10 A (3), B (3), C (4)\n894 33 39 65 82 113 47 17 2 A  \n1016 33 38 30 82 118 43 17 4 B  \n2097 33 38 30 238 104 43 36 2 B\n2642 33 38 30 79 104 35 17 3 D\n3097 33 39 30 2 104 56 1 1 B\n8578 33 39 418 82 113 85 17 3 E\n8778 2 39 30 82 188 43 5 1 A\nUC 5150 292 179 30 82 113 206 17 1 B\nUC 7108 33 157 30 557 113 117 68 2 ACC ST a AllelesNo. of isolates Farm bStudy I  \n78 \n instability may be explained by the fact that Campylobacter  and other small -\ngenome bacteria are in constant need of genetic rearrangements in order to \nincrement their potential  and adapt to the environment (Manning et al., 2001; \nWassenaar, 2000) . Also, the high diversity of genotypes might be due to the \nexistence of different sources of Campylobacter  in the external environment of the \nfarms that during the rearing cycles end up colonizing broiler flocks (Kaakoush et \nal., 2015) . \nWhile PFGE is widely used for food -borne pathogen typing in short \nepidemiological studies (rapid detection of outbreaks) (Swaminathan et al., 2001) , \nMLST has been valuable for the identification of the main sources of human \ndisease and it is an important tool in  both short and long -term epidemiological \nstudies (Dingle et al., 2002, 2008) .  \nGenotyping of the isolates has de monstrated that C. jejuni and C. coli  are \ngenetically diverse, regardless of the method used for typing. We have detected a \nbroader genetic diversity by PFGE ( 92 macrorestriction profiles compared to 46 \nSTs among the 127 isolates typed with MLST).  Also, some isolates showing \nidentical PFGE profile presented different STs and CCs by MLST. These apparently \ndifferences between typing methods might be attributed to the fact that the \nCampylobacter genome presents a genetic instability that negatively aff ects the \nPFGE profiles (H\u00e4nninen et al., 1999; Wassenaar et al., 1998) . In highly clonal \nlineages of C. jejuni , PFGE may not be sufficiently discriminatory for epidemiologic \ninvestigat ions (Taboada et al., 2013) . In addition, it appears that integration of \nmobile genetic elements such as bacteriophage can alter PFGE profiles, even in \nclosely related strains (Barton et al., 2007) . Additionally, Campylobacter has a \nweakly clonal population due to extensive horizontal gene transfer and intra -\nmolecular recombination  (Dingle et al., 2005, 2001b) . \nThe reduced number of analysed isolates per sampling in each crop  may have \nlimited our abi lity to assess the succession of genotypes in the different crops. \nThese isolates come from a longitudinal study where the sampling ended when the Study I  \n79 \n 30 cloacal swabs from 30 different birds were positive but only 5 isolates per bird \nage were preserved for fu rther studies. Despite of this, we could observe a high \ngenetic diversity in C. jejuni and C. coli  isolates . Persistent genotypes were detected \nas well in different age groups within the same crop in the same farm.  \nWe did not identify in any farm the same  persistent genotype in consecutive crops. \nThis points to efficient cleaning and disinfection practices in all farms during \ndowntime. However, we have identified four genotypes common to different farms \nduring the same sampling period, but no common source  of Campylobacter  could \nbe identified; it should be taken into account that the five farms belonged to \ndifferent \u201c integrators \u201d and that there is no relation between the m. Distances \nbetween those farms were 15 to 20 km and it seems unlikely a direct transmission \nbetween farms.  \nMLST analysis showed four predominant CC (CC21, CC257, CC206 for C. jejuni ; \nCC828 for C. coli), all of them associated both with human infections and with \npoultry, other farm animals and water  sources (Colles et al., 2003; Dingle et al., \n2001a) . CC61 is predominantly found in bovine and ovine (Colles et al., 2003; \nDingle et al., 2001a)  and only found in farm B, this finding might be related to the \nfact that this far m had in its proximity a bovine farm.  \nOn the other hand, the CC828 has been mainly found in isolates from pigs \n(Manning et al., 2003) , since this CC is from C. coli  and swine is the main animal \nhost for this Campylobacter  species. However, other authors have reported \nisolates within the CC828 that originated from humans or bovi ne from different \nparts of the world (Dingle et al., 2005, Miller et al., 2006). Also, despite this CC has \nbeen associated primarily to C. coli isolates, it has been reported once in C. jejuni \nisolates from turkeys (Kashoma et al., 2014). In this study, al l isolates from CC828 \nwere exclusively C. coli and mostly from farm B. This farm had low level of \nbiosecurity and the farmers also managed a second farm which had both broiler \nhouses and swine houses. The CC206 has been found on a variety of hosts; in \nhuma n infections, it has been associated with sporadic cases of Guillain -Barr\u00e9 Study I  \n80 \n syndrome, as reported in the Pubmlst database \n(www.pubmlst.org/campylobacter ). \nCuriously, within the CC21, ST47 that was isolated in one of the farms  has been \nassociated mostly with beach sand (www.pubmlst.org/campylobacter ). It is \nnoteworthy that the farm where this ST was detecte d is located in the Ebro Delta, \nnearby sand beaches, although it is not possible to establish any direct relation \nbetween the isolation of ST47 in that farm and its geographical location.  It is worth \nnoting that ST45, the central ST of CC45, which has a wo rldwide distribution and is \nfrequently found in isolates from broilers, was found only once. In a broad study \nperformed in Spanish broilers, a low frequency for this ST was observed (our \ngroup unpublished data). According to data from the Pubmlst, this ST is broadly \ndistributed in northern Europe and other countries, such as USA, Canada and \nAustralia.  \nFurthermore, we have observed certain seasonal behaviour of some CC during the \ntwo-year study. CC21 and CC206 were found throughout the year, increasing in \nfrequency during the warmer months and being absent during the coldest \ntrimester (December -February). On the other hand, CC48 was much less frequent, \nand was only observed during the warmer months (June -July). The detection of \nnovel STs in farms occurred spo radically and it coincided mainly with the warmest \nmonths of the year (June -October). These findings are opposite to those reported \nby  Colles et al. (2015 ), where new STs were detected during the winter -spring \nmonths. Sproston et al. (2 011 ), suggests that the population dynamics of \nCampylobacter  colonization is not dependent on meteorological variables, and \ninstead it might be linked to other environmental factors related to the source of \ninfection.  \nIn conclusion, PFGE and MLST have demonstrated their usefulness in order to \nstudy the population dynamics of Campylobacter  strains in Spanish broiler farms, \nproviding insight into the variety of genotypes that are currently circulating. Also, \nMLST remains highly discriminatory and more por table and reproducible than Study I  \n81 \n PFGE. However, h igh-throughput sequencing is revolutionizing research in the \nfield of microbiology, among others. With the drop of costs of bacterial genome \nsequencing, this technology will become a rapid and cost -effective tool  in \nmolecular epidemiology studies r eplacing typing methods such as PFGE and MLST \nused here.  \n  \n \n  \n \n   \n \n  \n \n \n \nStudy II  \nAntimicrobial resistance and virulence factors of  C. jejuni  and C. \ncoli isolated  from broilers along a two-year period  \n   \n \n  \n  Study II  \n85 \n ABSTRACT  \nWith the aim to investigate the occurrence and patterns of antimicrobial \nresistance of Campylobacter  isolates from broilers during a broad period, we \nstudied those isolates recovered during a two -year longitudinal study in five \nbroiler farms. Farms belonged to different poultry integrators. Overall, 344 \nCampylobacter  isolates ( C. jejuni  n = 261; C. coli  n = 83) were tested using the disk -\ndiffusion method. Resistance to quinolones ( nalidixic acid and ciprofloxacin) was \nthe most prevalent, followed by tetracyclines ( tetracycline  and doxicycline ), \nwhereas the resistance rates to erythromycin and gentamicin w ere low. Only five \nisolates of C. jejuni  and one C. coli  isolate from different farms were pansusceptible. \nBesides, all the analyzed isolates were susceptible to chloramphenicol, amoxicillin \nplus clavula nic acid, imipenem and meropenem. No isolate was resi stant to all of \nthe antimicrobials tested, but 62,2 % of the isolates were multidrug -resistant \n(MDR) with some isolates resistant to up to five different classes of antimicrobials. \nHowever, resistance to three classes of antimicrobials with the profile nali dixic \nacid, ciprofloxacin, enrofloxacin, tetracycline, doxicycline , ampicillin was the most \ncommon (13,6%).  A different trend of drug resistance between C. jejuni  and C. coli  \nwas observed along the two -year follow up, with an important increase of \nresistant isolates observed for tetracycline and doxicycline in C. jejuni  and for \nenrofloxacin in C. coli . On the contrary, a great drop in erythromycin resistance \noccurred in C. col i isolates.  On the other hand, we analyzed the occurrence of 14 \nvirulence genes involved in colonization and infection ( flaA, flaB , cadF, dnaJ, pdlA, \nvirB11,  racR , cdtA, cdtB,  cdtC , wlaN, ciaB , ceuE,  hcp) and all of them were  widely \ndistributed in all farm s. Interestingly, we detected the wlaN gene, involved in the \nGuillain -Barr\u00e9 syndrome, in 19% of C. jejuni  and C. coli  isolates. Also, the hcp  gene \nthat encodes a putative type 6 secretion system (T6SS) was detected both in C. \njejuni  and C. coli  isolates, w ith an overall prevalence of 18,2%. MDR, \nfluoroquinolone, tretracycline and macrolide resistance in Campylobacter  Study II  \n86 \n populations are of public health concern, as well as the carriage of certain \nvirulence genes, such as wlaN . \nINTRODUCTION   \nCampylobacteriosis is the leading cause of food -borne  disease in the European \nUnion (EU) with an steady increase of confirmed cases in the last years (EFSA, \n2016) . The main source of infection to humans is  the handling and/or \nconsumption of po orly cooked chicken meat (Friedman et al., 2004) . During 20 15, \nthe notification rate of campylobacteriosis in Spain was 63,3 for every 100.000 \ninhabitants, with a total of 13.227 confirmed cases, which represents an increase \nof 15,3% with respect to the previous year (EFSA, 2016) . However, due to unde r-\nreporting, this figure under estimates  the true impact of the disease.  \nThe great majority of infections in humans are caused by Campylobacter jejuni , \nfollowed by  Campylobacter coli  with most infections being sporadic and self -\nlimiting (Butzler, 2004) . Due to this self -limiting nature of campylobacteriosis, \nantimicrobials are only  recommended for treatment when there is a prolonged or \nsystemic infection. Antimicrobials of preference are fluoroquinolones \n(ciprofloxacin) and  macrolides (erythromycin), followed by tetracyclines as an \nalternative drug  (Butzler, 2004; Iovine, 2013; Yat es, 2005) . \nThe alarming increase of  antimicrobial  drug resistance in human and veterinary \nmedicine is of concern, as it compromises the effectiveness of treatment. Since the \nEU banned in 2006 the use of antimicrobials in feed as growth promoters, only \ncertain compounds are allowed for  the treatment of animal diseases. In poultry \nproduction, the uses of chloramphenicol, olaquindex (second generation \nquinolones) and third and fourth generation of cephalosporin are prohibited.  \nConsidering the main cause of human campylobacteriosis, it is relevant the \nassessment of the antimicrobial resistance of Campylobacter  isolates from poultry.  Study II  \n87 \n Several studies have reported the antimicrobial resistance rates of avian  \nCampylobacter  spp. isolates in different countries and  a diversity of resistance \nrates among countries is frequently found (Skarp et al., 2016) . Widespread  \nCampylobacter  resistance to quinolones has been reported in poultry isolates  \n(Duarte et al., 2014; Messad et al., 2014; Nobile et al., 2013; Wimalarathna et al., \n2013) . Also, multidrug resistant C. jejuni  and C. coli have been reported in isolates \nfrom consumption animals,  particularly poultry and pigs (Datta et al., 2003; \nThakur et al., 2006; Thakur and Gebreyes, 2005; Zhao  et al., 2001) . Some studies in \nSpain have reported C. jejuni  and C. coli resistance rates in poultry, although a \nlimited number of isolates were tested (Melero et al., 2012; Oporto et al., 2009; \nS\u00e1enz et al., 2000) . In most of them, high resistance rates to fluoroquinolones and \ntetracyclines were found.  \nOn the other hand, the severity of Campylobacter  spp. infections depends mainly \non the virulence of the strain and the immunological state of the host. In spite of \nCampylobacter  importance as a pathogen transmitted by food, exact mechanisms \nthrough which infection is produced are still unknown. In fact,  the specific \nvirulence factors are still not clear for this bacterium, probably due to the lack of \nsimilarity between Campylobacter  spp. and other enteric pathogens (Dasti et al., \n2010; Guerry, 2007) . Several virulence factors involved in motility ( flaA and flaB ), \nintestinal adhesion ( cadF, dnaJ, pdlA, virB11  and racR ), toxin production ( cdtA, \ncdtB and cdtC ), invasion ( ciaB  and ceuE ), or the gene involved in the Guillain -Barr\u00e9 \nsyndrome ( wlaN ), among oth ers, have been identified.  \nThe aim of this study was to monitor the resistance to a panel of 12 antimicrobials \nand to assess the virulence -associated genes of Campylobacter  strains isolated \nfrom broilers along the rearing cycles of those flocks raised dur ing two years in \nfive farms in Spain.  \n  Study II  \n88 \n MATERIALS AND METHODS  \nBacterial isolates  \nThree hundred and forty four Campylobacter  isolates ( C. jejuni  n = 261,  C. coli  n = \n83) from broilers from five farms from different  poultry integrators were tested \nfor their susceptibility to a panel of antimicrobials.  Determination of virulence -\nassociated genes was performed on a selection of 126 isolates ( 93 of  C. jejuni and \n33 of  C. coli ) according to their different genotype (according to study I). Those \nisolates were obta ined from a two -year longitudinal study carried out in five \nbroiler farms  (Urdaneta, 2016) . All farms were located in Catalonia region \n(Northeastern Spain). Six to seven flocks per farm were raised each year, and \nweekly visits were performed  (each 2 to 5 days). From each Campylobacter -\npositive sampling  per crop, five  isolates from five different birds randomly \nselected among up to 30 Campylobacter  positive birds per sampling,  were \nspeciated and preserved at -80\u00b0C in brain heart infusion broth with 20% glycerol . \nFresh cultures of the  isolates were prepared on Columbia blood agar plates \n(bioM\u00e9rieux, Marcy -l\u2019Etoile, France). Plates were incubated at 37\u00b0C for 48 h under \nmicroaerobic conditions using a microaerobic atmosphere generator (Anaerocult\u00ae \nC, Merck, Darmstadt, Germany).  \nDetermination of antimicrobial resistance  \nAntimicrobial susceptibility testing was performed according to the Clinical \nLaboratory and Standard Institute (CLSI) disk diffusion method (M100 -S18; CLSI, \n2008) using Neo -Sensitabs\u2122 (Rosco  Diagnostica, Taastrup, Denmark) with CLSI \npotencies according to t he manufacturer\u2019s instructions. Mueller -Hinton II agar \nsupplemented with 5% desfibrinated  sheep blood (BioM\u00e9rieux, Marcy l'Etoile, \nFrance ) was streaked to form a bacterial lawn of Campylobacte r and incubated \nwith antimicrobial discs  at 37 \u00b0C for 48 h under microaerobic conditions. C. jejuni  \nATCC35560 reference strain was used as a quality control. All C ampylobacter  Study II  \n89 \n isolates were tested for susceptibility against 12  antimicrobial agents which \nincluded  four \u03b2 -lactams: ampicillin (AMP ; 10\u00b5g), amoxicillin + clavulanate (AMC; \n20+10\u00b5g), imipenem (IMI; 10\u00b5g), meropenem (MER; 10\u00b5g); three quinolones: \nnalidixic acid (NAL; 30\u00b5g), ciprofloxacin (CIP; 5\u00b5g), enrofloxacin (ENR; 10\u00b5g); two \ntetracyclines: tetracycline (TET; 30\u00b5g) and doxicycline (D OX; 30\u00b5g); and three  \nother  miscellaneous  antimicrobials: gentamicin (GEN; 10\u00b5g); erytromycin (ERY; \n15\u00b5g), and chloramphenicol (CHL; 30\u00b5g).  The diameter of the bacterial growth  \ninhibition  was  measured and designated as resistant, intermediate, or susceptibl e \non the basis of Clinical  Laboratory  Standards (Neo -sensitabs  Potency  according to \nCLSI 2013).  An isolate  was  considered  as multidrug  resistant (MDR) when  it was  \nresistant to three or more  classes  of antimicrobials  (Schwarz et al., 2010) . \nDetection of virulence -associated genes  \nThe presence of 14 different  virulence genes involved in motility ( flaA , flaB ), \nadhesion ( cadF, dnaJ, pdlA  and racR ), invasion ( ciaB  and ceuE ), citotoxicity ( cdtA, \ncdtB, virB11  and cdtC ), the gene involved in the Guillain -Barr\u00e9 syndrome ( wlaN ) \nand type 6 secretion system (T6SS - hcp) were determined by PCR. Details of the \nstudied genes, primers used, size of the amplicon and temperature of annealing \nare presented in Table 1. All the PCR amplifications were performed using the \nprotocol standardized by (Koolman et al., 2015) , with some modifications in the \nannealing temperature detailed in Table 1.  \nStatistical analysis of results  \nThe prevalence of each antimicrobial resistance between Campylobacter  species \nwas compared using Chi -squared test analyses. Statistical significance was defined \nat the p\u22640.05.  \n  Study II  \n90 \n Table 1. PCR primers used for virulence gene detection.  \n \nRESULTS  \nAntimicrobial resistance  \nOverall, 344 isolates ( C. jejuni =261 and C. coli =83) from five different broiler farms \nwere evaluated for their antimicrobial susceptibilities to 12 antimicrobials. \nResistance against the quinolones NAL and CIP , was the most prevalent, with over \n90% of the isolates being resistant, followed by resistanc e to tetracyclines  (72,9% \nTET and 61,3% DOX) and AMP (61,3%)  (Table 2). On the other hand, resistance to  \nERY (18,6%) and GEN (9,3%) were the less prevalent. All the analysed isolates \nwere susceptible  to CHL , AMC , IMI and MER . Certain differences in drug re sistance \nrates were detected among farms, such as lower resistance to ENR  in farms C and \nD, whilst higher rate of resistance was found in farm E; lower frequency of TET  \nGene Primer Sequence 5'- 3'Amplicon \nsize (bp)Annealing \ntemperatureReference\nflaA flaA 664 AATAAAAATGCTGATAAAACAGGTG 855 55\u00b0C Datta et al., 2003\nflaA 1494 TACCGAACCAATGTCTGCTCTGATT\nflaB flaB-F AAGGATTTAAAATGGGTTTTAGAATAAACACC 260 55\u00b0C Goon et al., 2003\nflaB-R GCTCATCCATAGCTTTATCTGC\ncadF cadF-F2B TTGAAGGTAATTTAGATATG 400 55\u00b0C Datta et al., 2003\ncadF-R1B CTAATACCTAAAGTTGAAAC\ndnaJ dnaJ-299 AAGGCTTTGGCTCATC 720 40\u00b0C Datta et al., 2003\ndnaJ-1003 CTTTTTGTTCATCGTT\nracR racR-25 GATGATCCTGACTTTG 584 40\u00b0C Datta et al., 2003\nracR-593 TCTCCTATTTTTACCC\nvirB11 virB-232 TCTTGTGAGTTGCCTTACCCCTTTT 494 45\u00b0C Datta et al., 2003\nvirB-701 CCTGCGTGTCCTGTGTTATTTACCC\npldA pldA-84 AAGCTTATGCGTTTTT 913 45\u00b0C Datta et al., 2003\nPld-981 TATAAGGCTTTCTCCA\nceuE (Cj) JEJ1 CCTGCTCGGTGAAAGTTTTG 794 50\u00b0C Bang et al., 2003\nJEJ2 GATCTTTTTGTTTTGTGCTGC\nceuE (Cc) COL1 ATGAAAAAATATTTAGTTTTTGCA 894 55\u00b0C Bang et al., 2003\nCOL2 ATTTTATTATTTGTAGCAGCG\nciaB ciaB-403 TTTTTATCAGTCCTTA 986 45\u00b0C Datta et al., 2003\nciaB-1373 TTTCGGTATCATTAGC\ncdtA DS-18 CCTTGTGATGCAAGCAATC 370 55\u00b0C Hickey et al., 2000\nDS-15 ACACTCCATTTGCTTTCTG\ncdtB cdtB-113 CAGAAAGCAAATGGAGTGTT 620 55\u00b0C Datta et al., 2003\ncdtB-713 AGCTAAAAGCGGTGGAGTAT\ncdtC  cdtC-351 CGATGAGTTAAAACAAAAAGATA 182 55\u00b0C Datta et al., 2003\ncdtC-351 TTGGCATTATAGAAAATACAGTT\nwlaN wlaN-DL-39 TTAAGAGCAAGATATGAAGGTG 672 45\u00b0C Linton et al., 2003\nwlaN-DL-41 CCATTTGAATTGATATTTTTG\nhcp hcp-F CAAGCGGTGCATCTACTGAA 463 56\u00b0C Corcionivoschi et al., 2015\nhcp-R TAAGCTTTGCCCTCTCTCCAStudy II  \n91 \n resistance in farm E compared to the other farms; or for ERY  and GEN  in farm C \nand E, w here no resistant isolates or with a very low proportion were detected \n(Table 2).  When comparing among Campylobacter  species, some differences were \nalso found.  A higher rate of resistance to TET , ERY  and GEN  was found in C. coli  \ncompared to C. jejuni  (Table 3).  On the contrary, AMP  resistance was higher in C. \njejuni isolates in three farms (B, C, and E). Also, whilst ENR  resistance was \nmoderately low in most farms, it was considerably higher in C. coli  in farm B and in \nC. jejuni  in farm E.  \nOnly  six isolates were pansusceptible, out of which five were C. jejuni  isolates from \nthe same crop  from farm C and one C. coli  isolate from farm B (Table 4).  On the \ncontrary, 62,20 % of the isolates were MDR  (55,1 % C. jejuni  and 84,3 % C. coli ). No \nisolates were  resistant to all of the antimicrobials tested.  The MDR resistance \nprofile \u201cNAL, CIP, TET, DOX\u201d was  identified at least once in all the farms  (5,8%).  No \nMDR profile common to all farms was found. However, \u201cNAL, CIP, ENR, TET, DOX, \nAMP\u201d  profile was the most  common (13,9 %) in four farms.  In farms A and B, MDR \nagainst up to five different families of antibiotics was detected  all in C. coli  isolates \n(Table 4).  Study II  \n92 \n Table 2. Frequency of resistance of Campylobacter spp. isolates per farm.  \n \n \n \n \n \n \n \na) Number of antimicrobial resistant isolates (%).  \nb) All isolates were sus ceptible to: chloramphenicol 30 \u00b5g; amoxicillin + clavulanate (20+10 \u00b5g), \nimipenem 10 \u00b5g. and meropenem 10 \u00b5g.  \n \n \n \n  \nFarm A Farm B Farm C Farm D Farm E \n(n=55) (n=76) (n=73) (n=55) (n=85)\nNalid\u00edxic acid  30 \u00b5g 55 (100)a75 (98,6) 58 (79,4) 55 (100) 80 (94,1) 323 (93,8)\nCiprofloxacin 5 \u00b5g 46 (83,6) 69 (90,7) 58 (79,4) 55 (100) 79 (92,9) 307 (89,2)\nEnrofloxacin 10 \u00b5g 18 (32,7) 35 (46) 13 (17,8) 9 (16,3) 54 (63,5) 129 (37,5)\nTetracycline 30 \u00b5g 45 (81,8) 63 (82,8) 68 (93,1) 45 (81,8) 30 (35,2) 251 (72,9)\nDoxycycline 30 \u00b5g 32 (58,1) 48 (63,1) 46 (63) 23 (41,8) 62 (72,9) 211 (61,3)\nErytromycin 15 \u00b5g 27 (49,1) 25 (32,8) 0 (0,00) 7 (12,7) 5 (5,8) 64 (18,6)\nGentamicin 10 \u00b5g 16 (29) 7 (9,2) 0 (0,00) 7 (12,7) 2 (2,3) 32 (9,3)\nAmpicillin 10 \u00b5g 28 (50,9) 56 (73,6) 33 (45,2) 34 (61,8) 60 (70,5) 211 (61,3)Total (%) \n(n=344)AntimicrobialsStudy II  \n93 \n Table 3. Frequency of antimicrobial resistance of C. jejuni and C. coli  isolates per farm.  \n \na) Number of antimicrobial resistant isolates (%).  \nb) All isolates susceptible to: chloramphenicol 30 \u00b5g; amoxicillin + clavul anate (20+10 \u00b5g) ; imipenem 10 \u00b5g. and meropenem 10 \u00b5g.  \n \n \nC. jejuni \n(n=31)C. coli \n(n=24)C. jejuni \n(n=55)C. coli \n(n=21)C. jejuni \n(n=53)C. coli \n(n=20)C. jejuni \n(n=49)C. coli \n(n=6)C. jejuni \n(n=73)C. coli \n(n=12)C. jejuni \n(n=261)C. coli \n(n=83)\nNalid\u00edxic acid  30 \u00b5g 31 (100)a24 (100) 55 (100) 20 (95,2) 38 (71,7) 20 (100) 49 (100) 6 (100) 68 (93,2) 12 (100) 241 (92,3) 82 (98,7) 323 (93,8)\nCiprofloxacin 5 \u00b5g 22 (71) 24 (100) 51(92,7) 18 (85,7) 38 (71,7) 20 (100) 49 (100) 6 (100) 67 (91,8) 12 (100) 227 (86,9) 80 (96,3) 307 (89,2)\nEnrofloxacin 10 \u00b5g 11 (35,4) 7 (29,2) 20 (36,4) 15 (71,4) 12 (22,6) 1 (5) 8 (16,3) 1 (16,7) 45 (61,6) 9 (75) 96 (36,7) 33 (39,7) 129 (37,5)\nTetracycline 30 \u00b5g 22 (71) 23 (95,8) 43 (78,2) 20 (95,2) 48 (90,6) 20 (100) 39 (79,6) 6 (100) 18 (24,7) 12 (100) 170 (65,1) 81 (97,5) 251 (72,9)\nDoxycycline 30 \u00b5g 9 (29) 23 (95,8) 31 (56,4) 17 (81) 29 (54,8) 17 (85) 17 (34,7) 6 (100) 50 (68,5) 12 (100) 136 (52,1) 75 (90,3) 211 (61,3)\nErytromycin 15 \u00b5g 4 (12,9) 23 (95,8) 5 (9,1) 20 (95,2) 0 (0,00) 0 (0,00) 1 (2) 6 (100) 5 (6,8) 0 (0,00) 15 (5,74) 49 (59,0) 64 (18,6)\nGentamicin 10 \u00b5g 0 (0,00) 16 (66,6) 0 (0,00) 7 (33,3) 0 (0,00) 0 (0,00) 1 (2) 6 (100) 2 (2,7) 0 (0,00) 3 (1,14) 29 (34,9) 32 (9,3)\nAmpicillin 10 \u00b5g 13 (42) 15 (62,5) 40 (72,8) 16 (46,2) 33 (62,3) 0 (0) 33 (67,3) 1 (83,3) 59 (80,8) 1 (8,3) 178 (68,1) 33 (39,7) 211 (61,3)Farm E TotalTotal (%) \n(n=344)AntimicrobialsFarm A Farm B Farm C Farm D Study II  \n94 \n A different trend of resistance to different antimicrobials was observed in C. jejuni  \nand C. coli  along the two -year follow up  (Figure 1, 2 and 3) . Whilst resistances to \ncertain antimicrobials remained stable throughout the two -year follow up, such as \nthose to nalidixic acid and ciprofloxacin, others varied greatly. This was the case \nfor enrofloxacin in C. coli  isolates, or for tetracycline and doxicy cline in C. jejuni  \nisolates, where an important increase of resistant isolates was observed. On the \ncontrary, a great drop in erythromycin resistance occurred in C. coli  isolates.  These \ndifferences between C. jejuni  and C. coli  highlight the importance of monitoring.  \nThese differences between C. jejuni  and C. coli  and in the temporal trend of \nantimicrobial resistance highlight the importance of resistance monitoring and to \ndifferentiate between Campylobacter  species to have an accurate picture  to have \nand a ctual scenario.  \nVirulence determinants  \nThe 14 virulence -associated genes tested were in general widely distributed in all \nfarms, although three of them with low frequency ( dnaJ,  wlaN , hcp ) (Table 5). T he \ngenes implicated in motility  (flagellin  genes  flaA and flaB) were evidenced more \nfrequently in C. coli  isolates. Conversely, the genes associated with adhesion ( cadF, \ndnaJ, racR, VirB11  and pdlA),  showed  a heterogeneous distribution between the \ntwo Campylobacter species, a lthough it was observed more  frequently  in C. jejuni . \nThe genes implicated in invasion  were more frequent in C. jejuni  isolates  in most of \nthe farms.  On the other hand, the cdtA, cdtB and cdtC  toxin genes were detected in \nall the studied farms, but more fr equently in C. jejuni  isolates. The  wlaN gene, \nassociated with Guillain -Barr\u00e9 syndrome, was detected in all farms, mostly in C. \njejuni  isolates  but it was also detected in 4 C. coli  isolates from two farms . Finally, \nthe recently described type 6 secretion system (T6SS) was detected in all but one \nfarm. Study II  \n95 \n Table 4. Antimicrobial resistance patterns of Campylobacter isolates according to farm origin.  \n \n \n  \nC. jejuni \n(n=31)C. coli \n(n=24)C. jejuni \n(n=55)C. coli \n(n=21)C. jejuni \n(n=53)C. coli \n(n=20)C. jejuni \n(n=49)C. coli \n(n=6)C. jejuni \n(n=73)C. coli \n(n=12)C. jejuni \n(n=261)C. coli \n(n=83)\nTET 1 0 0 0 0 10 0 4 0 1 0 15 0\nNAL, CIP 1 2 0 1 0 0 0 0 0 0 0 3 0\nNAL, TET 2 8 0 0 0 0 0 0 0 0 0 8 0\nNAL, AMP 2 0 0 1 0 0 0 0 0 0 0 1 0\nNAL, CIP,ENR 1 1 0 8 0 0 0 1 0 1 0 11 0\nNAL, CIP, TET 2 4 0 1 0 0 0 9 0 0 0 14 0\nNAL, CIP, AMP 2 1 0 2 0 0 0 5 0 7 0 15 0\nNAL, TET, AMP 3 0 0 1 0 0 0 0 0 0 0 1 0\nNAL, TET, ERY 3 0 0 0 2 0 0 0 0 1 0 1 2\nNAL, TET, DOX 2 1 0 0 0 0 0 0 0 0 0 1 0\nTET, DOX, AMP 2 0 0 0 0 0 0 0 0 5 0 5 0\nNAL, CIP, ENR, TET 2 1 0 0 0 0 0 0 0 0 0 1 0\nNAL, CIP, ENR, AMP 2 5 1 0 0 0 0 0 0 6 0 11 1\nNAL, CIP, ENR, DOX 2 0 0 0 0 0 0 0 0 1 0 1 0\nNAL, CIP, TET, AMP 3 0 0 8 0 2 0 11 0 4 0 25 0\nNAL, CIP, TET, DOX 2 4 0 5 0 1 0 1 0 6 3 17 3\nNAL, CIP, TET, ERY 3 0 0 0 1 0 3 0 0 0 0 0 4\nNAL, TET, DOX, AMP 3 0 0 1 0 0 0 0 0 1 0 2 0\nNAL, CIP, ENR, TET, AMP 3 0 0 0 0 8 0 1 0 1 0 10 0\nNAL, CIP, ENR, TET, DOX 2 0 0 0 0 3 0 0 0 2 8 5 8\nNAL, CIP, ENR, DOX, ERY 3 0 0 0 0 0 0 0 0 1 0 1 0\nNAL, CIP, ENR, GEN, AMP 3 0 0 0 0 0 0 0 0 1 0 1 0\nNAL, CIP, TET, DOX, ERY 3 0 0 7 0 0 16 0 0 0 0 7 16\nNAL, CIP, TET, DOX, AMP 3 0 0 5 0 23 0 11 0 4 0 43 0\nNAL, TET, DOX, ERY, AMP 4 0 0 2 0 0 0 0 0 0 0 2 0Total Farm D Farm E \nAntimicrobial resistance profile aAntimicrobial \nclass bFarm A Farm B Farm C Study II  \n96 \n Table 4.  Continued  \n \na) NAL: nalidixic acid (30 \u00b5g), CIP: ciprofloxacin (5 \u00b5g), ENR: enrofloxacin (10 \u00b5g), TET: tetracycline (30 \u00b5g), DOX: doxicycline (30 \u00b5g), ERY: erytromycin \n(15 \u00b5g), GEN: gentamicin (10 \u00b5g), AMP: ampicillin (10 \u00b5g).  \nb) Number of different antimicrobial classes per resistance profile; resistance t o \u2265 3 antimicrobial classes is a multiresistant phenotype.  \n \n \n \n \n  \nC. jejuni \n(n=31)C. coli \n(n=24)C. jejuni \n(n=55)C. coli \n(n=21)C. jejuni \n(n=53)C. coli \n(n=20)C. jejuni \n(n=49)C. coli \n(n=6)C. jejuni \n(n=73)C. coli \n(n=12)C. jejuni \n(n=261)C. coli \n(n=83)\nNAL, CIP, ENR, TET, DOX, ERY 3 0 0 0 0 0 1 0 0 0 0 0 1\nNAL, CIP, ENR, DOX, ERY, GEN 4 0 0 0 0 0 0 0 0 1 0 1 0\nNAL, CIP, ENR, TET, DOX, AMP 3 0 0 11 0 1 0 5 0 30 1 47 1\nNAL, CIP, TET, DOX, ERY, GEN 4 0 8 0 0 0 0 0 0 0 0 0 8\nNAL, CIP, TET, DOX, ERY, AMP 4 0 3 2 2 0 0 0 1 0 0 2 6\nNAL, CIP, ENR, TET, DOX, ERY, GEN 4 0 1 0 6 0 0 1 5 0 0 1 12\nNAL, CIP, ENR, TET, DOX, ERY, AMP 4 4 4 0 3 0 0 0 0 0 0 4 7\nNAL, CIP, TET, DOX, ERY, GEN, AMP 5 0 6 0 0 0 0 0 0 0 0 0 6\nNAL, CIP, ENR, TET, DOX, ERY, GEN, AMP 5 0 1 0 6 0 0 0 0 0 0 0 7\nPan-susceptible 0 0 0 1 5 0 0 0 0 0 5 1Antimicrobial resistance profile aAntimicrobial \nclass bFarm A Farm B Farm C Farm D Farm E TotalStudy II  \n97 \n Table 5. Prevalence of virulence genes among C. jejuni  and C. coli  isolates.  \n \na) Number of isolates positive (%) . \nC. jejuni \n(n=12)C. coli \n(n=7)C. jejuni \n(n=20)C. coli \n(n=13)C. jejuni \n(n=17)C. coli \n(n=5)C. jejuni \n(n=15)C. coli \n(n=3)C. jejuni \n(n=29)C. coli \n(n=5)C. jejuni \n(n=93)C. coli \n(n=33)\nMotility\n     flaA 8 (66,6)a5 (71,4) 9 (45) 12 (92,3) 11 (64,7) 5 (100) 7 (46,6) 2 (66,6) 19 (65,5) 5 (100) 54 (58) 29 (88) 83 (65,8)\n     flaB 11 (91,6) 7 (100) 17 (85) 13 (100) 14 (82,3) 5 (100) 13 (86,6) 3 (100) 25 (86,2) 5 (100) 80 (86) 33 (100) 113 (89,6)\nAdhesion\n     cadF 7 (58,3) 3 (42,8) 13 (65) 2 (15,3) 12 (70,5) 3 (60) 5 (33,3) 1 (33,3) 17 (58,6) 1 (20) 54 (58) 10 (30) 64 (50,8)\n     dnaJ 1 (8,3) 1 (14,2) 7 (35) 0 (0) 2 (11,7) 2 (40) 2 (13,3) 0 (0) 4 (13,7) 1 (20) 16 (17) 4 (12) 20 (15,8)\n     racR 6 (50) 1 (14,2) 12 (60) 0 (0) 4 (23,5) 2 (40) 2 (13,3) 0 (0) 8 (27,5) 1 (20) 31 (33) 4 (12) 35 (27,7)\n     virB11 6 (50) 0 (0) 12 (60) 1 (7,6) 7 (41,1) 4 (80) 1 (6,6) 2 (66,6) 5 (17,2) 2 (40) 31 (33) 9 (27) 40 (31,7)\n     pdlA 11 (91,6) 5 (71,4) 15 (75) 5 (38,4) 12 (70,5) 3 (60) 4 (26,6) 0 (0) 18 (62) 2 (40) 60 (65) 15 (45) 75 (59,5)\nInvasion\n     ceuE 7 (58,3) 1 (14,2) 10 (50) 2 (15,3) 9 (52,9) 2 (40) 5 (33,3) 0 (0) 21 (72,4) 1 (20) 52 (56) 6 (18) 58 (46)\n     ciaB 11 (91,6) 4 (57,1) 16 (80) 8 (61,5) 6 (35,2) 2 (40) 2 (13,3) 0 (0) 10 (34,4) 1 (20) 45 (48) 15 (45) 60 (47,6)\nToxin \nproduction \n     cdtA 8 (66,6) 3 (42,8) 18 (90) 1 (7,6) 12 (70,5) 3 (60) 14 (93,3) 3 (100) 25 (86,2) 1 (20) 77 (83) 11 (33) 88 (69,8)\n     cdtB 9 (75) 3 (42,8) 17 (85) 5 (38,5) 13 (76,4) 3 (60) 11 (73,3) 3 (100) 23 (79,3) 1 (20) 73 (78) 15 (45) 88 (69,8)\n     cdtC 12 (100) 4 (57,1) 19 (95) 5 (38,5) 13 (76,4) 4 (80) 14 (93,3) 3 (100) 27 (93,1) 1 (20) 85 (91) 17 (52) 102 (80,9)\nGBS\n     wlaN 7 (58,3) 1 (14,2) 8 (40) 3 (23) 2 (11,7) 0 (0) 1 (6,6) 0 (0) 3 (10,3) 0 (0) 21 (23) 4 (12) 25 (19,8)\nT6SS\n     hcp 1 (8,3) 2 (28,5) 3 (15) 2 (15,3) 4 (23,5) 4 (80) 0 (0) 0 (0) 6 (20,6) 1 (20) 14 (15) 9 (27) 23 (18,2)Total \n(n=126) Farm E \nGeneFarm A Farm B Farm C Farm D TotalStudy II  \n98 \n DISCUSSION  \nWith the aim to determine the presence and pattern of antimicrobial resistance in \nCampylobacter  isolates on farm, and to study their pathogenic potential, the  \nisolates recovered along a long term monitoring in  five poultry farms in Catalonia \n(north -eastern  Spain ) were analyzed . Campylobacter  infections caused by resistant \nstrains may cause treatment failure and since poultry handling or consumption is \nthe main risk factor of acquiring campylobacteriosis, assessment of the resistance \nof Campylobacter  in poul try farms is of relevance.  \nThe disc diffusion method has been described in several studies as an adequate \nscreening method  to assess  antimicrobial resistance for a large number of isolates  \n(Lehtopolku et al., 2010) , and was the method of choice in this study . Also, it is \naccepted by the CLSI and other organizations (i.e., EUCAST) for the discrimination \nbetween resistant and susceptible strains  \nA high resistance to quinolones ( NAL  and CIP), tetracyclines and ampicillin was \nfound  throughout the study period . This is of concern, since  quinolones are used as \nthe first choice to treat serious human Campylobacter  infections, whereas \ntetracyclines are used as an alternative therapy  (Butzler, 2004; Moore et al., 2006) . \nOur findings of high quinolone resistance are in line with s tudies performed in \nSpain and other EU countries, that have demonstrated that poultry isolates \npresent a high resistance against this class of antimicrobials (Luber et al., 2003; \nMelero et al., 2012; P\u00e9rez -Boto et al., 2013a) . Among the different quinolones \ntested, the lowest resistance  rate  was detected for ENR . This is surprising  given \nthat this antimicrobial was frequently administered  in all of the studied farms \nwhen required . Higher rate of quinolone resistance was found among C. coli  \nisolates, similarly to what has commonly been reported for poultry isolates \n(Desmont s et al., 2004) . Nonetheless, opposite findings have been recently \nreported from isolates from avian origin in Spain (P\u00e9rez -Boto et al., 2013a) . The Study II  \n99 \n use of quinolones, mainly ENR , in veterinary praxis, has been related with the \nincrease of resistan ce to CIP in Campylobacter  strains from EU countries (Piddock, \n1995) , including Spain (Vel\u00e1zquez et al., 1995) . However, it has been show n that in \nthe absence of antibiotic selection pressure, fluoroquinolone resistance did not \ndecrease. This may be explained by the fact that fluoroquinolone resistance seems \nto provide certain advantage in the colonization of birds without loss of their \nbiological fitness (Luo et al., 2005) .  \nResistance to t etracyclines (TET and DOX)  was the second most frequent, with  an \noverall resistance rate to TET  (72,9%) higher than what has b een reported in \navian isolates in Spain (P\u00e9rez -Boto et al., 2013a) . However, the extremely high \nproportion of TET  resistance in C. coli  isolates (97,5%) was similar to that \nreported previously in poultry in Spain  (Duar te et al., 2016; Melero et al., 2012; \nP\u00e9rez -Boto et al., 2013a) . A high proportion of resistant isolates from  farm A were \ndetected , despite that this was the only farm where this antimicrobial had not \nbeen used during the two -year follow up . The high percentage of resistance \nagainst tetracyclines in C. coli  isolates has been linked  with the regular use of these \nantibiotics in porcine husbandry (Payot et al., 2004) . Swine is the main host for C. \ncoli, but it also appears frequent ly in poultry (Horrocks et al., 2009) . \nAmong \u03b2-lactam s tested , resistance was only observed against AMP  (61,3%), with \na higher resistance in C. jejuni  compared to  C. coli . These  results are higher than \nthe 55% reported by S\u00e1enz et al. ( 2000) , in broilers in Spain. Remarkably, \u03b2-\nlactam s (especially ampicillin and amoxicillin)  were frequently used in all five \nstudy farms. It should be noted that t he European Food Safety Authority (EFSA) \nconsiders the surveillance  of \u03b2-lactam s as a low priority  (EFSA, 2008) , since they \nare not used in human campilobacteriosis treatment . \nMacrolides are considered as the treatment  of choice for severe cases of \ncampilobacteriosis and resistance rates are generally low among avian  isolates \n(0,3% - 20%) (Gyles, 2008) . In this study, resistance against these antimicrobials Study II  \n100  \n was 18,6% of all the studied isolates,  and was more frequent in C. coli  than  in C. \njejuni  isolates . This rate  is higher than that described by others in avian isolates \nfrom Spain (2,3%) (P\u00e9rez -Boto et al., 2014b)  or in other European countries (UK, \n2%) (Gyles, 2008) . As for tetracyclines, resistance against macrolides has been \nusually linked with C. coli , and it is believed that it is due to the use of macrolide \nderivatives ( tylosin) as a growth promoter for pigs for many years  (Gibreel and \nTaylor, 2006) . \nOverall, the lowest resistance was reported to GEN  (9,3%) and it was more \nfrequently found in C. coli  isolates. Gentamycin used to be  an effective agent in the \ntreatment of Campylo bacter -caused enteritis in humans (Aarestrup et al., 1997; \nVel\u00e1zquez et al., 1995) . Resistance against GEN  in isolates from animals may be \nrelated to the u se of apramycin (an aminoglycoside, structurally related to GEN ) in \nveterinary therapy (S\u00e1enz et al., 2000) . \nNo antimicrobial resistance was found against AMC , IMI, MER and CHL. \nAdditionally, in our study, 1,74 % of the isolates were pan-susceptible, despite \nsharing the same e nvironmental niche as the rest of the resistant isolates (Table \n4). MDR was lower  in C. jejuni  (55,1 %) than in C. coli  (84,33 %), according  to what \nhas been reported in other studies where avian isolates were analysed (D\u2019Lima et \nal., 2007; Desmonts et al. , 2004; P\u00e9rez -Boto et al., 2013 ). This high prevalence of \nMDR is worrisome and is notably higher than that reported in other studies of \navian isolates using the same screening method   (P\u00e9rez -Boto et al., 2013 ). \nOn the other hand,  the present study provides information about 14 virulotypes in  \nC. jejuni  and C. coli  isolates. It is known that, for colonization to take place in the \nintestine, it is required that the bacteria have the capacity to produce motility, \nadhesion, invasion an d production of toxins (Bang et al., 2003) . Among the \nflagellar genes, the flab was  present i n all C. coli  isolates, while it was present in a \nhigh proportion of C. jejuni  isolates, similarly to what has  been previously \ndescrib ed by Datta et al. (2003)  and M\u00fcller et al.  (2006) . Flagellum -based motility Study II  \n101  \n is a very important factor for Campylobacter  colonization (Velayudhan et a l., 2004)  \nand it is essential to survive the intestinal peristalsis (Hendrixson and DiRita, \n2004) . Additionally, it is believed that the flagellum possesses the abilit y to secrete \nnon-flagellar proteins that might be associated with virulence (Poly and Guerry, \n2008) .   \nThe presence of genes involved in adhesion and invasion ( cadF, dnaJ, racR, virB11 , \npdlA, ceuE and ciaB ), presented a rather heterogeneous distribution among C. \njejuni  isolates and to a lesser degree in C. coli  isolates . This data suggests that the \nadhesion and invasion genes are not very conserved between Campylobacter  \nisolates, as previously reported  by Datta  (2003) . The hcp gene encodes a putative \nT6SS , a mutation of which can cause a six fold reduction in adherence compared to \nthe wild -type strain (Bacon et al., 2000) . \nCytolethal distending toxin genes (cdtABC) had a high prevalence among isolates \nfrom different farms . However, we detected a lower prevalence of the cdtA gene \nand a higher prevalence for the cdtC gene . These data is similar to that reported by \nKoolman et al.( 2015) , while it differs from that reported by Bang et al.  (2003) . It is \nknown that both cdtA  and cdtC  are necessary for the b inding with the host cell, \nwhereas the cdtB  is the active residue that penetrates the cell in order to provoke \ncellular dea th (Dasti et al., 2010 ). Furthermore, the wlaN  gene, responsible for the \nappearance of Guillain -Barr\u00e9 syndrome, was detected in 19% of the total analysed \nisolates , mostly in C. jejuni . This frequency similar to that previously reported by  \nKoolman et al. (2015) , but notably higher than what was reported by Datta et al. \n(2003) . \nAdditionally, t he T6SS has been recently reported in Campylobacter . This secretion \nsystem has been related with C. jejuni  isolates and associated with severe forms of \ncampilobacteriosis (Bleumink -Pluym et al., 2013) . A significant component of the \nT6SS is the product of the hcp gene and its presence has been described as an \nindicative of a functional T6SS in C. jejuni  (Bleumink -Pluym et al., 2013) . It has Study II  \n102  \n been reported that the incidence of the hcp gene is relatively higher in C. jejuni  \nisolates from Asia, whereas in the United Kingdom, the proportion of poultry \npositive for T6SS is low (Harrison et al., 2014) . However, in the present study we \nhave found C. jejuni  isolates positive for the hcp gene on four out of the five studied \nfarms, in addition, we also detected C. coli  isolates positiv e for the presence of hcp \nwhich coincides with the findings of Moran  (2009) , while differing from studies \nperformed by Corcionivoschi  (2015) , where the higher incidence of the hcp gene \nwas found on C. coli  isolates and therefore those strains could potentially be more \nvirulent.  \nIn summary , our study provides new data on the antimicrobial resistance among  \nC. jejuni  and C. coli . Differences in the prevalence and pattern s of resistances were \nfound betwe en the two species.  The high prevalence of resistance against \nfluoroquinolones and tetracycline s, in broilers is of the highest concern , since they \nare the drugs of choice to treat human Campylobacter  infections . Nevertheless, the \npercentage of resistance obtained are higher  than studies previously performed in \nSpain years ago and are comparable with other EU countries . C. coli showed higher \nlevels of MDR and C. jejuni a higher prevalence of virulence -associated genes, \nwhich could be associated to the fact that the majority of cases of human \ncampilobacteriosis are caused by C. jejuni . Enhanced biosecurity measures on farm \nwould improve the general sanitary status of the farms, and consequently, the \nneed to use antimicrobials in animal therapeutics. In addition, the maintenance of \na prudent use and correct dosage of antimicrobials in broiler production is \nrequired. Al l together would reduce the antimicrobial pressure that would limit \nthe populations of resistant bacteria.   \n \n  \n \n \n \n \nStudy III  \nCharacterization of Campylobacter jejuni  and Campylobacter coli  \nbroiler isolates by whole genome sequencing  \n \n \n   \n \n  \n Study III  \n105  \n ABSTRACT  \nCampylobacter  has been the most commonly reported cause of bacterial \ndiarrhoeal disease in humans in the EU since 2005 (EFSA, 2016). M ost broiler \nbatches at slaughter are colonized with Campylobacter  and the major source of \ninfection is contaminate d poultry meat. The aim of this study was to characterize a \nselection of C. jejuni  and C. coli isolates from broilers through whole genome \nsequencing (WGS). A total of 16 isolates ( C. jejuni = 12 and C. coli = 4) from five \nbroiler farms from Catalonia (northeastern Spain) were analyzed. A phylogenetic \nanalysis based on 8420 SNPs showed two main clusters grouping strains by \nspecies . Phenotypic resistances to quinolones (100%), tetracycline (81%),  \nstreptomycin (75%), erythromycin (56%) and gentamicin (13% ) were found. A ll \nthe isolates carried the C257T point mutation in the subunit A of the DNA gyrase \ngene  (Thr86Ile ) conferring resistance to quinolones , whilst all the isolates \nshowing resistance to tetracycline carried the tet(O) gene. The genes aph(3\u00b4) -III \nand aadE conferring resistance to aminoglycosides were identified in the two \nisolates (one C. jejuni  and one C. coli ) resistant to streptomycin and gentamicin . \nThe point mutation A2075G on the 23S rDNA conferring high resistance to \nmacrolides was detecte d in three C. coli  isolates. The CmeABC multidrug efflux \npump was also detected, both in C. jejuni  and C.coli  isolates. All C. jejuni and C. coli  \nisolates were positive for most of the 34 virulence -associated genes studied \nrelated to motility, chemotaxis, adhesion and invasion. Interestingly, the wlaN  \ngene involved in the Guillain -Barr\u00e9 syndrome, was found in two isolates. The \nresults underline the power of WGS for investigation of virulence, clonality and \nantimicrobial resistance in Campylobacter .  \n \n  Study III  \n106  \n INTRODUCTION  \nWhile cases of salmonellosis are steadily decreasing due to the effect of control \nprogrammes, the cases of campylobacteriosis are still increasing. Since 2005,  \nCampylobacter  has outnumbered Salmonella  as the most commonly reported \ncause of  ba cterial diarrhoeal disease in humans in the EU (EFSA, 2014) . The two \nspecies responsible for the vast majority of infections are C. jejuni and C. coli \n(Eberle and Kiess, 2012) . In some c ases, this infection can subsequently lead to \nserious neuromuscular disorders such as Guillain -Barr\u00e9 syndrome (Crushell et al., \n2004) . In the majority of the EU countries (Scandinavia is the exception), most of \nthe broiler batches are colonized with Campylobacter  at slaughter and the main \nsource of campylobacteriosis in humans is chicken meat, which can account for up \nto 70% of cases (Boysen et al., 2013) . The prevention of broiler flock colonizati on \nhas therefore become a f ood safety priority in the EU.  \nCampylobacteriosis follows a seasonal trend, with a peak of cases during summer \n(EFSA, 2014) . However, the majority of Campylobacter  infections in humans are \nsporadic and self -limiting which complicates the determination of the true \nincidence rate (H\u00e4nninen et al., 2000) . Due to the self -limiting behavior of the \ndisease the use of antimicrobials is not usually prescribed for treatment, except in \nsevere cases where fluoroquinolones and macr olides are the drugs of choice \n(Butzler, 2004; Moore et al., 2006) . Tetracyclines have also been suggested as an \nalternative choice, but in  practice they are rarely used.  \nThe pathogenicity of Campylobacter strains have been linked to multiple factors \nincluding host susceptibility and, more importantly, the expression of different \nvirule nce factors and resistance to antimicrobials. Several putative virulence \nfactors have been identified in Campylobacter  species that contribute to motility, \nintestinal adhesion, colonization, toxin production and tissue invasion (Bolton, \n2015; Dasti et al., 2010) . Also, multidrug -resistant C. jejuni  and C. coli  have been Study III  \n107  \n reporte d worldwide from farm animals and retail meats, including poultry and \nswine (Datta et al., 2003; Zhao et al., 2010) . \nPhenotypic methods have been widely used to c haracterize C. jejuni  and C. coli \nstrains at the species and subspecies level. However, these methods have mostly \nbeen replaced by genotypic methods that are more accurate and have higher \ndiscrimination power, such as pulsed -field gel electrophoresis (PFGE ) and \nmultilocus sequence typing (MLST) (Pfaller, 1999) . While PFGE has a high \ndiscriminatory power and has been su ccessfully used in focused short -term \nepidemiological studies (Baqar et al., 2010; Ribot et al., 2001) , MLST is especially \nwell adapted to long -term epidemiological investigation and sou rce attribution \n(Sabat et al. , 2013) . Nowadays, with the advent of next -generation sequencing, the \npossibility of generating high -resolution full genome data is being increasingly \nused to differentially characterize strains. This technology allows for a rapid \nidentification of a br oad range of genotypic traits of the isolates, such as their pool \nof virulence and antimicrobial resistance determinants. Hence, the aim of this \nstudy was to use whole genome sequencing (WGS) to characterize a selection of C. \njejuni  and C. coli  isolates from broilers obtained from a longitudinal study \nperformed in different farms. The characterization included the determination of \nthe MLST genotype, the identification of virulence and antimicrobial determinants \nas well as a phylogenetic study of  the isolates through the discovery of single \nnucleotide polymorphisms (SNPs) between the different strains analysed.  \nMATERIALS AND METHODS  \nStudy design  \nA total of 16 poultry isolates ( C. jejuni = 12 and C. coli= 4) from five broiler farms \nwere included in the study. The isolates were selected from Campylobacter  \npositive flocks of a broad two -year longitudinal study, where six to seven flocks \nwere studied each year by cloacal swab sampling a subset of birds. Selection of the Study III  \n108  \n isolates was performed according to their PFGE  patterns and an antimicrobial \nmultidrug -resistant profile by disc diffussion (unpublished data). The five different \nfarms (A, B, C, D and E) were located in Catalonia (northeastern Spain). Poultry \nhouses had a capacity of 12,000 to 46,000 bir ds. Details concerning the strains \nincluded in the study are shown on Table 1. Campylobacter  isolation and \nidentification was performed as previously described (Urdaneta et al., 2015). \nIsolates were preserved in brain heart infusion broth (BHI, Merck KGaA,  \nDarmstadt, Germany), with 20% glycerol at -80\u00baC until used and fresh cultures of \nthe isolates were prepared on Columbia blood agar plates (bioM\u00e9rieux, Marcy -\nl\u2019Etoile, France). Plates were incubated at 37 \u00b0C for 48 h under microaerobic \nconditions using a m icroaerobic atmosphere generator (Anaerocult\u00ae C, Merck, \nDarmstadt, Germany).  \nAntimicrobial susceptibility testing  \nIsolates were tested for antimicrobial susceptibility using a minimum inhibitory \nconcentration (MIC) based broth microdilution (VetMIC GN -mo; National \nVeterinary Institute, Uppsala, Sweden) for the following antimicrobial agents: \nnalidixic acid (1 to 64 mg/L), ciprofloxacin (0.06 to 8 mg/L), tetracycline (0.12 to \n16 mg/L), streptomycin (0.5 to 64 mg/L), gentamicin (0.12 to 16 mg/L ), and \nerythromycin (0.5 to 64 mg/L). C. jejuni  ATCC 33560 and C. coli  ATCC 33559 were \nused as control strains. An isolate was considered multidrug -resistant when \nshowing resistance to three or more non -related antimicrobials. Isolates were \nconsidered to b e susceptible or resistant based on epidemiological cutoff values \naccording to EUCAST guidelines ( www.eucast.org ). When reporting data using \nEUCAST epidemiological cut -off values, bacteria should be reported as \u2018wild -type\u2019 \n(WT) or \u2018non -wild -type\u2019 (non -WT) (Schwarz et al., 2010) . For simplicity of the \nterms, susceptible and resistant has been used here.  \n Study III  \n109  \n Table 1. Identification and origin of the poultry Campylobacter  isolates used in this \nstudy.  \n \nWhole genome sequencing (WGS) and assembly  \nGenomic DNA was extracted using QIAamp DNA mini kit (QIAGEN) according to \nthe manufacturer\u00b4s instructions. The libraries were prepared with Nextera XT \nDNA sample preparation kit (Illumina Inc., San Diego, CA, cat. no. FC -131 -1024) \nfollowed by multiplexed p aired -end sequencing with a read length of 2 \u00d7 251 bp, \nusing Illumina\u2019s MiSeq platform (Illumina).  The raw reads were trimmed and \ncleaned for adapters, and assembling was performed using the online tool \nAssembler v1.2 with default parameters. All these ste ps are integrated in a \npipeline available at the Center for Genomic Epidemiology (CGE) \n(www.genomicepidemiology.org ). Contiguous assemblies were analyzed using the \nCLCbio \u2019s Genomics Workbench v6.5 (CLCbio \u2019s, Aarhus, Denmark) . The raw \nsequence dataset is available in the NCBI database. SRA Accession number \nSUB2617930.  \nFarm Isolates Species Age (days) Flock n\u00ba Year\nA A1 C. coli 37d 1 2011\nA A2 C. jejuni 28d 7 2012\nB B3 C. jejuni 34d 1 2011\nB B4 C. jejuni 39d 5 2011\nB B5 C. jejuni 21d 7 2012\nB B6 C. jejuni 18d 9 2013\nC C7 C. coli 21d 3 2012\nC C8 C. coli 29d 7 2012\nC C9 C. jejuni 21d 12 2013\nC C10 C. jejuni 14d 9 2013\nD D11 C. jejuni 14d 2 2011\nD D12 C. jejuni 29d 1 2011\nE E13 C. jejuni 27d 1 2011\nE E14 C. jejuni 28d 2 2011\nE E15 C. jejuni 25d 12 2013\nE E16 C. coli 21d 10 2013Study III  \n110  \n Analysis of resistance and virulence -associated genes  \nResFinder v2.1 and MyDbFinder v1.1, both available at the CGE \n(www.genomicepidemiology.org ), were used for identification of resistance and \nvirulence genes, respectively. All strains were subjected to analysis of the presence \nof resistance determinants to quinolones, te tracyclines, aminoglycosides and \u03b2 -\nlactams. C. jejuni and C. coli strains were tested for 34 virulence -associated genes. \nGenes including motility (six), chemotaxis (five), adhesion (four), invasion (three), \ncytolethal distending toxin (three), multidrug an d bile resistance (three), stress \nresponse and survival (two), iron uptake (two), capsule (two), Guillian -Barr\u00e9 \nsyndrome (one) and hippuricase (one), were selected as previously described \n(Koolman e t al., 2015) . All genes were identified with a selected identity threshold \nof 80%, corresponding to the percentage of nucleotides that are identical between \nbest -matching resistance gene in the database and the corresponding query \n(Zankari et al., 2012) , and a minimum coverage of 20 % of the query sequence \nlength.  \nIn order to analyze the presence/absence of specific mutations related to \nantibiotic resistances, the raw fastq files for each of the isolates were aligned with \nbwa mem algortithm (Li and Durbin, 2009)  with the corresponding reference \ngenome (AL111168 for C. jejuni  and CP011015 for C. coli ). The alignment files and \nthe corresponding annotated reference genome, wer e inspected manually using \nTablet (Milne et al., 2013)  as the visualizing tool. If the mutation appeared with \nless frequency than 0.5% of the total reads in that position, it was considered \nabsent.   \nIdentification of SNPs  \nThe SNP discovery was done using the CSI Phylogeny v1.4 pipeline CGE (Kaas et \nal., 2014) . Briefly, the paired -end reads from each of the isolates were reference -\naligned using strain 12 for C. jejuni  and 4 for C. coli  with BWA v.0.7.2 s oftware (Li Study III  \n111  \n and Durbin, 2009) . SNP calling was done with SAMtools v.0.1.18 (\u2018mpileup\u2019 \nmethod, Li & Durbin 2009)  and filtering was done with BEDTools (Quinlan and \nHall, 2010) . To select the valid SNPs the same criteria previousl y described was \nfollowed (Kaas et al., 2014) . SNPs were filtered out if the mapping quality  was \nbelow 25 or the SNP quality was below 30, and if they were called within the \nvicinity of 10 bp of another SNP (pruning) . To perform the phylogenetic analysis, \nconcatenation of the sequences and subsequent aligning with MUSCLE was done \n(Edgar, 2004) . Maximum likelihood trees were  created using CSI Phylogeny 1.4, a \nweb server tool available at www.genomicepidemiology.org  (based on FastTree \nalgorithm) (Price et al., 2010) ,  that calls the SNPs, filter and validate them in order \nto infer phylogeny based on the concatenated alignment of the high quality SNPs. \nThe analysis was run considering the following parameters , i.e. minimun depth at \nSNP position was set at 10x, the min. SNP quality accepted was 30 and the min. \nread mapping quality allowed was 25. The reference genome used was C. coli ( Acc \nnum CP011015).  \nMultilocus sequence typing (MLST)  \nThe de novo  assembled co ntigs were used t o identify the multilocus sequence \ntypes (ST) and clonal complexes (CC) using the web server MLST v1.8 available at \nthe CGE website ( www.genomicepidemiology.org ). \nRESULTS  \nWhole genome sequencing  \nThe isolates were sequenced to an average coverage that varied from 49,73 to  \n127,2 x . From the assembled contigs of the sixteen isolates, nine previously -\ndescribed sequence types (ST) were recognized (Figure 1). Besides, two novel STs \nnot previo usly reported in the PubMLST database \n(http://pubmlst.org/campylobacter/ ) were identified, ST8586 (E13, C. jejuni Study III  \n112  \n isolate) and ST8578 (E16, C. coli  isolate). All the STs found belong to five different \nCC. T he most frequent CC in C. jejuni  were CC257 and CC21 followed by CC206, \nwhilst the less prevalent was CC45 with only one C. jejuni isolate from ST45 \nbelonging to this group. All of the C. coli  isolates belonged to the same clonal \ncomplex (CC828), which inc luded three different STs (ST854, ST854 and ST8578).  \nComparison of the sequences obtained from the sixteen isolates allowed the \nidentification of a total of 8420 SNPs, which were used to perform the \nphylogenetic analysis. The representation of the SNP tre e is depicted in Figure 1 \nand a heatmap representing the SNP counts between the genomes is shown in \nFigure 2.  None of the isolates analyzed were identical. The isolates showed \ndistribution in two main clusters, with all strains grouped by species.  \nAntimicrobial susceptibility  \nThe phenotypic antimicrobial susceptibility patterns determined for the sixteen strains \nanalysed is shown in Table 2. All the strains showed  a multi drug resistan t profile, with \nresistance to quinolones (nalidixic acid and cipro floxacin)  being common to all of them. \nThe resistance to tetracycline was the second most commonly observed (81%) with \nonly three strains being sensitive to this antibiotic. Seventy -five % of the isolates were \nresistant to streptomycin, with at least one r esistant strain per farm, whilst 56% were \nresistant to erythromycin. Among the latter, one third of C. jejuni  isolates were \nresistant, whilst all C. coli  isolates showed resistance to this antimicrobial. Gentamicin \nresistance was the less prevalent, detect ed only in two isolates from farms A and B \n(13%).   \nIn order to study the potential mechanisms of antimicrobial resistance, the assembled \ngenomes of each of the strains under study were investigated for particular patterns \nknown to be associated to resistance. Phenotypic antimicrobial resistances obtained \nwith the MIC analysis corresponded well for most of the isolates with the identification \nof specific antimicrobial resistance genes detected by WGS  (Table 2) .Study III  \n113  \n Figure 1. M aximun -likelihood phylogenetic tree based on SNPs from the assembled genomes and genoty pic MLST types of \nthe Campylobacter isolates. T he tree was drawn to scale, with branch lengths measured in the number of substitutions per \nsite.  \n \na Reference genomes for C. jejuni  NCTC 11168 (Accession number: AL111168) and for C. coli  FB1 (Accession number: CP011015) were \nincluded in the analysis. T he tree was drawn to scale, with branch lengths measured in the number of substitutions per site.  \nb ST, sequence type; CC, clonal complex.  \n  \n0.1\n\u2026\u2026...........\n\u2026\u2026\u2026\u2026\u2026\u2026\n\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\n\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.....\u2026\u2026.\u2026\u2026..\u2026\u2026\u2026....\u2026\n\u2026\u2026\u2026\u2026\u2026\n\u2026\u2026\u2026\u2026\u2026\u2026\u2026\n\u2026\u2026\u2026\u2026\u2026\u2026.\n\u2026\u2026\u2026\u2026\n\u2026\u2026.\u2026\n\u2026\u2026\u2026\u2026\u2026\n\u2026\u2026\u2026\u2026\u2026\n\u2026\u2026\u2026\u2026\u2026.\n\u2026\u2026..\u2026\n\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.........\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...\u2026.\u2026..0,61120,23310,1344\n0,0267\n0,1621\n0,0601\n0,11350,0196\n0,0521\n0,0396\n0,2795\n0,237\n0,1934\n0,0088\nE15 C. jejuni 45 45\nE14 C. jejuni 824 257\nB6 C. jejuni 257 257\nC10 C. jejuni 257 257\nB3 C. jejuni 257 257\nD12 C. jejuni 572 206\nB4 C. jejuni 572 206\nA2 C. jejuni 122 206\nD11 C. jejuni 50 21\nE13 C. jejuni 8586 21\nB5 C. jejuni 21 21\nNCTC 11168 C. jejuni\nC9 C. jejuni 21 21\nFB1 C. coli\nE16 C. coli 8578 828\nC7 C. coli 827 828\nA1 C. coli 854 828\nC8 C. coli 854 828Isolates Species ST CCa\nab bStudy III  \n114  \n Figure 2. Heatmap representing the SNPs between the genomes.  \nStudy III  \n115  \n All the isolates carried the C257T point mutation in the subunit A of the DNA \ngyrase gene  (Thr86Ile ) conferring resistance to quinolones . Other less common \nmutations in gyrA (Asp -90-Asn and Ala -70-Thr) were not detected in any of the \nisolates. All the isolates showing resistance to tetracycline carried the tet(O) gene. \nWithin the two isolates resistant to streptomycin and gentamicin , the genes \naph(3\u00b4) -III and aadE conferri ng resistance to aminoglycosides were identified. \nThree C. coli  isolates were found to show a mutation in the A2075G position of the \n23S rDNA region, which confers a high level of resistance to macrolides. The \nCmeABC multidrug efflux pump has been describe d as the major efflux pump \nmechanism conferring resistance to a wide range of antimicrobials, and it was \nidentified in 15 out of the 16 isolates analyzed.  \nVirulence determinants  \nAll isolates of C. jejuni  and C. coli were positive for almost all of the 34 virulence -\nassociated genes studied, including motility, chemotaxis, adhesion and invasion \ngenes, with few exceptions (Table 3). Among the genes coding for the flagellin, \nonly half of the C. jejuni  isolates carried the  flaA gene, while flaB  was only detected \nin two isolates. Interestingly, one C. jejuni  isolate from farm E was negative for \ncmeB (component of the CmeABC efflux pump) and another C. jejuni  isolate from \nthe same farm was the only one found to be negative fo r cfrA  (gene involved in \niron uptake ). Remarkably, the wlaN gene, involved in the Guillain -Barr\u00e9 syndrome, \nwas detected in two C. jejuni  isolates from different farms. It is interesting to \nmention that the hipO  and wlaN  genes were not detected in any strai n of C. coli . Study III  \n116  \n Table 2.  Antimicrobial susceptibilities (MIC) and resistance mechanisms of C. jejuni  and C. coli  isolates.  \n \na Nal: Nalidixic acid, Ci: Ciprofloxacin, Tc: Tetracycline, Sm: Streptomycin, Gm: Gentamicin and Ery: Erythromycin.  \nb Interpretation of MIC values  for C. jejuni epidemiological cut -off values: Nal (R, \u2264 16 mg/L); CI (R, \u2264  0,5 mg/L); Tc (R, \u2264  1 mg/L); Sm (R, \u2264  4 mg/L);  Gm \n(R, \u2264  2 mg/L) and Ery (R, \u2264  4 mg/L). Interpretation for C. coli  epidemiological cut -off values: Nal (R, \u2264 16 mg/L); CI (R, \u2264  0,5 mg/L); Tc  (R, \u2264  2 mg/L); Sm \n(R, \u2264  4 mg/L);  Gm (R, \u2264  2 mg/L) and Ery (R, \u2264  8 mg/L.  \nc R-mech: resistance mechanism. Thr86Ile: point mutations in the subunit A of the DNA gyrase gene; tet(O), aphA(3\u2019) and aadE: presence of these genes; \n23S rDNA: point mutation on  this region of the genome.  \n  \nNal aCiR-mech c \nThr86IleTcR-mech \ntet(O)SmR-mech \naphA(3\u00b4)R-mech \naadEGm  R-mech \naphA(3\u00b4)EryR-mech \n23S \nrDNA\nA1 C. coli R (> 64) b R (> 8) + S (0,5)  \u0336 R (32) +  \u0336 R (2) + R (32) + + + + \nA2 C. jejuni R (32) R (> 8) + S (0,5)  \u0336 S (0,5)  \u0336  \u0336 S (0,12)  \u0336 R (32)  \u0336 + + + \nB3 C. jejuni R (> 64) R (> 8) + R (> 16) + R (32)  \u0336  \u0336 S (0,12)  \u0336 R (> 64)  \u0336 + + + \nB4 C. jejuni R (32) R (0,5) + R (> 16) + R (8)  \u0336  \u0336 S (0,12)  \u0336 S (1)  \u0336 + + + \nB5 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64) + + R (2) + S (0,5)  \u0336 + + + \nB6 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64)  \u0336  \u0336 S (1)  \u0336 S (1)  \u0336 + + + \nC7 C. coli R (> 64) R (4) + R (2) + R (32)  \u0336  \u0336 S (0,12)  \u0336 R (> 64) + + + + \nC8 C. coli R (> 64) R (4) + R (> 16) + R (> 64)  \u0336  \u0336 S (0,25)  \u0336 R (> 64) + + + + \nC9 C. jejuni R (32) R (4) + R (> 16) + S (0,5)  \u0336  \u0336 S (0,12)  \u0336 S (1)  \u0336 + + + \nC10 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64)  \u0336  \u0336 S (0,12)  \u0336 R (> 64)  \u0336 + + + \nD11 C. jejuni R (> 64) R (> 8) + R (> 16) + S (0,5)  \u0336  \u0336 S (0,12)  \u0336 S (1)  \u0336 + + + \nD12 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64)  \u0336  \u0336 S (1)  \u0336 R (> 64)  \u0336 + + + \nE13 C. jejuni R (> 64) R (4) + R (> 16) + S (0,5)  \u0336  \u0336 S (0,12)  \u0336 S (1)  \u0336 + + + \nE14 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64)  \u0336  \u0336 S (0,12)  \u0336 R (8)  \u0336 + + \nE15 C. jejuni R (> 64) R (> 8) + S (0,5)  \u0336 R (16)  \u0336  \u0336 S (0,25)  \u0336 S (1)  \u0336 + + + \nE16 C. coli R (16) R (> 8) + R (> 16) + R (4)  \u0336  \u0336 S (0,12)  \u0336 R (> 64)  \u0336 + + + \nTotal 100% 100% 81% 75% 13% 56%Efflux \npump \nCmeA,B,CIsolates SpeciesQuinolones Tetracycline Aminoglycosides MacrolideStudy III  \n117  \n Table 3. Distribution of virulence genes in C. jejuni  and C. coli  isolates.  \n \n \n \n  \nflaA flaB flhA flhB flgB flgE fliM fliY cheA cheB cheR cheW cheY cadF dnaJ pldA racR kpsM waaF iamA ciaB ceuE\nA1 C. coli + + + + + + + + + + + + + + + + + + + + + +\nA2 C. jejuni  \u0336  \u0336 + + + + + + + + + + + + + + + + + + + +\nB3 C. jejuni  \u0336  \u0336 + + + + + + + + + + + + + + + + + + + +\nB4 C. jejuni + + + + + + + + + + + + + + + + + + + + + +\nB5 C. jejuni +  \u0336 + + + + + + + + + + + + + + + + + + + +\nB6 C. jejuni  \u0336  \u0336 + + + + + + + + + + + + + + + + + + + +\nC7 C. coli + + + + + + + + + + + + + + + + + + + + + +\nC8 C. coli + + + + + + + + + + + + + + + + + + + + + +\nC9 C. jejuni + + + + + + + + + + + + + + + + + + + + + +\nC10 C. jejuni  \u0336  \u0336 + + + + + + + + + + + + + + + + + + + +\nD11 C. jejuni +  \u0336 + + + + + + + + + + + + + + + + + + + +\nD12 C. jejuni  \u0336  \u0336 + + + + + + + + + + + + + + + + + + + +\nE13 C. jejuni +  \u0336 + + + + + + + + + + + + + + + + + + + +\nE14 C. jejuni  \u0336  \u0336 + + + + + + + + + + + + + + + + + + + +\nE15 C. jejuni +  \u0336 + + + + + + + + + + + + + + + + + + + +\nE16 C. coli + + + + + + + + + + + + + + + + + + + + + +\nTotal 10 6 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16Chemotaxis Adhesion InvasionIsolatesa CapsuleSpeciesMotilityStudy III  \n118  \n Table 3. Continuated.  \n  \naA: isolates from farm A; B: isolates from farm B; C: isolates from farm C; D: isolates from farm D  \n and E: isolates from farm E.  \nb Hippuricase gene.\nGBSHip. b \ngene\ncdtA cdtB cdtC  wlaN cmeA cmeB cmeC katA sodB cfrA fur hipO\nA1 C. coli + + +  \u0336 + + + + + + +  \u0336\nA2 C. jejuni + + +  \u0336 + + + + + + + +\nB3 C. jejuni + + +  \u0336 + + + + + + + +\nB4 C. jejuni + + +  \u0336 + + + + + + + +\nB5 C. jejuni + + +  \u0336 + + + + + + + +\nB6 C. jejuni + + +  \u0336 + + + + + + + +\nC7 C. coli + + +  \u0336 + + + + + + +  \u0336\nC8 C. coli + + +  \u0336 + + + + + + +  \u0336\nC9 C. jejuni + + + + + + + + + + + +\nC10 C. jejuni + + +  \u0336 + + + + + + + +\nD11 C. jejuni + + +  \u0336 + + + + + + + +\nD12 C. jejuni + + +  \u0336 + + + + + + + +\nE13 C. jejuni + + + + + + + + + + + +\nE14 C. jejuni + + +  \u0336 +  \u0336 + + + + + +\nE15 C. jejuni + + +  \u0336 + + + + +  \u0336 + +\nE16 C. coli + + +  \u0336 + + + + + + +  \u0336\nTotal 16 16 16 2 16 15 16 16 16 15 16 12IsolatesaSpeciesCytolethal \ndistending toxinMultidrug and bile \nresistanceStress \nresponse and \nsurvivalIron \nuptakeStudy III  \n119  \n DISCUSSION  \nThe whole -genome sequence data revealed that the C. jejuni  and C. coli  isolates \nbelonged to five different CC, all of them associated both with poultry and human \ncampylobacteriosis in many countries ( Campylobacter  PubMLST; \nhttp://PubMLST.org ). The two p ositive isolates to wlaN  gene, related to the \nGuillain Barr\u00e9 Syndrome, belonged to ST21 and to the novel ST8586, both from \nCC21. In the Campylobacter  PubMLST database, there are only seven isolates \nwithin CC21 associated with the Guillain -Barr\u00e9 syndrome an d none of them belong \nto the widespread ST21.  \nThe comparison of the assembled genomes revealed a large number of nucleotide \nchanges (SNPs), among the isolates and the reference genomes. The identified \nvariations were used to study the phylogeny to infer th e relationship among the \nisolates, which were in concordance to the species they belong (Fig. 1). Not \nsurprisingly, isolates of identical ST were more closely related compared to \nisolates of different STs.  \nThe antimicrobial resistances found are of relevan ce in a public health context, \nparticularly those to fluoroquinolones, macrolides (mainly ciprofloxacin and \nerythromycin, respectively) and tetracyclines. Quinolones and macrolides are the \nantibiotic of choice to treat severe human Campylobacter infections , whilst \ntetracyclines are used as an alternative treatment (Butzler, 2004; Moore et al., \n2006) . Aminoglycosides are also recommended for the treatment of bacteraemia \ncaused by Campylobacter (Kassa et al., 2007) , and a significant number of \nresistances to this group of antimicrobials was detected as well . Resistance to \nfluoroquinolones and macrolides is quite common in poultry (Thakur, 2010) . High \nquinolone resistance in poultry has previously been reported in Spain (Melero et \nal., 2012; P\u00e9rez -Boto et al., 2013b) , as well as in other EU countries (Luber et al. \n2003; Nobile et al. 2013) . The high MIC values  detected here may be related to the \npresence of Thr86Ile in all of the isolates, which in itself provides high resistance  Study III  \n120  \n to quinolones (MIC >16 mg/L) (Ruiz et al., 1998) . This mutation is the most \nprevalent in clinical and veterinary isolates  (Butzler, 2004; Horme\u00f1 o et al., 2016) . \nThe high prevalence of isolates resistant to tetracyclines is similar to that \npreviously reported in poultry in Spain (Duarte et al., 2016 ; Melero et al., 2012; \nP\u00e9rez -Boto et al., 2013b) . This resistance is mediated by the tet(O) gene which was \ndetected in all isolates showing tetracycline resistance. Besides the chromosomal \nlocation of this gene, it has also been reported in plasmids (Avrain et al., 2004; \nIovine, 2013) . In contrast, resistance to aminoglycosides was diverse, with a \nconsiderably high resistance to streptomycin (75%) and a much lower resistance \nto gentamicin (13%), in agreement wit h Duarte  et al. (2016)  and P\u00e9rez -Boto et al. \n(2013). The aph(3\u00b4) -III and aadE  genes involved in aminoglycoside resistance \nwere identified in some strains. However, a high resistance to streptomycin was \nobserved in some strains in the absence of those genes. This could be attributed to \nantimicrobial r esistance associated with plasmids or undiscovered genes  (Iovine, \n2013) . Gentamicin resistance in Campylobacter  spp. is a rare event all over \nEuropean countries (Carreira et al. 2012; De Jong et al. 2009; P\u00e9rez -Boto et al. \n2013) . Over 50% of isolates were resistant to eryt hromycin and was more \ncommon among C. coli  than C. jejuni , similarly to what has been previously \nreported in poultry in the EU (Duarte et al., 2016; Wimala rathna et al., 2013) . \nErythromycin resistance is acquired through point mutations in domain V of the \n23S rDNA at positions 2074 and 2075 (positions 2058 and 2059 in E. coli  \nnumbering) (Iovine, 2013) ; the point mutation A2075G  which is the most \nprevalent in Campylobacter spp. and confers high -level resistance to macrolides, \nwas identified in  three C. coli  isolates.  The overall resistances detected here are \nthose also common in food -producing animals in the UE, as reported by EFSA \n(2015) . Particularly, the pattern of resistance among Campylobacter  isolates was \npredominantly quinolones (ciprofloxacin and nalidixic acid) and tetracyclines, \nwhilst resistance to erytromycin and gentamicin was comparatively low . Study III  \n121  \n Several virulence factors have been identified in Campylobacter , which include \nflagella -mediated motility, bacterial adherence to intestinal mucosa, invasive \ncapability and the ability to produce toxins. C. jejuni  isolates were positive for the \npresence of most of the virulence genes analyzed related to these virulenc e factors. \nHowever, differences were found for the flaA  and flaB  genes. Those adjacent genes \nencode for the protein flagellin which compose the flagellar filament, an important \ncolonization factor (Koolman et al., 2015; Silva et al., 2011) . Therefore, the \nnegative results for the flaA  gene (80% coverage) in half of the isolates, and lack of \nflaB  gene (80% coverage)  in all but two isolates, with o nly two isolates positive \nfor both genes is surprising. Despite it has been suggested that the flaB  gene might \nnot be essential for motility ( Koolman et al. 2015) , the lack of these genes might \nlead to a reduced motility and colonization ability of the isolates ( Neal -McKinney \net al. 2010) . The gene wlaN , responsible for the expression of Guillain -Barr\u00e9 \nsyndrome, was detected with a low frequency, in agreement with other repo rts \n(Datta et al., 2003; Koolman et al., 2015; Talukder et al., 2008) . In contrast, the \nmultidrug CmeABC efflux system responsible for antimicrobial resistance was \npresent in all but one isolate, which lacked the CmeB gene. The efflux system is \ncommon in Campylobacter  and consists of an external membrane protein (CmeC), \na drug transporter in the internal membrane (CmeB) and an external membrane \nprotein (CmeA). They all form a membrane channel that expels toxic substances \nfrom the cell (Lin et al. 2002) . The HipO gene, which is specific for C. jejuni , was not \npresent in any of the C. coli  isolates. Besides this gene, and the wlaN gene, which is \nrelatively rare, all virulence genes analyzed were present in all C. coli  strains . It is \nnoteworthy to highlight that the sodB gene involved in stress defense, and that \nwas first reported in C. coli  isolates by Koolman et al. (2015) , it has also been \nfound in all C. coli  isolates in this study.  \nThe use of WGS technology has allowed us an in -depth characterization of \nCampylobacter field isolates. Despite this potent tool does not provide information \nabout e.g. gene expression levels or synergistic effects among different resistance Study III  \n122  \n mechanisms, it has an enormous potential. WGS technology has become a fast and \naffordable tool and may become a rapid and cost -effective approach to \ncharacterize Campylobacter  isolates from epidemiological studies.  \n  \n \n  \n \n \n \n \n \nConclusiones    \n \n  Conclusiones  \n125  \n 1. La gran diversidad de cepas circulantes en las diferentes granjas, con una \nsucesi\u00f3n de genotipos de una crianza a la siguiente y un reducido n\u00famero de cepas \npersistentes, sugiere or\u00edgenes diversos desde multitud de reservorios diferentes \nde Campylobacter en el medio ambiente exterior de las granjas, que se introducen \nf\u00e1cilmente en las naves por diferentes v\u00edas durante la crianza, colonizando \nr\u00e1pidamente a las aves.  \n2. La au sencia de un mismo genotipo en lotes sucesivos indica una correcta \nlimpieza y desinfecci\u00f3n durante el vac\u00edo sanitario, en el cual se elimina cualquier \nCampylobacter presente dentro de las naves.  \n3. La elevada proporci\u00f3n de cepas resistentes a quinolonas y  tetraciclinas en pollos \nde engorde es preocupante, dado que estos antimicrobianos son los de elecci\u00f3n \npara tratar los casos graves de campilobacteriosis. Si estas cepas o los genes de \nresistencia llegan a introducirse en la cadena alimentaria, ello supone  un riesgo \npara la salud p\u00fablica. M\u00e1s preocupante a\u00fan es la elevada proporci\u00f3n de cepas \nmultiresistentes (84,33% en C. jejuni  y 57,47% en C. coli ) a hasta a 5 clases \ndiferentes de antimicrobianos.  \n4. La elevada proporci\u00f3n de cepas de Campylobacter resisten tes o multiresistentes \npuede estar asociada a la presi\u00f3n antibi\u00f3tica, dada la frecuente utilizaci\u00f3n de \ndiversas familias de estos f\u00e1rmacos en los programas de medicina preventiva.  \n5. La amplia distribuci\u00f3n de la mayor\u00eda de genes asociados a virulencia en los \naislados analizados son similares a las descritas en cepas aisladas en humanos. Es \ndestacable la relativa frecuencia del gen wlaN , relacionado con el s\u00edndrome de \nGuillain -Barr\u00e9, as\u00ed como del sistema de secreci\u00f3n tipo 6 (T6SS) asociado con \nformas graves  de campilobacteriosis, en aislados de pollos de engorde, lo que \napunta a un riesgo potencial para el consumidor final.  \n6. La secuenciaci\u00f3n masiva es una herramienta que nos permiti\u00f3 la caracterizaci\u00f3n \nen profundidad de los aislados de Campylobacter, desde la determinaci\u00f3n del \ngenotipo, a la identificaci\u00f3n de determinantes  de virulencia y de resistenciaConclusiones  \n126  \n antimicrobiana, as\u00ed como establecer su relaci\u00f3n filogen\u00e9tica. Presenta un enorme \npotencial aunque no proporciona informaci\u00f3n sobre niveles de expresi\u00f3n g\u00e9nica o \nsobre el efecto sin\u00e9rgico entre diferentes mecanismos de resistencia \n \n  \n \n \n \n \nBn  Referencias  \n   \n \n  \n  Referencias  \n129  \n Aarestrup, F.M., Engberg, J., 2001. Antimicrobial resistance of thermophilic \nCampylobacter . Vet. Res. 32, 311 \u2013321. doi:10.1051/vetres:2001127  \nAarestrup, F.M., Nielsen, E.M., Madsen, M., Engberg, J., 1997. Antimicrobial \nsusceptibility patterns of thermophilic Campylobacter  spp. from humans, \npigs, cattle, and broilers in Denmark. Antimicrob. Agents Chemother. 41, \n2244 \u20132250.  \nAgunos, A., Waddell, L. , L\u00e9ger, D., Taboada, E., 2014. A systematic review \ncharacterizing on -farm sources of Campylobacter  spp. for broiler chickens. \nPLoS One 9. doi:10.1371/journal.pone.0104905  \nAlfredson, D.A., Korolik, V., 2007. Antibiotic resistance and resistance mechanisms \nin Campylobacter jejuni  and Campylobacter coli . FEMS Microbiol. Lett. 277, \n123 \u2013132. doi:10.1111/j.1574 -6968.2007.00935.x  \nAllen, V.M., Bull, S.A., Corry, J.E.L., Domingue, G., J\u00f8rgensen, F., Frost, J.A., Whyte, R., \nGonzalez, A., Elviss, N., Humphrey, T.J., 2007. Campylobacter  spp. \ncontamination of chicken carcasses during processing in relation to flock \ncolonisation. Int. J. Food Microbiol. 113, 54 \u201361. \ndoi:10.1016/j.ijfoodmicro.2006.07.011  \nAltekruse, S.F., Stern, N.J., Fields, P.I., Swerdlow, D.L., 1999. Cam pylobacter jejuni  - \nAn emerging foodborne pathogen. Emerg. Infect. Dis. 5, 28 \u201335. \ndoi:10.3201/eid0501.990104  \nAsakura, M., Samosornsuk, W., Hinenoya, A., Misawa, N., Nishimura, K., Matsuhisa, \nA., Yamasaki, S., 2008. Development of a cytolethal distending to xin (cdt) \ngene -based species -specific multiplex PCR assay for the detection and \nidentification of Campylobacter jejuni, Campylobacter coli  and C ampylobacter \nfetus . FEMS Immunol. Med. Microbiol. 52, 260 \u2013266. doi:10.1111/j.1574 -\n695X.2007.00369.x  \nAvrain, L., Vernozy -Rozand, C., Kempf, I., 2004. Evidence for natural horizontal \ntransfer of tetO gene between Campylobacter jejuni  strains in chickens. J. \nAppl. Microbiol. 97, 134 \u2013140. doi:10.1111/j.1365 -2672.2004.02306.x  \nBacon, D.J., Alm, R., Burr, D.H., Hu, L., Kop ecko, D.J., Ewing, C.P., Trust, T.J., Guerry, \nP., 2000. Involvement of a plasmid in virulence of Campylobacter jejuni  81-\n176. Infect. Immun. 68, 4384 \u20134390. doi:10.1128/IAI.68.8.4384 -4390.2000  \nBaggerman, W.I., T, K., 1992. A comparison of enrichment and mem brane filtration \nmethods for the isolation of Campylobacter  from fresh and frozen foods. Food \nNicrobiology 9:, 87 \u201394. \nBang, D., Scheutz, F., Ahrens, P., Pedersen, K., Blom, J., Madsen, M., 2001. Prevalence \nof cytolethal distending toxin (cdt) genes and CDT  production in Referencia  \n130  \n Campylobacter  spp. isolated from Danish broilers. J. Med. Microbiol. 50, \n1087 \u20131094. doi:10.1099/0022 -1317 -50-12-1087  \nBang, D.D., Nielsen, E.M., Scheutz, F., Pedersen, K., Handberg, K., Madsen, M., 2003. \nPCR detection of seven virulence and t oxin genes of Campylobacter jejuni  and \nCampylobacter coli  isolates from Danish pigs and cattle and cytolethal \ndistending toxin production of the isolates. J. Appl. Microbiol. 94, 1003 \u20131014. \ndoi:10.1046/j.1365 -2672.2003.01926.x  \nBaqar, S., Tribble, D.R., Car molli, M., Sadigh, K., Poly, F., Porter, C., Larsson, C.J., \nPierce, K.K., Guerry, P., Ventrone, C., Dill, E., Daunais, P., Cummings, G., Lyon, \nC., Fingar, A., Gilliland, T., Jones, E., Ewing, C.P., Dadouk, S., Sincock, S., Lee, L., \nBuchwaldt, C., Puel, P.,  Miller, R., Mattiesen, D., Darsley, M., Kirkpatrick, B., \n2010. Recrudescent Campylobacter jejuni infection in an immunocompetent \nadult following experimental infection with a well -characterized organism. \nClin. Vaccine Immunol. 17, 80 \u201386. doi:10.1128/CVI.0 0252 -09 \nBarton, C., Ng, L.K., Tyler, S.D., Clark, C.G., 2007. Temperate bacteriophages affect \npulsed -field gel electrophoresis patterns of Campylobacter jejuni . J. Clin. \nMicrobiol. 45, 386 \u2013391. doi:10.1128/JCM.01513 -06 \nBattersby, T., Whyte, P., Bolton, D.J ., 2016. The pattern of Campylobacter \ncontamination on broiler farms; external and internal sources. J. Appl. \nMicrobiol. 120, 1108 \u20131118. doi:10.1111/jam.13066  \nBless, P.J., Schmutz, C., Suter, K., Jost, M., Hattendorf, J., M\u00e4usezahl -Feuz, M., \nM\u00e4usezahl, D.,  2014. A tradition and an epidemic: Determinants of the \ncampylobacteriosis winter peak in Switzerland. Eur. J. Epidemiol. 29, 527 \u2013\n537. doi:10.1007/s10654 -014 -9917 -0 \nBleumink -Pluym, N.M.C., van Alphen, L.B., Bouwman, L.I., W\u00f6sten, M.M.S.M., van \nPutten, J.P. M., 2013. Identification of a Functional Type VI Secretion System in \nCampylobacter jejuni Conferring Capsule Polysaccharide Sensitive \nCytotoxicity. PLoS Pathog. 9, 16 \u201318. doi:10.1371/journal.ppat.1003393  \nBolton, D.J., 2015. Campylobacter  virulence and surv ival factors. Food Microbiol. \n48, 99 \u2013108. doi:10.1016/j.fm.2014.11.017  \nBoysen, L., Rosenquist, H., Larsson, J.T., Nielsen, E.M., S\u00f8rensen, G., Nordentoft, S., \nHald, T., 2013. Source attribution of human campylobacteriosis in Denmark. \nEpidemiol. Infect. 1 \u201310. doi:10.1017/S0950268813002719  \nBuhr, R., Cox, N., Stern, N., Musgrove, M., Wilson, J., Hiett, K., 2002. Recovery of \nCampylobacter  from segments of the reproductive tract of broiler breeder \nhens. Avian Dis. 46(4):, 919 \u201324. \nBull, S.A., Allen, V.M., Domingu e, G., J\u00f8rgensen, F., Frost, J.A., Ure, R., Whyte, R., Referencias  \n131 \n Tinker, D., Corry, J.E.L., Gillard -King, J., Humphrey, T.J., 2006. Sources of \nCampylobacter  spp. colonizing housed broiler flocks during rearing. Appl. \nEnviron. Microbiol. 72, 645 \u2013652. doi:10.1128/AEM. 72.1.645 -652.2006  \nBull, S.A., Thomas, A., Humphrey, T., Ellis -Iversen, J., Cook, A.J., Lovell, R., Jorgensen, \nF., 2008. Flock health indicators and Campylobacter  spp. in commercial \nhoused broilers reared in Great Britain. Appl. Environ. Microbiol. 74, 5408 \u2013\n5413. doi:10.1128/AEM.00462 -08 \nButzler, J, P., P, D., M, D., F, D., 1973. Related vibrio in stools. J. Pediatr. 82, 82, 493 \u2013\n495.  \nButzler, J.P., 2004. Campylobac ter, from obscurity to celebrity. Clin. Microbiol. \nInfect. 10, 868 \u2013876. doi:10.1111/j.1469 -0691.2004.00983.x  \nButzler, J.P., Skirrow, M.B., 1979. Campylobacter  enteritis. J. Clin. Gastroenterol. \n82:, 737 \u2013765.  \nCagliero, C., Mouline, C., Cloeckaert, A., Payot , S., 2006. Synergy between efflux \npump CmeABC and modifications in ribosomal proteins L4 and L22 in \nconferring macrolide resistance in Campylobacter jejuni  and Campylobacter \ncoli.  Antimicrob. Agents Chemother. 50, 3893 \u20133896. \ndoi:10.1128/AAC.00616 -06 \nCaldw ell, D.B., Wang, Y., Lin, J., 2008. Development, stability, and molecular \nmechanisms of macrolide resistance in Campylobacter jejuni . Antimicrob. \nAgents Chemother. 52, 3947 \u20133954. doi:10.1128/AAC.00450 -08 \nCallicott, K.A., Frioriksd\u00f3ttir, V., Reiersen, J., L owman, R., Bisaillon, J.R., \nGunnarsson, E., Berndtson, E., Hiett, K.L., Needleman, D.S., Stern, N.J., 2006. \nLack of evidence for vertical transmission of Campylobacter  spp. in chickens. \nAppl. Environ. Microbiol. 72, 5794 \u20135798. doi:10.1128/AEM.02991 -05 \nCant \u00f3n, R., 2010. Interpretive reading of the antibiogram: A clinical necessity. \nEnferm. Infecc. Microbiol. Clin. 28, 375 \u2013385.  \nCant\u00f3n, R., 2009. Antibiotic resistance genes from the environment: A perspective \nthrough newly identified antibiotic resistance mech anisms in the clinical \nsetting. Clin. Microbiol. Infect. 15, 20 \u201325. doi:10.1111/j.1469 -\n0691.2008.02679.x  \nCarreira, A., Clemente, L., Rocha, T., Tavares, A., Geralde, M., Barahona, M., Botelho, \nA., Cunha, M., 2012. Comparative Genotypic and Antimicrobial Su sceptibility \nAnalysis of Zoonotic Campylobacter  Species Isolated from Broilers in a \nNationwide Survey, Portugal. J. Food Prot. 75, 2100 \u20132109. doi:10.4315/0362 -\n028X.JFP -12-183  Referencia  \n132  \n Cawthraw, S.., Newell, D.., 2010. Investigation of the presence and protective \neffects of maternal antibodies against Campylobacter jejuni  in chickens. Avian \nDis. 54(1):  \nCawthraw, S., Wassenaar, T., Ayling, R., & Newell, D., 1996. Increased colonization \npotential of Campylobacter jejuni  strain 81116 after passage through \nchickens and i ts implication on the rate of transmission within flocks. \nEpidemiol. Infect. 117(1):, 213 \u2013215.  \nCerd\u00e0 -Cu\u00e9llar, M., Laureano, L., Ayats, T., Corujo, A., Hald, B., Dolz, R., 2015. Efficacy \nof biosecurity measures in Spanish broiler farms to prevent thermophil ic \nCampylobacter colonization. 18th Int. Work. Campylobacter , Helicobacter \nRelat. Org.  \nChang, C., Miller, J.F., 2006. Campylobacter jejuni  colonization of mice with limited \nenteric flora. Infect. Immun. 74, 5261 \u20135271. doi:10.1128/IAI.01094 -05 \nChatelain, R. V.M., 1973. Taxonomic study of the genus Campylobacter . Sebald and \nV\u00e9ron and designation of the neotype strain for the type species, \nCampylobacter fetus  (Smith and Taylor), Sebald and V\u00e9ron. . Int. J. Syst. \nBacteriol. 23:, 122 \u2013134.  \nChaveerach, P., Chaveerach, P., Huurne,  a a H.M., Huurne,  a a H.M., Lipman, L.J. a, \nLipman, L.J. a, Knapen, F. Van, Knapen, F. Van, 2003. Survival and \nResuscitation of Ten Strains of. Society 69, 711 \u2013714. \ndoi:10.1128/AEM.69.1.711  \nChopra, I., Roberts, M., 2001. Tetracycl ine Antibiotics\u202f: Mode of Action , \nApplications , Molecular Biology , and Epidemiology of Bacterial Resistance \nTetracycline Antibiotics\u202f: Mode of Action , Applications , Molecular Biology , \nand Epidemiology of Bacterial Resistance. Microbiol. Mol. Biol. Re v. 65, 232 \u2013\n260. doi:10.1128/MMBR.65.2.232  \nChuma, T., Makino, K., Okamoto, K., Yugi, H., 1997. Analysis of distribution of \nCampylobacter jejuni  and Campylobacter coli in broilers by using restriction \nfragment length polymorphism of flagellin gene. J. Vet. M ed. Sci. 59, 1011 \u2013\n1015. doi:10.1292/jvms.59.1011  \nChuma, T., Yamada, T., Yano, K., K, O., Yugi, H., 1994. A survey of Campylobacter \njejuni in broilers from assignment to slaughter using DNA -DNA hybridization. \nJ. Vet. Med. Sci. 56(4):, 697 \u2013700.  \nCoker, A.O., Isokpehi, R.D., Thomas, B.N., Amisu, K.O., Larry Obi, C., 2002. Human \ncampylobacteriosis in developing countries. Emerg. Infect. Dis. 8, 237 \u2013243. \ndoi:10.3201/eid0803.010233  \nColles, F.M., Jones, K., Harding, R.M., Maiden, M.C.J., 2003. Genetic Diversity of Referencias  \n133  \n Campylobacter jejuni Isolates from Farm Animals and the Farm Environment \nGenetic Diversity of Campylobacter jejuni  Isolates from Farm Animals and the \nFarm Environment. Appl. Environ. Microbiol. 69, 7409 \u20137413. \ndoi:10.1128/AEM.69.12.7409  \nColles, F.M., Mccart hy, N.D., Bliss, C.M., Layton, R., Maiden, M.C.J., 2015. The long -\nterm dynamics of Campylobacter  colonizing a free -range broiler breeder \nflock: An observational study. Environ. Microbiol. 17, 938 \u2013946. \ndoi:10.1111/1462 -2920.12415  \nConnell, S.R., Trieber, C.A ., Dinos, G.P., Einfeldt, E., Taylor, D.E., Nierhaus, K.H., \n2003. Mechanism of Tet(O) -mediated tetracycline resistance. EMBO J. 22, \n945 \u2013953. doi:10.1093/emboj/cdg093  \nCorcionivoschi, N., Gundogdu, O., Moran, L., Kelly, C., Scates, P., Stef, L., Cean, A., \nWren, B., Dorrell, N., Madden, R.H., 2015. Virulence characteristics of hcp (+) \nCampylobacter jejuni  and Campylobacter coli  isolates from retail chicken. Gut \nPathog. 7, 20. doi:10.1186/s13099 -015 -0067 -z \nCorry, J., Atabay, H., 2001. Poultry as a source of Cam pylobacter  and related \norganisms. Symp. Ser. Soc. Appl. Microbiol. (30):, 96 \u2013114.  \nCox, N., LJ, R., JJ, M., ME, B., PJ, F. -C., Buhr RJ, B.J., MD, L., CL, H., PM, O., AM, L., AG, C., \nSG, T., MP., D., 2012. Evidence for horizontal and vertical transmission in  \nCampylobacter  passage from hen to her progeny. J. Food Prot. 75(10):, 1896 \u2013\n902.  \nCrushell, E., Harty, S., Sharif, F., Bourke, B., 2004. Enteric Campylobacter : Purging \nIts Secrets? Pediatr. Res. 55, 3 \u201312. \ndoi:10.1203/01.PDR.0000099794.06260.71  \nD\u2019Costa, V.M., Griffiths, E., Wright, G.D., 2007. Expanding the soil antibiotic \nresistome: exploring environmental diversity. Curr. Opin. Microbiol. 10, 481 \u2013\n489. doi:10.1016/j.mib.2007.08.009  \nD\u2019Lima, C.B., Miller, W.G., Mandrell, R.E., Wright, S.L., Siletzky, R.M.,  Carver, D.K., \nKathariou, S., 2007. Clonal population structure and specific genotypes of \nmultidrug -resistant Campylobacter coli  from Turkeys. Appl. Environ. \nMicrobiol. 73, 2156 \u20132164. doi:10.1128/AEM.02346 -06 \nDasti, J.I., Tareen, A.M., Lugert, R., Zautner,  A.E., Gro\u00df, U., 2010. Campylobacter \njejuni : A brief overview on pathogenicity -associated factors and disease -\nmediating mechanisms. Int. J. Med. Microbiol. 300, 205 \u2013211. \ndoi:10.1016/j.ijmm.2009.07.002  \nDatta, S., Niwa, H., Itoh, K., 2003. Prevalence of 11 p athogenic genes of \nCampylobacter jejuni  by PCR in strains isolated from humans, poultry meat Referencia  \n134  \n and broiler and bovine faeces. J. Med. Microbiol. 52, 345 \u2013348. \ndoi:10.1099/jmm.0.05056 -0 \nde Jager, A.E., Sluiter, H.J., 1991. Clinical signs in severe Guillain -Barr\u00e9 syndrome: \nanalysis of 63 patients. J. Neurol Sci. 104(2):, 143 \u201350. \nDe Jong, A., Bywater, R., Butty, P., Deroover, E., Godinho, K., Klein, U., Marion, H., \nSimjee, S., Smets, K., Thomas, V., Vall??, M., Wheadon, A., 2009. A pan -\nEuropean survey of antimicr obial susceptibility towards human -use \nantimicrobial drugs among zoonotic and commensal enteric bacteria isolated \nfrom healthy food -producing animals. J. Antimicrob. Chemother. 63, 733 \u2013744. \ndoi:10.1093/jac/dkp012  \nDebretsion, A., Habtemariam, T., Wilson, S. , Nganwa, D., Yehualaeshet, T., 2007. \nReal -time PCR assay for rapid detection and quantification of Campylobacter \njejuni  on chicken rinses from poultry processing plant. Mol. Cell. Probes 21, \n177 \u2013181. doi:10.1016/j.mcp.2006.10.006  \nDebruyne, L., Gevers, D.,  Vandamme, P., 2005. Taxonomy of the family \nCampylobacteraceae, in Campylobacter . Am. Soc. Microbiol. Press. \nWashington, DC.  \nDeckert, A.E., Taboada, E., Mutschall, S., Poljak, Z., Reid -Smith, R.J., Tamblyn, S., \nMorrell, L., Deckert, P.S.E., Taboada, E., Mu tschall, S., Poljak, Z., Reid -Smith, \nR.J., Tamblyn, S., Morrell, L., Seliske, P., Jamieson, F.B., Irwin, R., Dewey, C.E., \nBoerlin, P., and Scott A. McEwen1liske, 6 Frances B. Jamieson, 7 Rebecca \nIrwin, 2 Cathe, 8 and Scott A. McEwen1, 2014. Molecular Epide miology of \nCampylobacter jejuni  Human and Chicken Isolates from Two Health Units. \nFoodborne Pathog. Dis. 11.  \nDesmonts, M.H., Dufour -Gesbert, F., Avrain, L., Kempf, I., 2004. Antimacrobial \nresistance in Campylobacter strains isolated from French broilers before and \nafter antimicrobial growth promoter bans. J. Antimicrob. Chemother. 54, \n1025 \u20131030. doi:10.1093/jac/dkh473  \nDingle, K., Colles, F., Ure, R., Al., E., 2002. Molecular Characterization of \nCampylobacter jejuni  Clones: A Basis for Epidemiologic Invest igation. Emerg. \nInfect. Dis. 8(9):, 949 \u2013955.  \nDingle, K.E., Colles, F.M., Falush, D., Maiden, C.J., Maiden, M.C.J., 2005. Sequence \nTyping and Comparison of Population Biology of Campylobacter coli and \nCampylobacter jejuni Sequence Typing and Comparison of P opulation \nBiology of Campylobacter coli and Campylobacter jejuni . Society 43, 340 \u2013347. \ndoi:10.1128/JCM.43.1.340  \nDingle, K.E., McCarthy, N.D., Cody, A.J., Peto, T.E.A., Maiden, M.C.J., 2008. Extended \nsequence typing of Campylobacter  spp., United Kingdom. Em erg. Infect. Dis. Referencias  \n135  \n 14, 1620 \u20131622. doi:10.3201/eid1410.071109  \nDingle, K.E., Van den Braak, N., Colles, F.M., Price, L.J., Woodward, D.L., Rodgers, \nF.G., Endtz, H.P., Van Belkum, A., Maiden, M.C.J., 2001a. Sequence typing \nconfirms that Campylobacter jejuni  strains associated with Guillain -Barr\u00e9 and \nMiller -Fisher syndromes are of diverse genetic lineage, serotype, and flagella \ntype. J. Clin. Microbiol. 39, 3346 \u20133349. doi:10.1128/JCM.39.9.3346 -\n3349.2001  \nDingle, K.E., Van den Braak, N., Colles, F.M., Price, L.J.,  Woodward, D.L., Rodgers, \nF.G., Endtz, H.P., Van Belkum, A., Maiden, M.C.J., 2001b. Sequence typing \nconfirms that Campylobacter jejuni  strains associated with Guillain -Barr?? \nand Miller -Fisher syndromes are of diverse genetic lineage, serotype, and \nflagell a type. J. Clin. Microbiol. 39, 3346 \u20133349. doi:10.1128/JCM.39.9.3346 -\n3349.2001  \nDoyle, M.P., 1984. Association of Campylobacter jejuni  with laying hens and eggs. \nAppl. Environ. Microbiol. 47, 533 \u2013536.  \nDrlica, K., Zhao, X., 1997. DNA gyrase, topoisomerase IV , and the 4 -quinolones. \nMicrobiol. Mol. Biol. Rev. 61, 377 \u2013392. doi:D - NLM: PMC232616 EDAT - \n1997/09/18 MHDA - 1997/09/18 00:01 CRDT - 1997/09/18 00:00 PST - \nppublish  \nDuarte, A., Santos, A., Manageiro, V., Martins, A., Fraqueza, M.J., Cani\u00e7a, M., \nDomingues, F.C., Oleastro, M., 2014. Human, food and animal Campylobacter  \nspp. isolated in Portugal: High genetic diversity and antibiotic resistance \nrates. Int. J. Antimicrob. Agents 44, 306 \u2013313. \ndoi:10.1016/j.ijantimicag.2014.06.012  \nDuarte, A., Seliwiorstow, T., Mi ller, W.G., De Zutter, L., Uyttendaele, M., Dierick, K., \nBotteldoorn, N., 2016. Discriminative power of Campylobacter  phenotypic \nand genotypic typing methods. J. Microbiol. Methods 125, 33 \u201339. \ndoi:10.1016/j.mimet.2016.03.004  \nEberhart -Phillips, J., Walker, N., Garrett, N., Bell, D., Sinclair, D., Rainger, W., Bates, \nM., Eberhart -Phillips, J., Walker, N., Garrett, N., Bell, D., Sinclair, D., Rainger, \nW., Bates, M., 1997. Campylobacteriosis in New Zealand: Results of a case -\ncontrol study. J. Epidemiol. Communi ty Health 51, 686 \u2013691.  \nEberle, K.N., Kiess, A.S., 2012. Phenotypic and genotypic methods for typing \nCampylobacter jejuni  and Campylobacter coli in poultry. Poult. Sci. 91, 255 \u201364. \ndoi:10.3382/ps.2011 -01414  \nEdgar, R.C., 2004. MUSCLE: Multiple sequence align ment with high accuracy and \nhigh throughput. Nucleic Acids Res. 32, 1792 \u20131797. doi:10.1093/nar/gkh340  Referencia  \n136  \n EFSA, 2015. EU Summary Report on antimicrobial resistance in zoonotic and \nindicator bacteria from humans, animals and food in 2013. EFSA J. 13, 1 \u2013178. \ndoi:10.2903/j.efsa.2015.4036  \nEFSA, 2014. The European Union summary report on trends and sources of \nzoonoses, zoonotic agents and food -borne outbreaks in 2014 European Food \nSafety Authority European Centre for Disease Prevention and Control. EFSA J. \n13. doi:1 0.2903/j.efsa.2015.4329  \nEFSA, 2013. The European Union summary report on trends and sources of \nzoonoses, zoonotic agents and food -borne outbreaks in 2011 has been \npublished. EFSA J. 18, 20449. doi:10.2903/j.efsa.2015.3991  \nEFSA, 2011. Scientific Opinion on Campylobacter in broiler meat production: \ncontrol options and performance objectives and/or targets at different stages \nof the food chain. EFSA J. 9, 1 \u2013141. doi:10.2903/j.efsa.2011.2105.  \nEFSA, 2010. Scientific Opinion on Quantification of the risk posed by  broiler meat \nto human campylobacteriosis in the EU 1. EFSA J. 8, 1 \u201389. \ndoi:10.2903/j.efsa.2010.1437.Available  \nEFSA, 2008. Harmonised monitoring of antimicrobial resistance in Salmonella  and \nCampylobacter  isolates from food animals in the European Union. Clin. \nMicrobiol. Infect. 14, 522 \u2013533. doi:10.1111/j.1469 -0691.2008.02000.x  \nEFSA, 2007. The community summary report on trends and sources of zoonoses, \nzoonotic agents, antimicrobial resistance and foodborn e outbreaks in the \nEuropean Union in 2006, Science.  \nEFSA, E., 2016. The Euroean Union summary report on trends and sources of \nzoonsoes, zoonotic agents and food -borne outbreaks in 2014. EFSA J. 13. \ndoi:10.2903/j.efsa. 2015.4329  \nEFSA, E., 2015. The Euroean Union summary report on trends and sources of \nzoonsoes, zoonotic agents and food -borne outbreaks in 2014. EFSA  J. 13. \ndoi:10.2903/j.efsa. 2015.4329  \nEmborg, H., Teunis, P., Simonsen, J., Krogfelt, K., J\u00f8rgensen, C., Takkinen, J., M\u00f8lbak, \nK., 2015. WAS THE INCREASE IN CULTURE -CONFIRMED CAMPYLOBACTER  \nINFECTIONS IN DENMARK DURING THE 1990S A SURVEILLANCE \nARTEFACT? Eurosurveillance 20.  \nEscherich, T., 1886. Articles adding to the knowledge of intestinal bacteria. III. On \nthe existence of vibrios in the intestines and feces of babies. M\u00fcnchener \nmedizinische Wochenscchrift 33:, 815 \u2013817, 833 \u2013835.  \nEvans, S.J., Sayers, A.R., 2000. A longitudinal study of Campylobacter  infection of Referencias  \n137  \n broiler flocks in Great Britain. Prev. Vet. Med. 46, 209 \u2013223. \ndoi:10.1016/S0167 -5877(00)00143 -4 \nFerrero, R.L., Lee, A., 1988. Motility of Campylobacter jejuni in a viscous \nenviroment: comparison with conventional rod -shaped bacteria. J. Gen. \nMicrobiol. 53 \u201359. \nFoley, S.L., Lynne, A.M., Nayak, R., 2009. Molecular typing methodologies f or \nmicrobial source tracking and epidemiological investigations of Gram -\nnegative bacterial foodborne pathogens. Infect. Genet. Evol. 9, 430 \u2013440. \ndoi:10.1016/j.meegid.2009.03.004  \nForsberg, K.J., Reyes, A., Wang, B., Selleck, E.M., Morten, O.A., 2012. The sh ared \nantibiotic resistome of soil bacteria and human pathogens 337, 1107 \u20131111. \ndoi:10.1126/science.1220761.The  \nFouts, D.E., Mongodin, E.F., Mandrell, R.E., Miller, W.G., Rasko, D.A., Ravel, J., \nBrinkac, L.M., Deboy, R.T., Parker, C.T., Daugherty, S.C., Dod son, R.J., Scott \nDurkin, A., Madupu, R., Sullivan, S.A., Shetty, J.U., Ayodeji, M.A., Shvartsbeyn, \nA., Schatz, M.C., Badger, J.H., Fraser, C.M., Nelson, K.E., 2005. Major structural \ndifferences and novel potential virulence mechanisms from the genomes of \nmultiple Campylobacter  species. PLoS Biol. 3. \ndoi:10.1371/journal.pbio.0030015  \nFoxman, B., Zhang, L., Koopman, J.S., Manning, S.D., Marrs, C.F., 2005. Choosing an \nappropriate bacterial typing technique for epidemiologic studies. Epidemiol. \nPerspect. Innov. 2, 10. doi:10.1186/1742 -5573 -2-10 \nFriedman, C.., Neimann, J., Wegener, H.., Tauxe, R.., 2000. Epidemiology of \nCampylobacter jejuni  infections in the United States and other industrialized \nnations. ASM Press. Washingt. 121 \u2013139.  \nFriedman, C., Hoekstra, R., S amuel, M., Marcus, R., Bender, J., Shiferaw, B., Reddy, S., \nAhuja, S.D., Helfrick, D.L., Hardnett, F., Carter, M., Anderson, B., Tauxe, R., \n2004. Risk factors for sporadic Campylobacter  infection in the United States: \nA case -control study in FoodNet sites.  Clin. Infect. Dis. 38 Suppl 3, S285 \u2013S296. \ndoi:10.1086/381598  \nGarc\u00eda de Lomas, J., Gimeno, C., 1997. Mecanismo de acci\u00f3n de los antibi\u00f3ticos. \nTrat. Antimicrob. Inf. Ter. del Sist. Nac. Salud. 22 \u2013No 3. \nGe, Z., Schauer, D.B., Fox, J.G., 2008. In vivo virulen ce properties of bacterial \ncytolethal -distending toxin. Cell. Microbiol. 10, 1599 \u20131607. \ndoi:10.1111/j.1462 -5822.2008.01173.x  \nGharst, G., Oyarzabal, O.A., Hussain, S.K., 2013. Review of current methodologies to \nisolate and identify Campylobacter  spp. from f oods. J. Microbiol. Methods 95, Referencia  \n138  \n 84\u201392. doi:10.1016/j.mimet.2013.07.014  \nGibbons, C.L., Mangen, M. -J.J., Plass, D., Havelaar, A.H., Brooke, R.J., Kramarz, P., \nPeterson, K.L., Stuurman, A.L., Cassini, A., Fevre, E.M., Kretzschmar, M.E.E., \nconsortium, B. of C.  diseases in E. (BCoDE), 2014. Measuring underreporting \nand under -ascertainment in infectious disease datasets: a comparison of \nmethods. BMC Public Health 14, 147. doi:10.1186/1471 -2458 -14-147 \nGibreel, A., Dobryan M, T., Nonaka, Lisa,  et al, 2004. Inciden ce of Antibiotic \nResistance in Campylobacter jejuni  Isolated in Alberta , Canada , from 1999 to \n2002 , with Special Reference to tet ( O ) -Mediated Tetracycline Resistance. \nAntimicrob. Agents Chemother. 3442 \u20133450. doi:10.1128/AAC.48.9.3442  \nGibreel, A., Ta ylor, D.E., 2006. Macrolide resistance in Campylobacter jejuni  and \nCampylobacter coli . J. Antimicrob. Chemother. 58, 243 \u2013255. \ndoi:10.1093/jac/dkl210  \nGillespie, I.A., O\u2019Brien, S.J., Frost, J.A., Adak, G.K., Horby, P., Swan, A. V., Painter, M.J., \nNeal, K.R., 2002. A case -case comparison of Campylobacter coli  and \nCampylobacter jejuni  infection: A tool for generating hypotheses. Emerg. \nInfect. Dis. 8, 937 \u2013942. doi:10.3201/eid0809.010187  \nGodschalk, P.C.R., Heikema, A.P., Gilbert, M., Komagamine, T., Wim Ang, C., Glerum, \nJ., Brochu, D., Li, J., Yuki, N., Jacobs, B.C., Van Belkum, A., Endtz, H.P., 2004. The \ncrucial role of Campylobacter jejuni  genes in anti -ganglioside antibody \ninduction in Guillain -Barr\u00e9 syndrome. J. Clin. Invest. 114, 1659 \u20131665. \ndoi:10.1172/JCI200415707  \nGregory, E., Barnhart, H., Dreesen, D.W., Stern, N.J., Corn., J.L., 1997. \nEpidemiological study of Campylobacter  spp. In broilers: Source, ti me of \ncolonization, and prevalence. Avian Dis. 41, 890 \u2013898.  \nGreig, J., 2003. Quinolone resistance in Campylobacter . J. Antimicrob. Chemother. \n51(3):, 740 \u20132. \nGriffiths, P.L., Park, R.W., 1990. Campylobacters associated with human diarrhoeal \ndisease. J. Appl . Bacteriol. 69:, 281 \u2013301.  \nGripp, E., Hlahla, D., Didelot, X., Kops, F., Maurischat, S., Tedin, K., Alter, T., \nEllerbroek, L., Schreiber, K., Schomburg, D., Janssen, T., Bartholom\u00e4us, P., \nHofreuter, D., Woltemate, S., Uhr, M., Brenneke, B., Gr\u00fcning, P., Ge rlach, G., \nWieler, L., Suerbaum, S., Josenhans, C., 2011. Closely related Campylobacter \njejuni  strains from different sources reveal a generalist rather than a \nspecialist lifestyle. BMC Genomics 12, 584. doi:10.1186/1471 -2164 -12-584 \nGuerry, P., 2007. Campy lobacter  flagella: not just for motility. Trends Microbiol. 15, \n456 \u2013461. doi:10.1016/j.tim.2007.09.006  Referencias  \n139  \n Guo, B., Wang, Y., Shi, F., Barton, Y.W., Plummer, P., Reynolds, D.L., Nettleton, D., \nGrinnage -Pulley, T., Lin, J., Zhang, Q., 2008. CmeR functions as a pleiotropic \nregulator and is required for optimal colonization of Campylobacter jejuni in \nvivo. J. Bact eriol. 190, 1879 \u20131890. doi:10.1128/JB.01796 -07 \nGyles, C., 2008. Antimicrobial resistance in selected bacteria from poultry. Anim. \nHeal. Res. Rev. 9, 149 \u2013158.  \nHald, B., Skovg\u00e5rd, H., Pedersen, K., Bunkenborg, H., 2008. Influxed insects as \nvectors for Campyl obacter jejuni  and Campylobacter coli  in Danish broiler \nhouses. Poult. Sci. 87, 1428 \u20131434. doi:10.3382/ps.2007 -00301  \nH\u00e4nninen, M., Haajanen, H., Pummi, T., Katila, M., Sarkkinen, H., Miettinen, I., 2003. \nDetection and Typing of Campylobacter jejuni  and Cam pylobacter coli  and \nAnalysis of Indicator Organisms in Three Waterborne Outbreaks in Finland \nDetection and Typing of Campylobacter jejuni and Campylobacter coli and \nAnalysis of Indicator Organisms in Thr. Appl. Environ. Microbiol. 69, 1391 \u2013\n1396. doi:10.112 8/AEM.69.3.1391  \nH\u00e4nninen, M.L., Hakkinen, M., Rautelin, H., 1999. Stability of related human and \nchicken Campylobacter jejuni  genotypes after passage through chick intestine \nstudied by pulsed -field gel electrophoresis. Appl. Environ. Microbiol. 65, \n2272 \u20132275. \nH\u00e4nninen, M.L., Perko -M\u00e4kel\u00e4, P., Pitk\u00e4l\u00e4, A., Rautelin, H., 2000. A three -year study \nof Campylobacter jejuni genotypes in humans with domestically acquired \ninfections and in chicken samples from the Helsinki area. J. Clin. Microbiol. 38, \n1998 \u20132000.  \nHansson, I., Ederoth, M., Andersson, L., V??gsholm, I., Engvall, E.O., 2005. \nTransmission of Campylobacter  spp. to chickens during transport to \nslaughter. J. Appl. Microbiol. 99, 1149 \u20131157. doi:10.1111/j.1365 -\n2672.2005.02689.x  \nHarrison, J.W., Dung, T.T.N., S iddiqui, F., Korbrisate, S., Bukhari, H., Vu Tra, M.P., \nVan Minh Hoang, N., Carrique -Mas, J., Bryant, J., Campbell, J.I., Studholme, D.J., \nWren, B.W., Baker, S., Titball, R.W., Champion, O.L., 2014. Identification of \npossible virulence marker from Campylob acter jejuni  isolates. Emerg. Infect. \nDis. 20, 1026 \u20131029. doi:10.3201/eid2006.130635  \nHendrixson, D.R., DiRita, V.J., 2004. Identification of Campylobacter jejuni  genes \ninvolved in commensal colonization of the chick gastrointestinal tract. Mol. \nMicrobiol. 52, 471 \u2013484. doi:10.1111/j.1365 -2958.2004.03988.x  \nHermans, D., Pasmans, F., Messens, W., Martel, A., Van Immerseel, F., Rasschaert, G., \nHeyndrickx, M., Van Deun, K., Haesebrouck, F., 2012. Poultry as a host for the \nzoonotic pathogen Campylobacter jejuni . Vector Borne Zoonotic Dis. 12, 89 \u2013Referencia  \n140  \n 98. doi:10.1089/vbz.2011.0676  \nHiett, K., GR, S., NA, C., RJ, B., MT, M., NJ, S., JL., W., 2003. Genotype analyses of \nCampylobacter  isolated from the gastrointestinal tracts and the reproductive \ntracts of broiler breeder ro osters. Avian Dis. 47(2):, 406 \u201314. \nHiett, K.L., Cox, N.A., Buhr, R.J., Stern, N.J., 2002. Genotype analyses of \nCampylobacter  isolated from distinct segments of the reproductive tracts of \nbroiler breeder hens. Curr. Microbiol. 45, 400 \u2013404. doi:10.1007/s0028 4-002-\n3771 -0 \nHofreuter, D., Tsai, J., Watson, R.O., Novik, V., Altman, B., Benitez, M., Clark, C., \nPerbost, C., Jarvie, T., Du, L., Gal\u00e1n, J.E., 2006. Unique features of a highly \npathogenic Campylobacter jejuni  strain. Infect. Immun. 74, 4694 \u20134707. \ndoi:10. 1128/IAI.00210 -06 \nHorme\u00f1o, L., Palomo, G., Ugarte -Ruiz, M., Porrero, M.C., Borge, C., Vadillo, S., P\u00edriz, \nS., Dom\u00ednguez, L., Campos, M.J., Quesada, A., 2016. Identification of the main \nquinolone resistance determinant in Campylobacter jejuni  and C ampylobac ter \ncoli by MAMA -DEG PCR. Diagn. Microbiol. Infect. Dis. 84, 236 \u2013239. \ndoi:10.1016/j.diagmicrobio.2015.11.002  \nHorrocks, S.M., Anderson, R.C., Nisbet, D.J., Ricke, S.C., 2009. Incidence and ecology \nof Campylobacter jejuni  and coli in animals. Anaerobe 15, 18 \u201325. \ndoi:10.1016/j.anaerobe.2008.09.001  \nHumphrey, T., Mason, M., Martin, K., 1995. The isolation of Campylobacter jejuni  \nfrom contaminated surfaces and its survival in diluents. Int. J. Food Microbiol. \n26, 295 \u2013303. doi:10.1016/0168 -1605(94)00135 -S \nHumphrey , T., O\u2019Brien, S., Madsen, M., 2007. Campylobacters as zoonotic \npathogens: A food production perspective. Int. J. Food Microbiol. 117, 237 \u2013\n257. doi:10.1016/j.ijfoodmicro.2007.01.006  \nIdris, U., Lu, J., Maier, M., Sanchez, S., Hofacre, C.L., Harmon, B.G., Ma urer, J.J., Lee, \nM.D., 2006. Dissemination of Fluoroquinolone -Resistant Campylobacter  spp . \nwithin an Integrated Commercial Poultry Production System Dissemination \nof Fluoroquinolone -Resistant Campylobacter  spp . within an Integrated \nCommercial Poultry Pro duction System 72, 3441 \u20133447. \ndoi:10.1128/AEM.72.5.3441  \nIovine, N.M., 2013. Resistance mechanisms in Campylobacter jejuni . Virulence 4, \n230 \u201340. doi:10.4161/viru.23753  \nJacobs -Reitsma, W.F., 1997. Aspects of epidemiology of Campylobacter  in poultry. \nVet. Q. 19(3):, 113 \u20137. Referencias  \n141  \n Jacoby, G.A., 2005. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 41 \nSuppl 2, S120 -6. doi:10.1086/428052  \nJagannathan, A. Penn, C., 2005. \u201cMotility\u201d, in Campylobacter . Mol. Cell. Biol. Norfolk: \nH, 331 \u2013347.  \nJain, D., Prasad, K.N.,  Sinha, S., Husain, N., 2008. Differences in virulence attributes \nbetween cytolethal distending toxin positive and negative Campylobacter \njejuni strains. J. Med. Microbiol. 57, 267 \u2013272. doi:10.1099/jmm.0.47317 -0 \nJanssen, R., Krogfelt, K.A., Cawthraw, S.A.,  Van Pelt, W., Wagenaar, J.A., Owen, R.J., \n2008. Host -pathogen interactions in Campylobacter  infections: The host \nperspective. Clin. Microbiol. Rev. 21, 505 \u2013518. doi:10.1128/CMR.00055 -07 \nJean -Paul, B., Johannes, O., 1991. Campylobacter : pathogenicity and s ignificance in \nfoods. J. Food Microbiol. 12, 1 \u20138. \nJin, S., Joe, A., Lynett, J., Hani, E.K., Sherman, P., Chan, V.L., 2001. JlpA, a novel \nsurface -exposed lipoprotein specific to Campylobacter jejuni , mediates \nadherence to host epithelial cells. Mol. Microbi ol. 39, 1225 \u20131236. \ndoi:10.1046/j.1365 -2958.2001.02294.x  \nJohnsen, G., Kruse, H., Hofshagen, M., 2006. Genetic diversity and description of \ntransmission routes for Campylobacter  on broiler farms by amplified -\nfragment length polymorphism. J. Appl. Microbiol. 101, 1130 \u20131139. \ndoi:10.1111/j.1365 -2672.2006.02995.x  \nJore, S., Viljugrein, H., Brun, E., Heier, B.T., Borck, B., Ethelberg, S., Hakkinen, M., \nKuusi, M., Reiersen, J., Hansson, I., Olsson Engvall, E., L\u00f8fdahl, M., Wagenaar, \nJ.A., van Pelt, W., Hofshagen, M., 2010. Trends in Campylobacter  incidence in \nbroilers  and humans in six European countries, 1997 -2007. Prev. Vet. Med. \n93, 33 \u201341. doi:10.1016/j.prevetmed.2009.09.015  \nKaakoush, N.O., Casta??o -Rodr??guez, N., Mitchell, H.M., Man, S.M., 2015. Global \nepidemiology of Campylobacter  infection. Clin. Microbiol. Rev.  28, 687 \u2013720. \ndoi:10.1128/CMR.00006 -15 \nKaas, R.S., Leekitcharoenphon, P., Aarestrup, F.M., Lund, O., 2014. Solving the \nproblem of comparing whole bacterial genomes across different sequencing \nplatforms. PLoS One 9, 1 \u20138. doi:10.1371/journal.pone.0104984  \nKan g, Y. -S., Cho, Y. -S., Yoon, S. -K., Yu, M. -A., Kim, C. -M., Lee, J. -O., Pyun, Y. -R., 2006. \nPrevalence and antimicrobial resistance of Campylobacter jejuni  and \nCampylobacter coli  isolated from rawchicken meat and human stools in \nKorea. J. Food Prot. 69, 2915 \u20132923.  \nKapperud, G., Skjerve, E., Vik, L., Hauge, K., Lysaker,  a, Aalmen, I., Ostroff, S.M., Referencia  \n142  \n Potter, M., 1993. Epidemiological investigation of risk factors for \nCampylobacter  colonization in Norwegian broiler flocks. Epidemiol. Infect. \n111, 245 \u2013255. doi:10 .1017/S0950268800056958  \nKassa, T., Gebre -Selassie, S., Asrat, D., 2007. Antimicrobial susceptibility patterns of \nthermotolerant Campylobacter  strains isolated from food animals in Ethiopia. \nVet. Microbiol. 119, 82 \u201387. doi:10.1016/j.vetmic.2006.08.011  \nKelly , D.J., 2001. The physiology and metabolism of Campylobacter jejuni  and \nHelicobacter pylori . Symp. Ser. Soc. Appl. Microbiol. 90:, 16S \u201324S.  \nKing, E.O., 1957. Human infections with Vibrio fetus and a closely related Vibrio \nisolated from cases of human vibri osis. J. Infect. Dis. 101:, 119 \u2013128.  \nKonkel, M.., Garvis, S.., Tipton, S.., Jr., A., D.E, Cieplak Jr, W., 1997. Identification and \nmolecular cloning of a gene encoding a fibronectin - binding protein (CadF) \nfrom Campylobacter jejuni . Mol. Microbiol. 24, 953 \u2013963.  \nKoolman, L., Whyte, P., Burgess, C., Bolton, D., 2015. Distribution of virulence -\nassociated genes in a selection of Campylobacter isolates. Foodborne Pathog. \nDis. 12, 424 \u201332. doi:10.1089/fpd.2014.1883  \nKorczak, B.M., Zurfluh, M., Emler, S., Kuhn -Oertl i, J., Kuhnert, P., 2009. Multiplex \nstrategy for multilocus sequence typing, fla typing, and genetic determination \nof antimicrobial resistance of Campylobacter jejuni  and Campylobacter coli  \nisolates collected in Switzerland. J. Clin. Microbiol. 47, 1996 \u20132007. \ndoi:10.1128/JCM.00237 -09 \nKurin\u010di\u010d, M., Botteldoorn, N., Herman, L., Smole Mo\u017eina, S., 2007. Mechanisms of \nerythromycin resistance of Campylobacter  spp. isolated from food, animals \nand humans. Int. J. Food Microbiol. 120, 186 \u2013190. \ndoi:10.1016/j.ijfoodmi cro.2007.03.012  \nLaing, C.R., Zhang, Y., Thomas, J.E., Gannon, V.P.J., 2011. Everything at once: \nComparative analysis of the genomes of bacterial pathogens. Vet. Microbiol. \n153, 13 \u201326. doi:10.1016/j.vetmic.2011.06.014  \nLef\u00e9bure, T., Bitar, P.D.P., Suzuki, H. , Stanhope, M.J., 2010. Evolutionary dynamics \nof complete Campylobacter  pan-genomes and the bacterial species concept. \nGenome Biol. Evol. 2, 646 \u2013655. doi:10.1093/gbe/evq048  \nLehtola MJ, T, P., MiebachL, L., I.T, M., 2006. Survival of Campylobacter jejuni  in \npotable water biofilms: a comparative study with different detection \nmethods. Water Sci. Technol. a J. Int. Assoc. Water Pollut. Res. 54:, 57 \u201361. \nLehtopolku, M., Nakari, U.M., Kotilainen, P., Huovinen, P., Siitonen, A., Hakanen, A.J., \n2010. Antimicrobial susceptibilities of multidrug -resistant Campylobacter Referencias  \n143  \n jejuni  and C. coli strains: In vitro activities of 20 antimicrobial agents. \nAntimicrob. Agents Chemother. 54, 1232 \u20131236. doi:10.1128/AAC.00898 -09 \nLevin, R.E., 2007. Campylobacter jejuni : a review of its  characteristics, \npathogenicity, ecology, distribution, subspecies characterization and \nmolecular methods of detection. Food Biotechnol. 21:, 271 \u2013347.  \nLi, H., Durbin, R., 2009. Fast and accurate short read alignment with Burrows -\nWheeler transform. Bioinfor matics 25, 1754 \u20131760. \ndoi:10.1093/bioinformatics/btp324  \nLin, J., Michel, L.O., Zhang, Q., 2002. CmeABC Functions as a Multidrug Efflux \nSystem in  Campylobacter jejuni  CmeABC Functions as a Multidrug Efflux \nSystem in Campylobacter jejuni. Society 46, 2124 \u20132131. \ndoi:10.1128/AAC.46.7.2124  \nLin, J., Yan, M., Sahin, O., Pereira, S., Chang, Y.J., Zhang, Q., 2007. Effect of macrolide \nusage on emergence of erythromycin -resistant Campylobacter  isolates in \nchickens. Antimicrob. Agents Chemother. 51, 1678 \u20131686. \ndoi:10.1 128/AAC.01411 -06 \nLoman, N.J., Pallen, M.J., 2015. Twenty years of bacterial genome sequencing. Nat. \nRev. Microbiol. 13, 1 \u20139. doi:10.1038/nrmicro3565  \nLuber, P., Wagner, J., Hahn, H., Bartelt, E., 2003. Antimicrobial Resistance in \nCampylobacter jejuni  and Campylobacter coli  Strains Isolated in 1991 and \n2001 -2002 from Poultry and Humans in Berlin , Germany.  Antimicrob. Agents \nChemother. 47, 3825 \u20133830. doi:10.1128/AAC.47.12.3825  \nLuo, N., Pereira, S., Sahin, O., Lin, J., Huang, S., Michel, L., Zhang, Q., 2005. E nhanced \nin vivo fitness of fluoroquinolone -resistant Campylobacter jejuni  in the \nabsence of antibiotic selection pressure. Proc. Natl. Acad. Sci. United States \nAm. 102, 541 \u2013546. doi:10.1073/pnas.0408966102  \nManning, G., Dowson, C.G., Mary, C., Ahmed, I.H., West, M., Newell, D.G., Bagnall, \nM.C., 2003. Multilocus Sequence Typing for Comparison of Veterinary and \nHuman Isolates of Campylobacter jejuni  Multilocus Sequence Typing for \nComparison of Veterinary and Human Isolates of Campylobacter jejuni . Appl. \nEnviro n. Microbiol. 69(11), 6370 \u20136379. doi:10.1128/AEM.69.11.6370  \nManning, G., Duim, B., Wassenaar, T., Wagenaar, J.A., Ridley, A., Newell, D.G., 2001. \nEvidence for a Genetically Stable Strain of Campylobacter jejuni.  Appl. \nEnviron. Microbiol. 67, 1185 \u20131189. doi :10.1128/AEM.67.3.1185 -1189.2001  \nManrique, C.T., 2012. La resistencia bacteriana a los antibi\u00f3ticos, siete d\u00e9cadas \ndespu\u00e9s de Fleming 1 \u201348. Referencia  \n144  \n Mart\u00ednez, J.L., Baquero, F., Andersson, D.I., 2011. Beyond serial passages: New \nmethods for predicting the emergence  of resistance to novel antibiotics. Curr. \nOpin. Pharmacol. 11, 439 \u2013445. doi:10.1016/j.coph.2011.07.005  \nMartinez, J.L., Coque, T.M., Baquero, F., 2015. What is a resistance gene? Ranking \nrisk in resistomes. Nat. Rev. Microbiol. 13, 116 \u2013123. \ndoi:10.1038/nrmicro3399  \nMatushek, M.G., Bonten, M.J., Hayden, M.K., 1996. Rapid preparation of bacterial \nDNA for pulsed -field gel electrophoresis. J. Clin. Microbiol. 34, 2598 \u20132600.  \nMcCarthy, N.D., Colles, F.M., Dingle, K.E., Bagnall, M.C., Manning, G., Ma iden, M.C.J., \nFalush, D., 2007. Host -associated genetic import in Campylobacter jejuni . \nEmerg. Infect. Dis. 13, 267 \u2013272. doi:10.3201/eid1302.060620  \nMcFarland, B.A., Neill, S.D., 1992. Profiles of toxin production by thermophilic \nCampylobacter  of animal ori gin. El sevier 30, 257 \u2013266.  \nMead, P.S., Slutsker, L., Dietz, V., McCaig, L.F., Bresee, J.S., Shapiro, C., Griffin, P.M., \nTauxe, R. V., 1999. Food -related illness and death in the United States. Emerg. \nInfect. Dis. 5, 607 \u2013625. doi:10.3201/eid0505.990502  \nMea de, K.G., Narciandi, F., Cahalane, S., Reiman, C., Allan, B., O\u2019Farrelly, C., 2009. \nComparative in vivo infection models yield insights on early host immune \nresponse to Campylobacter  in chickens. Immunogenetics 61, 101 \u2013110. \ndoi:10.1007/s00251 -008-0346 -7 \nMelero, B., Juntunen, P., H\u00e4nninen, M.L., Jaime, I., Rovira, J., 2012. Tracing \nCampylobacter jejuni  strains along the poultry meat production chain from \nfarm to retail by pulsed -field gel electrophoresis, and the antimicrobial \nresistance of isolates. Food Microbiol. 32, 124 \u2013128. \ndoi:10.1016/j.fm.2012.04.020  \nMessad, S., Hamdi, T.M., Bouhamed, R., Ramdani -Bouguessa, N., Tazir, M., 2014. \nFrequency of contamination and antimicrobial resistance of thermotolerant \nCampylobacter  isolated from some broiler farms and  slaughterhouses in the \nregion of Algiers. Food Control 40, 324328. \ndoi:10.1016/j.foodcont.2013.12.016  \nMichaud, S., Menard, S., Gaudreau, C., Arbeit, R.D., 2001. Comparison of SmaI -\ndefined genotypes of Campylobacter jejuni examined by Kpn I: A population -\nbased study. J. Med. Microbiol. 50, 1075 \u20131081.  \nMiller, R.S., Miller, W.G., Behringer, M., Hariharan, H., Matthew, V., Oyarzabal, O.A., \n2010. DNA identification and characterization of Campylobacter jejuni  and \nCampylobacter coli  isolated from caecal samples o f chickens in Grenada. J. \nAppl. Microbiol. 108, 1041 \u20131049. doi:10.1111/j.1365 -2672.2009.04507.x  Referencias  \n145  \n Miller, W.G., Chapman, M.H., Yee, E., On, S.L.W., McNulty, D.K., Lastovica, A.J., \nCarroll, A.M., McNamara, E.B., Duffy, G., Mandrell, R.E., 2012. Multilocus \nsequence typing methods for the emerging Campylobacter  Species C. \nhyointestinalis, C. lanienae, C. sputorum, C. concisus , and. Front. Cell. Infect. \nMicrobiol. 2, 45. doi:10.3389/fcimb.2012.00045  \nMiller, W.G., On, S.L.W., Wang, G., Fontanoz, S., Lastovica, A.J ., Mandrell, R.E., Town, \nC., Africa, S., Icrobiol, J.C.L.I.N.M., 2005. Extended Multilocus Sequence Typin g \nSystem for Campylobacter coli . J. Clin. Microbiol. 43, 2315 \u20132329. \ndoi:10.1128/JCM.43.5.2315  \nMilne, I., Stephen, G., Bayer, M., Cock, P.J.A., Pritchar d, L., Cardle, L., Shawand, P.D., \nMarshall, D., 2013. Using tablet for visual exploration of second -generation \nsequencing data. Brief. Bioinform. 14, 193 \u2013202. doi:10.1093/bib/bbs012  \nMonteville, M.R., Konkel, M.E., 2002. Fibronectin -facilitated invasion of T84 \neukaryotic cells by Campylobacter jejuni occurs preferentially at the \nbasolateral cell surface. Infect. Immun. 70, 6665 \u20136671. \ndoi:10.1128/IAI.70.12.6665 -6671.2002  \nMoore, J.E., 2005. Campylobacter . Vet. Res. 36:, 351 \u2013382. doi:10.1051/vetres  \nMoore, J.E.,  Barton, M.D., Blair, I.S., Corcoran, D., Dooley, J.S.G., Fanning, S., Kempf, I., \nLastovica, A.J., Lowery, C.J., Matsuda, M., McDowell, D.A., McMahon, A., Millar, \nB.C., Rao, J.R., Rooney, P.J., Seal, B.S., Snelling, W.J., Tolba, O., 2006. The \nepidemiology of antibiotic resistance in  Campylobacter . Microbes Infect. 8, \n1955 \u20131966. doi:10.1016/j.micinf.2005.12.030  \nMoran, L., Scates, P., Madden, R., 2009. Prevalence of Campylobacter spp. in raw \nretail poultry on sale in Northern Ireland. J Food Prot. 72, 1830 \u20135. \nM\u00fcller, J., Schulze, F., M\u00fcller, W., H\u00e4nel, I., 2006. PCR detection of virulence -\nassociated genes in Campylobacter jejuni  strains with differential ability to \ninvade Caco -2 cells and to colonize the chick gut. Vet. Microbiol. 113, 123 \u2013\n129. doi:10.1016/j.v etmic.2005.10.029  \nM\u00fcllner, P., Collins -Emerson, J.M., Midwinter, A.C., Carter, P., Spencer, S.E.F., Van \nDer Logt, P., Hathaway, S., French, N.P., 2 010. Molecular epidemiology of \nCampylobacter jejuni in a geographically isolated country with a uniquely \nstru ctured poultry industry. Appl. Environ. Microbiol. 76, 2145 \u20132154. \ndoi:10.1128/AEM.00862 -09 \nNachamkin, I., Allos, B.M., Ho, T., 1998. Campylobacter  species and Guillain -Barre \nsyndrome. Clin Microbiol Rev 11, 555 \u2013567.  \nNadeau, E., Messier, S., Quessy, S., 2002. Prevalence and comparison of genetic \nprofiles of Campylobacter  strains isolated from poultry and sporadic cases of Referencia  \n146  \n campylobacteriosis in humans. J. Food Prot. 65(1):, 73 \u20138. \nNeal -McKinney, J., 2010. NIH Public Acce ss. Computer (Long. Beach. Calif). 144, \n724 \u2013732. doi:10.1038/jid.2014.371  \nNewell, D.G., Fearnley, C., 2003. Sources of Campylobacter  colonization in broiler \nchickens. Appl. Environ. Microbiol. 69, 4343 \u20134351. \ndoi:10.1128/AEM.69.8.4343  \nNewell, D.G., Wagenaar , J.A., 2000. Poultry infections and their control. \nCampylobacter , 2nded. I. Nachamkin, ed. J.J. Blaser ASM Press, 497 \u2013510.  \nNobile, C.G.A., Costantino, R., Bianco, A., Pileggi, C., Pavia, M., 2013. Prevalence and \npattern of antibiotic resistance of Campylo bacter  spp. in poultry meat in \nSouthern Italy. Food Control 32, 715 \u2013718. \ndoi:10.1016/j.foodcont.2013.02.011  \nNotermans, S., 1994. Epidemiology and surveillance of Campylobacter  infections. \nWorld Heal. Organ. Geneva, Switz. 35 \u201344. In Report on a WHO consulta tion \non epidemio.  \nNylen, G., Dunstan, F., Palmer, S.R., Andersson, Y., Bager, F., Cowden, J., Feierl, G., \nGalloway, Y., Kapperud, G., Megraud, F., Molbak, K., Petersen, L.R., Ruutu, P., \n2002 . The seasonal distribution of Campylobacter infection in nine Eur opean \ncountries and New Zealand. Epidemiol. Infect. 128, 383 \u201390. \ndoi:10.1017/S0950268802006830  \nO, S., O, L., S, H., Q, Z., 2003. Effect of Campylobacter -specific maternal antibodies on \nCampylobacter jejuni colonization in young chickens. Appl. Environ. \nMicrobiol. 69:, 5372 \u20135379.  \nOlive, D.M., Bean, P., 1999. Principles and applications of ligation mediated PCR \nmethods for DNA -based typing of microbial organisms. J. Clin. Microbiol. \n1661 \u20131669. doi:10.18388/abp.2015_1192  \nOn, S.L., 2001. Taxonomy of Campylob acter, Arcobacter, Helicobacter  and related \nbacteria: current status, future prospects and inmediate concers. J. Appl. \nMicrobiol. 90:, 1S \u201315S.  \nOn, S.L., Nielsen, E.M., Engberg, J., Madsen, M., 1998. Validity of SmaI -defined \ngenotypes of Campylobacter jejun i examined by SalI, KpnI, and BamHI \npolymorphisms: evidence of identical clones infecting humans, poultry, and \ncattle. Epidemiol Infect 120, 231 \u2013237. doi:10.1017/S0950268898008668  \nOn, S.L.W., 2013. Isolation, identification and subtyping of Campylobacter : Where \nto from here? J. Microbiol. Methods 95, 3 \u20137. \ndoi:10.1016/j.mimet.2013.06.011  Referencias  \n147  \n Oporto, B., Juste, R.A., Hurtado, A., 2009. Phenotypic and genotypic antimicrobial \nresistance profiles of Campylobacter jejuni  isolated from cattle, sheep, and \nfree -range po ultry faeces. Int. J. Microbiol. 2009. doi:10.1155/2009/456573  \nOyarzabal, O.A., Williams, A., Zhou, P., Samadpour, M., 2013. Improved protocol for \nisolation of Campylobacter  spp. from retail broiler meat and use of pulsed \nfield gel electrophoresis for the typing of isolates. J. Microbiol. Methods 95, \n76\u201383. doi:10.1016/j.mimet.2013.03.008  \nParkhill, J., Wren, B.W., Mungall, K., Ketley, J.M., Churcher, C., 2000. First genome \nsequence paper 665 \u2013668. doi:10.1038/35001088  \nPayot, S., Bolla, J.M., Corcoran, D., Fa nning, S., M\u00e9graud, F., Zhang, Q., 2006. \nMechanisms of fluoroquinolone and macrolide resistance in Campylobacter  \nspp. Microbes Infect. 8, 1967 \u20131971. doi:10.1016/j.micinf.2005.12.032  \nPayot, S., Dridi, S., Laroche, M., Federighi, M., Magras, C., 2004. Prevalence and \nantimicrobial resistance of Campylobacter coli  isolated from fattening pigs in \nFrance. Vet. Microbiol. 101, 91 \u201399. doi:10.1016/j.vetmic.2004.03.014  \nPearson, A.D., Greenwood,  M., Healing, T.D., Rollins, D., Shahamat, M., Donaldson, J., \nColwell, R.R., 1993. Colonization of broiler chickens by waterborne \nCampylobacter jejuni . Appl. Environ. Microbiol. 59, 987 \u2013996.  \nPearson, B.M., Gaskin, D.J.H., Segers, R.P.A.M., Wells, J.M., Nui jten, P.J.M., Van Vliet, \nA.H.M., 2007. The complete genome sequence of Campylobacter jejuni  strain \n81116 (NCTC11828). J. Bacteriol. 189, 8402 \u20138403. doi:10.1128/JB.01404 -07 \nPei, Z., Blaser, M.J., 1993. PEB1, the major cell -binding factor of Campylobacter \njejuni, is a homolog of the binding component in gram -negative nutrient \ntransport systems. J. Biol. Chem. 268, 18717 \u201318725.  \nPendleton, S., Hanning, I., Biswas, D., Ricke, S.C., 2013. Evaluation of whole -genome \nsequencing as a genotyping tool for Campylobacte r jejuni  in comparison with \npulsed -field gel electrophoresis and flaA typing. Poult. Sci. 92, 573 \u201380. \ndoi:10.3382/ps.2012 -02695  \nP\u00e9rez -Boto, D., Garc\u00eda -Pe\u00f1a, F.J., Abad -Moreno, J.C., Echeita, M.A., 2013 . \nAntimicrobial susceptibilities of Campylobacter jejun i and Campylobacter coli  \nstrains isolated from two early stages of poultry production. Microb. Drug \nResist. 19, 323 \u201330. doi:10.1089/mdr.2012.0160  \nP\u00e9rez -Boto, D., Herrera -Le\u00f3n, S., Garc\u00eda -Pe\u00f1a, F.J., Abad -Moreno, J.C., Echeita, M. a, \n2014 . Molecular mechani sms of quinolone, macrolide, and tetracycline \nresistance among Campylobacter  isolates from initial stages of broiler \nproduction. Avian Pathol. 43, 176 \u201382. doi:10.1080/03079457.2014.898245  Referencia  \n148  \n Pfaller, M.A., 1999. Molecular epidemiology in the care of patients.  Arch. Pathol. \nLab. Med. 123, 1007 \u20131010.  \nPickett, C.L., Whitehouse, C.A., 1999. The cytolethal distending toxin family. Trends \nMicrobiol. 7, 292 \u2013297. doi:10.1016/S0966 -842X(99)01537 -1 \nPiddock, L.J. V., 1995. Quinolone resistance and Campylobacter  spp. J Antimicrob \nChemother 36, 891 \u2013898.  \nPiddock, L.J. V, Ricci, V., Pumbwe, L., Everett, M.J., Griggs, D.J., 2003. \nFluoroquinolone resistance in Campylobacter  species from man and animals: \ndetection of mutations in topoisomerase genes. J. Antimicrob. Che mother. 51, \n19\u201326. doi:12493783  \nPoly, F., Guerry, P., 2008. Pathogenesis of Campylobacter . Curr. Opin. \nGastroenterol. 24(1):, 27 \u201331. \nPrice, M.N., Dehal, P.S., Arkin, A.P., 2010. FastTree 2 - Approximately maximum -\nlikelihood trees for large alignments. PLoS  One 5. \ndoi:10.1371/journal.pone.0009490  \nPumbwe, L., Piddock, L.J., 2002. Identification and molecular characterisation of \nCmeB, a Campylobacter jejuni  multidrug efflux pump. FEMS Microbiol Lett \n206, 185 \u2013189.  \nQuinlan, A.R., Hall, I.M., 2010. BEDTools: A fl exible suite of utilities for comparing \ngenomic features. Bioinformatics 26, 841 \u2013842. \ndoi:10.1093/bioinformatics/btq033  \nRibot, E.M., Fitzgerald, C., Kubota, K., Swaminathan, B., Barrett, T.J., 2001. Rapid \nPulsed -Field Gel Electrophoresis protocol for subty ping of Campylobacter \njejuni . J. Clin. Microbiol. 39, 1889 \u20131894. doi:10.1128/JCM.39.5.1889  \nRidley, A.M., Morris, V.K., Cawthraw, S.A., Ellis -Iversen, J., Harris, J.A., Kennedy, \nE.M., Newell, D.G., Allen, V.M., 2011. Longitudinal molecular epidemiological \nstudy of thermophilic campylobacters on one conventional broiler chicken \nfarm. Appl. Environ. Microbiol. 77, 98 \u2013107. doi:10.1128/AEM.01388 -10 \nRidley, A.M., Toszeghy, M.J., Cawthraw, S.A., Wassenaar, T.M., Newell, D.G., 2008. \nGenetic instability is associate d with changes in the colonization potential of \nCampylobacter jejuni in the avian intestine. J. Appl. Microbiol. 105, 95 \u2013104. \ndoi:10.1111/j.1365 -2672.2008.03759.x  \nRivoal, K., Ragimbeau, C., Salvat, G., Colin, P., Ermel, G., 2005. Isolates Recovered \nfrom Free -Range Broiler Farms and Comparison with Isolates of Various \nOrigins \u2020 71, 6216 \u20136227. doi:10.1128/AEM.71.10.6216  \nRosef, O., Kapperud, G., 1983. House flies ( Musca domestica ) as possible vectors of Referencias  \n149  \n Campylobacter fetus  subsp. jejuni . Appl. Environ. Micro biol. 45, 381 \u2013383.  \nRuiz, J., Go\u00f1i, P., Marco, F., Gallardo, F., Mirelis, B., Jimenez De Anta, T., Vila, J., 1998. \nIncreased resistance to quinolones in Campylobacter jejuni : a genetic analysis \nof gyrA gene mutations in quinolone -resistant clinical isolates . Microbiol. \nImmunol. 42, 223 \u2013226.  \nSabat, A.J., Budimir, A., Nashev, D., S\u00e1 -Le\u00e3o, R., van Dijl, J. m, Laurent, F., \nGrundmann, H., Friedrich, A.W., ESCMID Study Group of Epidemiological \nMarkers (ESGEM), 2013. Overview of molecular typing methods for outbrea k \ndetection and epidemiological surveillance. Euro Surveill.  Bull. Eur. sur les \nMal. Transm. = Eur. Commun. Dis. Bull. 18, 20380. doi:20380 [pii]  \nS\u00e1enz, Y., Zarazaga, M., Lantero, M., Jos\u00e9, M., Baquero, F., Torres, C., Jose, M., Sa, Y., \n2000. Antibiotic R esistance in Campylobacter  Strains Isolated from Animals , \nFoods , and  Humans in Spain in 1997 \u2212 1998. Antimicrob. Agents Chemother. \n44, 267 \u2013271. doi:10.1128/AAC.44.2.267 -271.2000.Updated  \nSahin, O., Fitzgerald, C., Stroika, S., Zhao, S., Sippy, R.J., Kwan,  P., Plummer, P.J., Han, \nJ., Yaeger, M.J., Zhang, Q., 2012. Molecular evidence for zoonotic transmission \nof an emergent, highly pathogenic Campylobacter jejuni  clone in the United \nStates. J. Clin. Microbiol. 50, 680 \u2013687. doi:10.1128/JCM.06167 -11 \nSails, A.D ., Swaminathan, B., Fields, P.I., 2003. Clonal complexes of Campylobacter \njejuni identified by multilocus sequence typing correlate with strain \nassociations identified by multilocus enzyme electrophoresis. J. Clin. \nMicrobiol. 41, 4058 \u20134067. doi:10.1128/JCM .41.9.4058 -4067.2003  \nSamuel, M.C., Vugia, D.J., Shallow, S., Marcus, R., Segler, S., McGivern, T., \nKassenborg, H., Reilly, K., Kennedy, M., Angulo, F., Tauxe, R. V, 2004. \nEpidemiology of sporadic Campylobacter  infection in the United States and \ndeclining trend in incidence, FoodNet 1996 -1999. Clin. Infect. Dis. 38 Suppl 3, \nS165 \u2013S174. doi:10.1086/381583  \nSchl\u00fcnzen, F., Zarivach, R., Harms, J., Bashan,  a, Tocilj,  a, Albrecht, R., Yonath,  a, \nFranceschi, F., 2001 . Structural basis for the interaction of antibiotics with the \npeptidyl transferase centre in eubacteria. Nature 413, 814 \u2013821. \ndoi:10.1038/35101544  \nSchorr, D., Schmid, H., Rieder, H.., Baumgartner, A., Vorkauf, H., Burnens, A., 1994. \nRisk factors for Campy lobacter  enteritis in Switzerland. 196(4):, 327 \u201337. \nSchulze, F., H\u00e4nel, I., Borrmann, E., 1998. Formation of cytotoxins by enteric \nCampylobacter  in humans and animals. ELSEVIER 288, 225 \u2013236.  \nSchwartz, D.C., Charles R, C., 1984. Separation of yeast chromoso me-sized DNAs by \npulsed field gradient gel electrophoresis. 37, 67 \u201375. Referencia  \n150  \n Schwarz, S., Kehrenberg, C., Doublet, B., Cloeckaert, A., 2004. Molecular basis of \nbacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. \n28, 519 \u2013542. doi:10.1016 /j.femsre.2004.04.001  \nSchwarz, S., Silley, P., Simjee, S., Woodford, N., van duijkeren, E., Johnson, A.P., \nGaastra, W., 2010. Editorial: Assessing the antimicrobial susceptibility of \nbacteria obtained from animals. J. Antimicrob. Chemother. 65, 601 \u2013604. \ndoi:10.1093/jac/dkq037  \nShane, S., Montrose, M., Harrington, K., 1985. Transmission of Campylobacter jejuni \nby the housefly (Musca domestica). Avian Dis. 29 (2):, 384 \u201391. \nShanker, S., Lee, A., Sorrell, T.C., 1990. Horizontal transmission of Campylobacter \njejuni amongst broiler chicks: experimental studies. Epidemiol. Infect. 104, \n101 \u201310. doi:10.1017/S0950268800054571  \nSheppard, S.K., Didelot, X., Meric, G., Torralbo, A., Jolley, K. a, Kelly, D.J., Bentley, \nS.D., Maiden, M.C.J., Parkhill, J., Falush, D., 2013. G enome -wide association \nstudy identi fi es vitamin B 5 biosynthesis as a host speci fi city factor in \nCampylobacter . Proc. Natl. Acad. Sci. U. S. A. 110, 1 \u20135. \ndoi:10.5061/dryad.28n35.  \nSheppard, S.K., McCarthy, N.D., Jolley, K.A., Maiden, M.C.J., 2011. Intro gression in \nthe genus Campylobacter : Generation and spread of mosaic alleles. \nMicrobiology 157, 1066 \u20131074. doi:10.1099/mic.0.045153 -0 \nSilva, J., Leite, D., Fernandes, M., Mena, C., Gibbs, P.A., Teixeira, P., 2011. \nCampylobacter spp. As a foodborne pathogen : A review. Front. Microbiol. 2, \n1\u201312. doi:10.3389/fmicb.2011.00200  \nSkarp, C.P.A., H\u00e4nninen, M.L., Rautelin, H.I.K., 2016. Campylobacteriosis: The role \nof poultry meat. Clin. Microbiol. Infect. 22, 103 \u2013109. \ndoi:10.1016/j.cmi.2015.11.019  \nSkirrow, M., Butzle r, J., 2000. In Campylobacter . Nachamkin, I., Blaser, M.J., (Eds.). \nAm. Soc. Microbiol. Press. Washington, DC. 89 \u2013120.  \nSkirrow, M.B., 1977. Campylobacter  enteritis: a \u201cnew\u201d disease. Br. Med. J. 2, 9 \u201311. \ndoi:10.1136/bmj.2.6078.9  \nSkirrow, M.B., Blaser, M.J.,  1992. Clinical and epidemiologic considerations. In \nCampylobacter jejuni : current status and future trends. Nachamkin, I., Blaser, \nM.J., Tompkins, L.S., (Eds.). Washington, DC. 3 \u20138. \nSmith, T., Taylor, M.S. 1919., 1919. Morphological characters 1993.  \nSpros ton, E.L., Ogden, I.D., MacRae, M., Dallas, J.F., Sheppard, S.K., Cody, A.J., Colles, \nF.M., Wilson, M.J., Forbes, K.J., Strachan, N.J.C., 2011. Temporal variation and Referencias  \n151  \n host association in the Campylobacter  population in a longitudinal ruminant \nfarm study. A ppl. Environ. Microbiol. 77, 6579 \u20136586. \ndoi:10.1128/AEM.00428 -11 \nSwaminathan, B., Barrett, T.J., Hunter, S.B., Tauxe, R. V., 2001. PulseNet: the \nmolecular subtyping network for foodborne bacterial disease surveillance, \nUnited States. Emerg. Infect. Dis. 7,  382 \u2013389. doi:10.3201/eid0703.017303  \nTaboada, E.N., Clark, C.G., Sproston, E.L., Carrillo, C.D., 2013. Current methods for \nmolecular typing of Campylobacter species. J. Microbiol. Methods 95, 24 \u201331. \ndoi:10.1016/j.mimet.2013.07.007  \nTalukder, K.A., Aslam, M., Islam, Z., Azmi, I.J., Dutta, D.K., Hossain, S., Nur -E-Kamal, \nA., Nair, G.B., Cravioto, A., Sack, D.A., Endtz, H.P., 2008. Prevalence of virulence \ngenes and cytolethal distending toxin production in Campylobacter jejuni  \nisolates from diarrheal patients in Bangladesh. J. Clin. Microbiol. 46, 1485 \u2013\n1488. doi:10.1128/JCM.01912 -07 \nTaroco R, S.V., Vignoli, R., 2008. Temas de bacteriologia y virologia medica. \nM\u00e9todos de estudios de la sensibilidad antibi\u00f3tica.  \nTauxe, R.V., 1992 . Epidemiology of Campylobacter jejuni  infections in the United \nStates and other industrialized nations. In Campylobacter jejuni : Current \nStatus and Future Trends ed. Washingt. Am. Soc. Microbiol. 9 \u201319. \nTaylor, D.E., Garner, R.S., Allan, B.J., 1983. Charac terization of tetracycline \nresistance plasmids from Campylobacter jejuni  and Campylobacter coli . \nAntimicrob. Agents Chemother. 24, 930 \u2013935. doi:10.1128/AAC.24.6.930  \nTenover, F.C., Arbeit, R.D., Goering, R. V., Mickelsen, P.A., Murray, B.E., Persing, D.H., \nSwaminathan, B., 1995. Interpreting chromosomal DNA restriction patterns \nproduced by pulsed - field gel electrophoresis: Criteria for bacterial strain \ntyping. J. Clin. Microbiol. 33, 2233 \u20132239. doi:0095 -1137/  \nTernhag, A., Asikainen, T., Giesecke, J., Ekdahl , K., 2007. A meta -analysis on the \neffects of antibiotic treatment on duration of symptoms caused by infection \nwith Campylobacter  species. Clin. Infect. Dis. 44, 696 \u2013700. \ndoi:10.1086/509924  \nThakur, S., 2010. Genotypic Profile Comparison of Campylobacter je juni and \nCampylobacter coli  Isolated from Humans and Retail Meats 7. \ndoi:10.1089/fpd.2009.0487  \nThakur, S., Gebreyes, W. a, 2005. Prevalence and antimicrobial resistance of \nCampylobacter  in antimicrobial -free and conventional pig production \nsystems. J. Food  Prot. 68, 2402 \u201310. doi:10.1128/JCM.43.11.5705  Referencia  \n152  \n Thakur, S., Morrow, W.E.M., Funk, J.A., Bahnson, P.B., Gebreyes, W.A., 2006. \nMolecular epidemiologic investigation of Campylobacter coli  in swine \nproduction systems, using multilocus sequence typing. Appl. Env iron. \nMicrobiol. 72, 5666 \u20135669. doi:10.1128/AEM.00658 -06 \nUrdaneta, S., 2016. Epidemiolog\u00eda de Campylobacter  spp. en granas de pollos de \nengorde: prevalencia, factores de riesgo y din\u00e1mica de infecci\u00f3n. Universitat \nAut\u00f2noma de Barcelona.  \nvan de Giessen,  a W., Bloemberg, B.P., Ritmeester, W.S., Tilburg, J.J., 1996. \nEpidemiological study on risk factors and risk reducing measures for \nCampylobacter  infections in Dutch broiler flocks. Epidemiol. Infect. 117, 245 \u2013\n250. doi:10.1017/S0950268800001412  \nVan Deun, K., Haesebrouck, F., Heyndrickx, M., Favoreel, H., Dewulf, J., Ceelen, L., \nDumez, L., Messens, W., Leleu, S., Van Immerseel, F., Ducatelle, R., Pasmans, F., \n2007. Virulence properties of Campylobacter jejuni  isolates of poultry and \nhuman origin. J. Med. Microb iol. 56, 1284 \u20131289. doi:10.1099/jmm.0.47342 -0 \nvan Vliet, A.., Ketley, J.M., 2001. Pathogenesis of enteric Campylobacter  infection. \nSymp. Ser. Soc. Appl. Microbiol. 30, 45S \u201356S.  \nvan Vliet, A.H., Ketley, J.M., 1991. Pathogenesis of enteric Campylobacter  infection. \nSymp. Ser. Soc. Appl. Microbiol. 41:, 88 \u2013103.  \nVandamme, P., 2000. Microbiology of Campylobacter  infections: taxonomy of the \nfamily C ampylobacteracea. Nachamkin, I., Blaser, M.J. (Eds.), Campylobacter. \nASM Press. Washingt. DC 3 \u201326. \nVandamme, P.,  De ley, J., 1991. Proposal for a new family, Campylobacteraceae. Int. \nJ. od Syst. Bacteriol. 41:, 451 \u2013455.  \nVelayudhan, J., Jones, M. a, Barrow, P. a, Kelly, D.J., 2004. L -Serine Catabolism via \nan Oxygen -Labile L -Serine Dehydratase Is Essential for Colon ization of the \nAvian Gut by Campylobacter jejuni  L -Serine Catabolism via an Oxygen -Labile \nL -Serine Dehydratase Is Essential for Colonization of the Avian Gut by \nCampyl. Infect. Immun. 72, 260 \u2013268. doi:10.1128/IAI.72.1.260  \nVel\u00e1zquez, J., Jim\u00e9nez, A., Chom \u00f3n, B., Villa, T., 1995. Incidence and transmission of \nantibiotic resistance in Campylobacter jejuni  and Campylobacter coli . J \nAntimicrob Chemother 35, 173 \u20138. \nVeron, M.S.M., 1963. Base DNA content and classification of Vibrios. Ann. I`Institut \nPasteur 105: , 897 \u2013910.  \nWalker, R.I., Schmauder -Chock, E.A. Parker, J.L., Burr, D., 2011. Selective \nassociation and transport of Campylobacter jejuni through M cells of rabbit Referencias  \n153  \n Peyer\u2019s patches. Can. J. Microbiol. 34:, 1142 \u20131147.  \nWassenaar, T.M., 2000. MINIREVIEW Genotyp ing of Campylobacter  spp . Appl. \nEnviron. Microbiol 66, 1 \u20139. doi:10.1128/aem.66.1.1 -9.2000  \nWassenaar, T.M., Fry, B.N., Lastovica, A.J., Wagenaar, J.A., Coloe, P.J., Duim, B., 2000. \nGenetic characterization of Campylobacter jejuni  O:41 isolates in relation with \nGuillain -Barre syndrome. J. Clin. Microbiol. 38, 874 \u2013876.  \nWassenaar, T.M., Geilhausen, B., Newell, D.G., 1998. Evidence of genomic instability \nin Campylobacter jejuni  isolated from poultry. Appl. Environ. Microbiol. 64, \n1816 \u20131821.  \nWHO, 2011. Colistin inhibits E. coli O157:H7 Shiga -like toxin release, binds \nendotoxins and protects Vero cells. New Microbiol. 39, 119 \u2013123. \ndoi:10.1371/journal.pmed.1001923  \nWHO, 1996. Guidelines for Drinking -Water Quality - Second Edition - Volume 2 - \nHealth Criteria and Oth er Supporting Information. Who 1996 2, 15.  \nWieczorek, K., Kania, I., Osek, J., 2013. Prevalence and antimicrobial resistance of \nCampylobacter  spp. isolated from poultry carcasses in Poland. J. Food Prot. \n76, 1451 \u20135. doi:10.4315/0362 -028X.JFP -13-035  \nWillis,  W., Murray, C., 1997. Campylobacter jejuni  seasonal recovery observations \nof retail market broilers. Poult. Sci. 76(2):, 314 \u20137. \nWillison, H.J., 2005. The immunobiology of Guillain -Barr\u00e9 syndromes. J. Peripher. \nNerv. Syst. 10, 94 \u2013112. doi:10.1111/j.1085 -9489.2005.0010202.x  \nWimalarathna, H.M.L., Richardson, J.F., Lawson, A.J., Elson, R., Meldrum, R., Little, \nC.L., Maiden, M.C.J., McCarthy, N.D., Sheppard, S.K., 2013. Widespread \nacquisition of antimicrobial resistance among Campylobacter  isolates from \nUK retail poultry and evidence for clonal expansion of resistant lineages. BMC \nMicrobiol. 13, 160. doi:10.1186/1471 -2180 -13-160 \nWiner, S., Evans, J.G., 1993. Guillain -Barr\u00e9 syndrome in Oxfordshire: clinical \nfeatures in relation to age. 22(3) :, 164 \u201370. \nWright, G.D., 2007. The antibiotic resistome: the nexus of chemical and genetic \ndiversity. Nat. Rev. Microbiol. 5, 175 \u2013186.  \nYao, R., Burr, D.H., Guerry, P., 1997. CheY -mediated modulation of Campylobacter \njejuni  virulence. Mol. Microbiol. 23, 10 21\u20131031. doi:DOI 10.1046/j.1365 -\n2958.1997.2861650.x  \nYates, J., 2005. Traveler\u2019s diarrhea. Am. Fam. Physician 71.  Referencia  \n154  \n Ying, W., Diane E, T., 1990. Chloramphenicol resistance in Campylobacter coli : \nnucleotide sequence, expression, and cloning vector construction . 94, 23 \u201328. \nYoung, K.T., Davis, L.M., Dirita, V.J., 2007. Campylobacter jejuni : molecular biology \nand pathogenesis. Nat. Rev. Microbiol. 5, 665 \u2013679. doi:10.1038/nrmicro1718  \nZanetti, F., Varoli, O., Stampi, S., De Luca, G., 2009. Prevalence of thermophilic  \nCampylobacter  and Arcobacter butzleri  in food of animal origin. Int. J. Food \nMicrobiol. 33:, 315 \u2013321.  \nZankari, E., Hasman, H., Cosentino, S., Vestergaard, M., Rasmussen, S., Lund, O., \nAarestrup, F.M., Larsen, M.V., 2012. Identification of acquired antimic robial \nresistance genes. J. Antimicrob. Chemother. 67, 2640 \u20132644. \ndoi:10.1093/jac/dks261  \nZhao, C., Ge, B., Villena, J. De, Sudler, R., Yeh, E., Zhao, S., White, D.G., Wagner, D., \n2001. Escherichia coli  and Salmonella  Serovars in Retail Chicken , Turkey , \nPork , and Beef from the Greater Washi ngton , DC. Area. Appl Microbiol 67, \n5431 \u20135436. doi:10.1128/AEM.67.12.5431  \nZhao, S., Young, S.R., Tong, E., Abbott, J.W., Womack, N., Friedman, S.L., McDermott, \nP.F., 2010. Antimicrobial resistance of Campylobacter  isolates from retail \nmeat in the United States between 2002 and 2007. Appl. Environ. Microbiol. \n76, 7949 \u201356. doi:10.1128/AEM.01297 -10 \n \n ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}